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Abstract
RN/AIDS has had a particularly devastating effect on sub-Saharan nations, including South
Africa. Thus, a national rollout of antiretroviral drugs - capable of mitigating the effects of the
epidemic - has been vigorously demanded by the South African public. Eventually bowing to
public pressure, the Government began to implement the rollout of the drugs at public health
facilities in early 2004. The University of KwaZulu-Natal announced in 2004 that it too would
provide access to antiretroviral drugs for all students who require them. Thus, there is an urgent
need for the institution to develop promotional campaigns that not only promote the service but
that also deal with the fall-out from the problematic national rollout, and that address the
complicated nature of antiretroviral therapy.
The focus of this dissertation is on a promotional needs analysis for the antiretroviral rollout at
the University. Specifically, the primary research aimed to determine the knowledge, attitudes
and beliefs of the general student population on the topic of antiretrovirals, and by doing so,
identify the needs of this audience that will have to be addressed by future promotional
campaigns. The theoretical framework used to inform the research design and questions is that of
social marketing; a relatively new approach to social change that uses principles of commercial
marketing to achieve results among target audiences.
The results of the research suggest that future promotional messages and campaigns directed at
the general student population will need to focus on the following issues: clarifying the
distinctions between different contexts of ARV use; increasing the awareness of the rollout at
UKZN as a prerequisite to stimulating demand; addressing negative beliefs and misconceptions
regarding ARVs; emphasising complementary practices to be used by individuals with
RN/AIDS; addressing issues of stigma and discrimination and encouraging students to act as
sources of support and information for other students. In the case of certain messages,
segmentation - on the basis of race and campus - may result in a more effective dissemination of
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This introductory chapter will provide a brief background to the topic under investigation and
will explain the motivation for the research. The research problem and questions will be stated,
and finally, a brief outline of each chapter will lead the reader into the literature review.
Backefound
South Africa has one of the most severe RN/AIDS epidemics in the world, with current
estimates indicating that between 4.7 and 6.6. million citizens are living with the disease
(Soul City and Khomanani, 2004: 11). Recent figures estimate that approximately 400 000
individuals with AIDS require immediate treatment with powerful antiretroviral drugs (Soul
City and Khomanani, 2004: 11) - the only effective means to treat the final stages of the
disease.
After extensive lobbying by international organisations and local activist groups like the
Treatment Action Campaign (TAC) - and much stalling by national authorities - the South
African Government fmally declared its intention to develop a detailed plan for the provision
of antiretroviral drugs (ARVs) to individuals with RN/AIDS on 8 August 2003. In April
2004, the University of KwaZulu-Natal (UKZN)1 announced that it too would provide
subsidised ARVs to all HIV positive students who require them.
At both a national and an institutional level there is a pressing need for appropriate
communication about ARVs in order to influence the knowledge, attitudes and behaviour of
RIV-infected individuals, individuals with AIDS and the general public. The empirical
component of this dissertation examines this issue in the context of the ARV rollout by
UKZN. A needs analysis - primarily utilising questionnaires - was conducted among the
general student population, at the Roward College and Westville campuses. An investigation
into students' current knowledge, attitudes and beliefs about ARVs, and their inferred
I The University of KwaZulu-Natal was formed on I January 2004, after the merger between the former University
of Natal and the former University of Durban-Westville. The University now consists of five campuses: Howard
College, Westville, Edgewood, Medical School and Pieterrnaritzburg.
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promotion-related needs, was deemed an essential precursor to the development of effective,
audience-driven communication materials around the subject.
The theoretical framework that has informed the present project is that of social marketing.
Social marketing can be defined as:
the application of commercial marketing techniques to the analysis, planning,
execution, and evaluation of programmes designed to influence the voluntary
behaviour of target audiences in order to improve their personal welfare and that of
their society (Andreasen, 1995 :7).
Social marketing draws on such diverse disciplines as commercial sector marketing, health
psychology, communication, and anthropology. Perhaps its most common application is to
problems of public health. Social marketing's central tenet of a customer orientation ensures
that practitioners' first aim is to understand a target audience's knowledge, beliefs, attitudes
and behaviour around a particular topic before designing a marketing mix that most appeals
to their needs. Thus, a needs analysis is an important part ofthis formative research process.
Motivation for research
My own academic background is in the fields of marketing and psychology. During my
Honours year, I came across the social marketing literature while conducting research for my
dissertation. Subsequently, I became interested in the application of marketing to social
problems. My Masters courses have allowed me to explore related fields, such as the history of
epidemics and entertainment-education for health promotion. Thus, this dissertation represents
a culmination of the academic knowledge I have gained throughout my six years of tertiary
education, and allows me the opportunity to critically apply the social marketing paradigm to a
particular area of research.
Besides my personal interest in the topic under investigation, the research is also motivated
by a need to address a relatively under-researched area of study. To date, most health
2
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communication2 research in the field of HN/AIDS has been focused on the need for the
promotion of sexual behaviour change in order to prevent infection with the disease. There is
a paucity of research concerning communications about the practical implications of ARV
treatment to the user and hislher support community. However, research into such issues is
essential to ensure that campaign developers have a better understanding of the target
audiences they need to address as well as the specific messages that should be designed for
particular audiences. This is particularly important in the context of the rollout at UKZN,
where it was estimated that approximately 16% of students were HIV positive in 2004
(Mitchell, 2004b:2). A relatively large proportion of the general student population, therefore,
may either require ARV therapy themselves, or know someone who does. Promotional
messages that are designed for the needs of target audiences within UKZN are capable of
influencing their knowledge, attitudes and beliefs to ensure that all those infected and affected
by HN/AIDS have sufficient understanding of the issues surrounding ARVs and thus can
make informed choices accordingly.
Statement of the problem and research questions
The communication needs of different target audiences concerning ARVs are likely to be
complex, diverse and challenging. Despite the hope that ARVs offer to those who would die
without them, treatment with the drugs is complex and gruelling. The drug regimen must be
strictly adhered to for the rest of the patient's life, notwithstanding often debilitating side
effects (see Evian, 2003; Loveday, 2003). The complicated nature of antiretroviral therapy
necessitates a great deal of social support for the individual on the drugs - a potentially
problematic issue in South Africa where stigma and discrimination directed towards those
with HN/AIDS is still prevalent (Soul City, 2003:10). Members of the general public may
also play an important role in passing on ARV-related information to those who most need it
(Joint Health and Treasury Task Team, 2003:65). In addition, the media publicity
surrounding the politicisation of the issue in South Africa, as well as a host of dissident
opinions, myths and rumours, has contributed to a general sense of confusion regarding the
drugs (see Willan, 2004). In the context of an individual institution like UKZN, therefore,
2 Unles~ otherwise stat~d, ~e terms "health promotion" or "health communication" have been used generically; as
promotion or commumcation methods designed to promote health.
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ARV provision as a service for students needs to be marketed in ways that address these
broad problems and issues. A needs analysis, then, is an essential pre-requisite for the
development of effective promotional messages and campaigns on the topic of antiretrovirals,
directed at the general student population.
The primary research will thus attempt to answer three major research questions:
1) What are the sources and content of the knowledge, attitudes and beliefs of the
general student population concerning antiretrovirals?
2) Are there significant differences in the knowledge, attitudes and beliefs of sub-groups
within the general student population that may justify audience segmentation when
delivering messages?
3) What are the promotion-related needs of the general student population concerning
the topic of antiretrovirals?
Chapter outline
Chapter 1: has provided a background to the study, and has described the motivation for the
research as well as the research problem and questions.
Chapter 2: discusses RN/AIDS in the South African context, elaborating on the sociological
drivers of the disease and the impact it has had on South Africans and, more specifically,
students at the University ofKwaZulu-Natal.
Chapter 3: focuses on the issue of antiretroviral drugs for the treatment of RN/AIDS. The
politicisation of the issue in the South African context is explained, and the rollout of the drugs
nationally and at UKZN analysed. Finally, the complexity of communications on the topic is
elucidated, and the national and institutional approaches to ARV-related communications
discussed.
Chapter 4: deals with the conceptual framework - social marketing. The most important tools
and techniques of the approach are discussed, and social marketing is contextualised within
other related fields.
Chapter 5: focuses on the methodology of the empirical component of the dissertation.
Importantly the research designs for the expert interview and questionnaires are elaborated on.
4
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Chapter 6: describes the findings of the questionnaire component of the primary research.
Descriptive statistics, graphs and, where appropriate, significance tests, are used to explore the
results.
Chapter 7: critically explores the findings of the primary research, discussing them in relation
to relevant literature. In addition, the limitations of the research and suggestions for further
research are outlined.
Chapter 8: concludes the dissertation.
Conclusion
This chapter has provided an introduction to the bulk of this dissertation. It has outlined the
background to the research and has provided motivation for the study. The theoretical
framework used to inform the present project - that of social marketing - has been introduced.
The research problem and questions have been stated, and finally, a chapter outline has been
given. The next chapter constitutes an analysis of the problem ofHIV/AIDS in South Africa.
5
Callen MorrisonlMasters Dissertation
Chapter 2: mV/AIDS in the South African context
"This, the last great pandemic ofthe twentieth century, and our responses to it are redefining the very fabric of
society throughout the world during this new millennium. "
(Pratt, 2003:4)
Like the Black Death and syphilis in previous centuries, HN/AIDS has become a harbinger of
doom in modem society, trailing death and destruction in its wake. The intimate nature in which
HN is transmitted has contributed to the extreme levels of stigma and discrimination
surrounding those infected by the virus. In developing countries especially, the disease has had
profound effects, adding to already high levels of poverty, unemployment and mortality. This
fIrst chapter of the literature review will outline the biological and sociological aspects of
HN/AIDS and analyse the impact it has had in the South African context. Finally, the prevalence
and consequences of the disease amongst students at the University of KwaZulu-Natal will be
discussed.
DIV/AIDS
Before moving on to the literature concerning the determinants and impact of the HN/AIDS
epidemic and later the issue of antiretrovirals, it is important to have a basic understanding of the
biological aspects of the disease. The human immuno-defIciency virus (HN) is a retrovirus
which gradually destroys the CD4 cells of the immune system, resulting in the opportunistic
infections which are characteristic of acquired immuno-defIciency syndrome (AIDS)
(Loewenson and Whiteside, 1998:13). HN is transmitted through contact with the bodily fluids
of an infected individual. There are three primary modes of transmission: sexual intercourse,
vertical transmission (from mother to infant, either prior to, or during birth, or through breast
milk), or directly into the bloodstream through the use of contaminated blood or blood products
or the sharing ofneedles by drug users (Loewenson and Whiteside, 1998:14-15).
The World Health Organisation (WHO) has classifIed HN infection into four stages. While
individuals in the fIrst two stages of the disease may exhibit only minor symptoms such as
swollen lymph glands and chest colds, patients in the fInal two stages suffer from debilitating
conditions such as drastic weight loss, chronic diarrhoea, tuberculosis (TB) and life-threatening
opportunistic diseases such as pneumonia, meningitis and cancers which ultimately result in
6
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death (WHO, 2002:98-99; Soul City and Khomanani, 2004:6). The final stage of AIDS-related
illness may, if treatment is not administered, last for up to two years before death occurs
(Loewenson and Whiteside, 1998:14). In sub-Saharan Africa, the average time from infection
with RN to the development of AIDS is five to ten years (Loewenson and Whiteside, 1998:14).
In order to prevent infection with RN/AIDS, the general public are typically advised to practise
safe sex (this includes abstinence, faithfulness and the use of barrier methods of prevention); be
aware of their RN status; never share needles; take precautions when handling blood and blood
products and not share toothbrushes and razor blades with someone who is RN positive (Soul
City and Khomanani, 2004:7-9).
Determinants of the South African epidemic
Despite massive information, education and communication efforts from a range of sources,
South Africa continues to have one of the most severe RN epidemics in the world. Current
estimates suggest that there are 40 million people living with RN globally, of which between
4.7 and 6.6 million are South Africans (approximately 14-16% of the national population) (Soul
City and Khomanani, 2004:11; see also Department of Realth, 2003; RSRC, 2002). The Nelson
Mandela/HSRC Study of RN/AIDS (2002:46) found an estimated 11.4% of the population to be
infected with the virus, that is: 12.9% of Black Africans, 6.2% of Whites, 6.1% of Coloureds and
1.6% of Indians. In the most highly affected age group of 20 to 30 year olds, it is estimated that
one in five individuals are living with RN3 (Soul City and Khomanani, 2004: 11). In 2004, about
400 000 South Africans had full-blown AIDS and required immediate antiretroviral treatment4,
with this figure potentially increasing to over one million by 2007/8 (Soul City and Khomanani,
2004:11).
The question that must be asked, then, is why RN/AIDS is so prevalent among certain
populations - in South Africa the poor, female, Black population is most affected - and not
others. While individual behaviour has been blamed repeatedly for variations in RN prevalence
3 Loewenson and Whiteside (1998: 16) note that statistics on AIDS cases and HIV prevalence need to be treated with
ca~tion as AIDS cases are not notifiable (legally reportable to the authorities). The World Health Organisation
estImates that only one-fourth of AIDS cases in developing countries are actually reported (1995 in Loewenson and
Whiteside, 1998:16).
4 UNAIDSfWHO (2003:9) estimate that this figure could be as high as 750 000.
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amongst different groups, this is an inadequate and potentially racist explanation that does not
address the root causes of the disease (see Katz, 2002). The next section of this chapter will
argue that the RN/AIDS epidemic is not simply a biological phenomenon. Rather, it is driven
and exacerbated by a range of factors in the South African context including gender, violence
against women, poverty, and stigma and discrimination.
Gender plays an important role in fuelling the RN/AIDS epidemic in South Africa. A potent
combination of physiological, socioeconomic, cultural and historical factors makes women more
vulnerable to infection than men and contributes to the spread of the disease. As a result of
physiological factors, such as the larger surface area of the vagina as compared to the penis and
the penetrative nature of sexual intercourse, women have a higher risk of contracting RN than
men (Parker et aI, 1998:16). The socioeconomic status of women in this country also places them
at an increased risk of RN infection (Soul City and Khomanani, 2004: 15-16). The generally
low status of women in South African society and within relationships, economic dependency,
and the threat of rejection or violence make it difficult for women to protect themselves from
infection against the wishes of their partners (loveLife, 2000:6). The fear of violence and
abandonment may also mean that women are less likely to disclose their RN status to their
partners or to seek help and treatment for RN/AIDS (Soul City and Khomanani, 2004:16).
The high incidence of rape in South Africa plays a part in the spread of RN and other sexually
transmitted diseases (STDs) (Parker et aI, 1998:2-3). Poverty forces many women into
prostitution, with its increased risk of disease, in order to earn money to support themselves and
their children (Soul City and Khomanani, 2004:15). Transactional sex is another factor that must
be considered. Researchers have noted the transactional nature of sexual relationships in Black
South African society; in exchange for sex, girls expect their (often older) boyfriends to provide
them with gifts, and even spending money and school-fees (Varga, 2000:53). These men are
more likely to have had numerous sexual partners which increases their own risk of contracting
RN and passing it onto their younger partners.
Cultural and social norms that accept and even encourage a high number of sexual partners,
especially amongst men, and that resist the use of condoms impede safer sexual practices that
8
Callen MorrisonlMasters Dissertation
could control the epidemic (loveLife, 2000:6). Historical evidence suggests that before the
influences of colonisation and the spread of Christianity and, later, the migrant labour system and
rapid urbanisation, Black South African societies had high degrees of sexual education and
regulation (see Delius and Glaser, 2002; Jochelson, 2001). The breakdown in community rituals
and traditions related to adolescence and sex as a result of these factors has caused high risk
sexual behaviour to become more common5, and with the advent of HIV/AIDS, considerably
more dangerous (Yun et aI, 2001 :5).

















Gender-related factors aside, the complex, bi-directional relationship between HN/AIDS and
poverty is an important determinant of the disease in South Africa (Soul City and Khomanani,
2004:17-18; see Figure 2.1, above). According to Parker et al (1998:2), the disease affects poorer
communities sooner and more vigorously than other communities. A number of social factors
synonymous with poverty may contribute to HN infection including lack of access to health and
social services, rapid urbanisation, unemployment, poor education, illiteracy, gender inequalities,
5 See Mon::is~n (~OO~) for a summary of the historical circumstances leading to the collapse of systems of traditional
sexual soclahsatIon III Black South African societies.
9
Callen MorrisonlMasters Dissertation
diversities in language and culture, crime, political instability and war (Parker et aI, 1998:2).
Psychologically, a sense of fatalism caused by limited life choices amongst poor individuals may
lead to high risk sexual behaviour (Yun et aI, 2001 :5). Poverty, therefore, contributes to the
spread of RIV as sexual behaviour is at least partly determined by people's economic and social
circumstances. An example serves to illustrate this point: migrant labour is a common
employment choice amongst poor, rural people due, in part, to high levels of poverty and the
legacy of apartheid (loveLife, 2000:6; see also RSRC, 2002). Separated from their families and
support structures, it is more likely that these workers will have unprotected sex with new
partners or prostitutes as well as their partners at home, thus increasing the risk of RIV infection
for all involved. Finally, Katz (2002) has presented a compelling case for the biological
vulnerability of severely malnourished individuals to the RI virus and has suggested that this
most basic factor has been largely ignored as a determinant of the high levels ofRIV infection in
poor populations.
The denial, stigma and discrimination associated with RIV/AIDS in South Africa and other
African countries serves to hamper behaviour change efforts and contributes to the spread of the
disease (UNAIDS, 2003: 1). Silence and secrecy about the disease are particularly strong in
African countries for two main reasons: RIV/AIDS is seen as a disease with mysterious
symptoms that could be related to the occult and in addition, it is primarily sexually transmitted
and thus an unacceptable subject in societies that rarely talk about sex in the public sphere or
across generational and gender boundaries (Caldwell, 2000:154). Researchers such as Leclerc-
Madlala (1999), Posel (2003) and Preston-Whyte (2003) have discussed the extreme levels of
secrecy and silence around sex - especially pre-marital sex - in Black South African cultures
particularll. The denial that results from this silence is so deep rooted that people who attend
funerals of AIDS victims in Africa are often unaware that s/he died of AIDS (Caldwell,
2000: 154). This attitude extends to the highest echelons of society and, as will be discussed in
Chapter 3, is evident in the reactions of South African politicians to the disease. As a result of the
denial and fear that surrounds the disease, stigma and discrimination against people with
RIV/AIDS are prevalent in South Africa. Consequently, individuals are less likely to be tested
6 See Morrison (2004) for a comprehensive review of the historical and societal issues underlying this silence around
sex and sexuality in Black South African cultures.
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for RIV or be open about their status, which drives the disease underground and makes it
difficult to control the epidemic. People may be prevented from seeking the care and treatment
they need, fearing that their status will be disclosed. Thus, people living with RN may be placed
under extreme stress, with little familial or societal support, and this can accelerate the onset of
AIDS (Soul City and Khomanani, 2004:13-14).
The impact of HIV/AIDS in South Africa
As discussed above, a range of complex and inter-related factors has contributed to the severe
nature of the RN/AIDS epidemic in South Africa, particularly amongst poor, Black South
Africans. Nevertheless, other sectors of society are also vulnerable to both infection with the
disease and to the widespread effects of such a high incidence of RN/AIDS in the country. The
RN/AIDS epidemic is likely to affect the nation as a whole - demographically,
developmentally, economically and socially - over an extended period of time.
Demographically, the effects of the RN/AIDS epidemic in South Africa will become
increasingly apparent in the next decade. The World Bank projects that, by 2020, life expectancy
in sub-Saharan Africa will have dropped from an average of 62 to an average of 43 due to the
impact of AIDS (Loewenson and Whiteside, 1998:22). More people, many in their reproductive
years, will die of the disease and thus, fertility rates may be reduced (Loewenson and Whiteside,
1998:20). Although the epidemic will not stop population growth, it will curb the rate of
population growth and significantly affect the structure of the population. In KwaZulu-Natal, the
population of the province is projected to rise from 9 084 000 in 1996 to 10376000 by 2016,
instead of 14391 000 in the absence of AIDS: a difference of27.9% (Loewenson and Whiteside,
1998:23). The size of the 20 to 40 year old age group as a proportion of the entire population will
decrease (Loewenson and Whiteside, 1998:20). As this group consists of the most productive
members of society, increased dependency ratios will result. The number of orphaned children
will increase and, with it, the burden on extended families to care for these children. As of June
2002, more than 13 million children around the world - over 90% of them living in sub-Saharan
Africa - had lost one or both parents to AIDS (Pratt, 2003:6). At the end of 2003,
UNAIDS/WHO (2004:2) estimated the total number of AIDS orphans in South Africa to be
about 1.1 million children.
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The epidemic is likely to have significant developmental consequences. Recent estimates have
suggested that HN/AIDS could reduce GDP growth rates in this country by an average of
between 0.3% and 0.4% per annum over the next 15 years (loveLife, 2000:15). Loewenson and
Whiteside (1998:23) note that if the definition of development is extended beyond relatively
superficial measures like economic growth and increases in GDP per capita, and is taken to
include measures such as longevity, the standard of living, infant, child and maternal mortality
and the distribution of income, then the impact of HN/AIDS on development will be severe.
HN/AIDS is likely to reverse hard-won development gains on the African continent and leave
individuals and nations worse off than before. Further attempts at development will be even
more difficult as HN/AIDS will first have to be dealt with before tackling other important
developmental problems (Loewenson and Whiteside, 1998:23).
The economic impact of the epidemic will be immeasurably high. The epidemic is likely to
affect national economies through the illness and death of potentially productive workers and the
consequent fall in companies' productivity (Whiteside and Sunter, 2000:85). Companies have
already reported increased mortality of their workers, lost time and longer periods of absenteeism
due to the impact of the disease (Loewenson and Whiteside, 1998:21). Over the next decade, the
number of employees lost to AIDS could be the equivalent of 40% to 50% of the current
workforce in some companies (loveLife, 2000:12). However, Loewenson and Whiteside
(1998:21) note that the impact of skills losses will be greater than total labour losses, resulting in
increased training costs to replace lost workers. In addition, the disease has other effects on
business. Companies could face a loss of customers, resulting in decreased profits, as well as
increased costs because extended employee benefits will be necessary (Whiteside and Sunter,
2000:99).
In the public sector, there will be increased demands for spending on health and social welfare.
Costs to health systems as a result of increased HN/AIDS rates are probably the most visible
and direct costs of the epidemic. Significant increases in other diseases and infections, such as
TB, are also related to HN infection (Loewenson and Whiteside, 1998:14). Thus, not only is
HN/AIDS a public health burden in itself, it is directly linked to the burden of other significant
public health problems. The additional demand on health services for an estimated 10% HN
12
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prevalence is projected to range from 3% to 11.5% (Decosas and Whiteside, 1996 in Loewenson
and Whiteside, 1998:21). Increased costs to social security and benefits schemes, to medical aid
schemes, to education and other social services, to food security and safety nets are also likely to
result from the epidemic (Loewenson and Whiteside, 1998:22).
The social impact of RIV/AIDS has been, and will continue to be, devastating. The illness and
death of individuals from AIDS affects the immediate family, community and broader society in
which they are located. RN/AIDS plays a major role in increasing the poverty levels of
individuals, communities and countries (see Figure 2.1, p.9). At the level of the household, an
RN positive diagnosis will always be traumatic and may be economically disastrous. The
diagnosis and disclosure of RN status results in major stress for the individual involved.
Psycho-social consequences are aggravated as the disease progresses, both for the infected
individual and for informal care-givers (loveLife, 2000:9).
It is likely that RN/AIDS will have a greater socio-economic impact on households than death
by other causes. The financial impact of AIDS on households alone is estimated to be as much as
30% greater than deaths from other causes (loveLife, 2000:9). One reason for this is that the
disease mainly affects adults aged between 25 and 45, so individuals face illness and death in the
years in which they would act as providers, carers and nurturers (loveLife, 2000:9). Because of
the stigma attached to the disease, individuals and households may be excluded from society, and
thus cut off from vital support networks. Furthermore, the protracted nature of the RN illness
means that there may be a lengthy depletion of household resources (Whiteside and Sunter,
2000:90). When breadwinners lose their jobs or die prematurely of AIDS, elderly people may be
forced to use their pensions to care for their children who are ill and/or grandchildren who are
orphaned (Soul City and Khomanani, 2004:18).
AIDS orphans are a particularly heartbreaking consequence of the epidemic. The loss of parental
love, care and support necessary for the emotional development of every child may result in
social problems that perpetuate poverty. The much lauded extended family structures of Africa,
once capable of caring for these children, are being weakened by the increasing AIDS death toll
among young adults, urbanisation and the migration of labour (Pratt, 2003 :7). In child-headed
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households, children (and girls in particular) may have to leave school to care for siblings, may
be deprived of their home and experience food insecurity, are particularly vulnerable to abuse
and may have to prostitute themselves to survive (Soul City and Khomanani, 2004: 19). These
circumstances can only increase the risks of RN infection and perpetuate poverty in an endless
cycle. Although the RN/AIDS epidemic affects all sectors of society, poor households carry the
greatest burden and have the least resources available to cope with the disease (loveLife,
2000:9). Accordingly, RN/AIDS is likely to increase socio-economic disparities in this country
(loveLife, 2000: 15).
As a mIcrocosm of South African society, the student population of UKZN has not been
untouched by RN/AIDS. UKZN is situated in the province with the highest incidence of
RN/AIDS in the country and in addition, tertiary education students fall within the most
vulnerable age category for new infections. A study in 1999 showed a 16% RN/AIDS
prevalence rate among 40 617 staff and students (Mthethwa, 2004: online), while research in
2000 at one of the University's campuses found that 26% of female students in their early 20's
and 12% of male students were RIV positive (Rossouw, 2004: online). Modelling exercises
suggest a prevalence rate of about 16.6% amongst students in 2004 (Mitchell, 2004b:2). The
impact of RIV/AIDS on tertiary education specifically includes the potential loss of human
capacity, possible defaulting on student loans and the draining of the University's health
insurance funds (Rossouw, 2004: online).
Conclusion
The incidence of RN/AIDS, a devastating and ultimately fatal disease, is particularly high in
sub-Saharan Africa. The epidemic is fuelled by a potent combination of economic and social
factors, and thus cannot be simply attributed to individual choices. RN/AIDS has had, and
continues to have, a devastating impact on individuals, households and communities in South
Africa. There is a clear need to move beyond AIDS awareness and prevention campaigns
towards more concrete measures designed to deal with those who are already infected with the
virus. In the developed world, the introduction of potent antiretroviral drugs to treat RN/AIDS
has turned a once fatal disease into a treatable, chronic illness. Although these drugs could check
the course of the epidemic in developing countries too, the financial and logistical quagmire that
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surrounds the rollout of ARVs must first be negotiated. In the following chapter, the rollout of
antiretrovirals in the South African public health sector, and at the University of KwaZulu-Natal
specifically, will be critically discussed.
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Chapter 3: Antiretrovirals in the South African context
" ...treatmentfor HIVand AIDS that includes anti-retroviral medicines should no longer be withheld as a result
ofgovernment policy. ART in the public sector is necessary and possible, and a start must be made to
implementing it as a matter ofurgency in the interests ofmillions oflives. " (The Bredell Consensus Statement,
19 November 2001: online)
In relatively wealthy nations, the introduction of potent antiretrovira1 drugs for the treatment of
RN/AIDS has had dramatic - almost miraculous - results. In South Africa, where it was
estimated that about 400000 people required immediate treatment with ARVs in 2004 (Soul City
and Khomanani, 2004:11), the long awaited national rollout of the drugs in that year was
welcomed by activists and the general public alike. In 2004 too, the University of KwaZu1u-
Natal, recognising the necessity of providing access to antiretrovira1 therapy (ART) as part of a
comprehensive response to the RN/AIDS epidemic, announced that it would facilitate the
provision of ART to all students who needed it. At both a national and an institutional level,
wide-scale communication campaigns on the topic of ARVs are necessary to inform, educate and
communicate to RN positive individuals and the general public. It is important to note that the
national rollout and the rollout at the University ofKwaZu1u-Nata1 are irrevocably linked - many
of the issues and debates around antiretrovira1s at a national level are likely to have had a
significant influence on the attitudes and beliefs of students concerning the topic. In addition, the
types of communication campaigns and the key messages of these that are developed at an
institutiona11eve1 are dependent on the kinds of communication that the South African public are
exposed to in the broader, national context. It is for this reason that much of this chapter aims to
contextua1ise the rollout at the University, with attention being paid to the politics surrounding
the national rollout and its implementation thus far. In addition, the basic mechanisms of, and
issues surrounding, antiretrovira1 drugs will be briefly outlined. Finally, the communication
needs that have arisen from the rollouts will be discussed, along with the tools and methods
presently used by the Government and the University to communicate vital information about the




Antiretroviral drugs work by blocking the enzymes HN uses to replicate itself and thereby
suppressing the replication of the HI virus (Evian, 2003:5). As a result the viralload7 decreases,
with a corresponding increase in the CD4 cell count8, and the immune system of the infected
individual is able to regain its strength and deal more effectively with opportunistic infections
(Soul City and Khomanani, 2004:37). Today, patients with HN/AIDS are likely to be treated
with a combination of three (or more) different types of ARVs; usually two nucleoside reverse
transcriptase inhibitors with either a non-nucleoside reverse transcriptase inhibitor or one or two
protease inhibitors (Pratt, 2003:366; see also Joint Health and Treasury Task Team, 2003). This
type of treatment regimen, as opposed to mono- or dual-therapy, is referred to as Highly Active
Antiretroviral Therapy (HAART)9 and is recommended to maintain viral suppression for as long
as possible and to combat the effects of drug resistance (WHO, 2002:12).
A patient with HN/AIDS is typically advised on the optimum time to start antiretroviral therapy
based on the results of the CD4 cell count test and the viral load test lO (Soul City and
Khomanani, 2004:37). These tests are also used to determine whether or not the treatment is
working. According to the Government's Comprehensive HN and AIDS Care, Management and
Treatment Plan for South Africa (Republic of South Africa, 2003b:29), individuals with
HN/AIDS are eligible to start ART once their CD4 cell count falls below 200 cells/mm3 or if
they have opportunistic infections associated with Stages III or N of HIV disease that may be
life threatening. Thus, ARVs are usually only administered to people who have developed full-
blown AIDS. In 2004, it was estimated that approximately 400 000 people in South Africa
required immediate treatment with ARVs (Soul City and Khomanani, 2004:11).
Antiretrovirals are not only used for the treatment of people with HN/AIDS as described above,
but also in two other situations; the first is in order to prevent mother-to-child transmission of the
7 The viral load refers to the level of HI virus in the bloodstream.
8 The CD4 cell count indicates the strength of the immune system.
9 For the sake of simplicity, the term "ART" (antiretroviral therapy) has been used throughout the present research
project rather than HAART. Unless otherwise indicated, the ART mentioned can be assumed to consist of the
three/more drug regimen characteristic ofHAART.
10 Vol.untary counselling and testing (VCT), although not discussed in detail in this chapter, is a prerequisite to an




disease and the second is as a prophylactic, in an attempt to prevent seroconversion after rape or
a needlestick injury (see Evian, 2003). The present research project, however, is concerned
primarily with ARVs for the treatment of individuals with HN/AIDS, and thus the alternative
uses for the drugs will not be discussed in detail.
When used for the treatment of HN/AIDS, antiretroviral drugs have a wide range of benefits.
While ART is not a cure for the disease and must be taken for life, the treatment prolongs and
improves the quality oflife of the patient. The goals of treatment with ARVs include maximum,
durable suppression of viral load, restoration and/or preservation of immune function,
improvement of quality of life and a decrease in HN-related morbidity and mortality (Southern
African HN Clinicians Society, 2002:4). At a conservative estimate, ART extends life for 3.6 to
4.4 relatively healthy years, as compared to non-ARV treatment (Joint Health and Treasury Task
Team, 2003:53). ART has had major impacts on HN-related deaths and illnesses where it is
widely available and studies from the United States, Australia and Europe show the positive
effects of ART in preventing opportunistic infections and prolonging AIDS-free survival
(Martinson et aI, 2002:235-236). In South Africa, between 2003 and 2010, an ARV coverage of
20% would result in the deferment of 293 000 deaths until after 2010, while an ARV coverage of
100% would defer 1 721 000 deaths (Joint Health and Treasury Task Team, 2003:53).
In South Africa and other developing countries, the widespread provision oftreatment is likely to
have a positive impact on the crippling poverty associated with HN/AIDS. ART is likely to
prolong the lives of economically active individuals so that households have greater economic
and emotional resources to draw on; minimise the emotional and psychological costs associated
with AIDS as families are able to stay together for longer; alleviate the burden on elderly people
to care for children orphaned by the disease; result in a more productive workforce and
ameliorate the negative effects of HN/AIDS on the economy and, in addition, decrease
dependency on government agencies for financial aid and health services (Soul City and
Khomanani, 2004:19; see also Joint Health and Treasury Task Team, 2003). The provision of
ARVs may also decrease the stigma associated with HN/AIDS, and result in greater acceptance
of prevention efforts. It may encourage more people to be tested for HN at an earlier stage of the
illness (Martinson et aI, 2002:241). It is also possible that ART may decrease the infectiousness
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of RN positive individuals and thus decrease the risk of transmission (Gray et aI, 2001 m
M<ptinson et aI, 2002:241).
Although antiretrovirals have tremendous benefits for individuals, communities and countries,
they are powerful, ultimately toxic drugs and must be treated with due caution. The drugs are
associated with a wide range of short-term and long-term side effects and drug interactions
(Pratt, 2003:366). Common side effects include nausea, vomiting, diarrhoea, headache, rash and
general fatigue. Long-term side effects can include liver toxicity, anaemia and body fat changes
(Loveday, 2003:383). The serious long-term side effects of current antiretroviral treatment
regimens mean that patients cannot remain healthy on these treatments for indefinite lengths of
time; eventually they will die from opportunistic diseases or from the effects of the drugs (pratt,
2003: xiv). Treatment with antiretrovirals is currently ongoing and life-long, with complicated
drug regimens (Evian, 2003:80). Some regimens may consist of two to three different tablets,
each needing to be taken two to three times a day; some with food and some without. Thus,
patients must adhere strictly to the recommended antiretroviral regimen (this issue will be
comprehensively discussed in a later section of this chapter).
Some patients cannot tolerate ARVs at all; others may develop resistance to the drugs and thus
have to change the particular drug regimen they have been prescribed in an attempt to find a
combination of drugs that works for them (Evian, 2003:79). There have been contradictory
reports on the "RN treatment optimism effect"; that is, optimism due to the beneficial effects of
ART increasing high-risk sexual behaviour and thus increasing the likelihood of RN
transmission (Martinson et aI, 2002:241). Patients should be advised to start/continue to practise
safe sex in order to prevent the spread of RN infection to others and to avoid re-infection with
RN - which is considered harmful (Evian, 2003:96).
If used carefully and correctly, however, there is no doubt that ARVs have the potential to
prolong the lives ofhundreds of thousands of South Africans who would otherwise die of AIDS.
Nevertheless, the complicated nature of the treatment regimen means that adherence is a major
issue that has to be addressed, particularly in the relatively complex South African environment.
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The issue of adherence
Adherence is one of the most important factors in determining the success of the large-scale
ARV rollout in South Africa. Dr Liz Thomson, the HN and AIDS co-ordinator for the
Department of Medicine, Pietermaritzburg Metropolitan Complex ofHospitals, in relation to this
issue states: "I think this is either going to be a miracle...or we might end up with the biggest
HN resistance in the world" (Witness reporter, 2004). In order for ART to be successful, at least
an 80% adherence to drug therapy is usually required (Evian, 2003: 176). Poor adherence
inevitably results in drug resistance, which not only limits the patient's treatment options, but
also limits the treatment options for others who become infected with drug-resistant variants of
HN (Pratt, 2003:xiii-xiv); Thus, widespread poor adherence could cause existing ARVs to
become redundant (Martinson et aI, 2002:241).
A number of factors have been found to affect adherence to antiretrovirals and other chronic
disease drug regimens. These include:
Levels of knowledge and understanding (treatment literacy): patient knowledge and
understanding of the therapy are the basis of all strategies to encourage adherence to ART.
Information about, for example, the consequences of poor adherence, possible side effects of the
drugs and the implications of lab results that are used to monitor treatment success, enables
patients to take part in the decision-making process and to assume responsibility for their choices
(Martinson et aI, 2002:240). The "buy-in" of patients is based on their understanding of the
rationale behind treatment and the degree to which they believe they have a role to play when
selecting their regimen (Saag, 2003:367).
Health beliefs: there is evidence that people who believe that ART has significant benefits may
have higher rates of adherence than those with reservations about the effectiveness of the
treatment (Joint Health and Treasury Task Team, 2003:45). The tenets of the health belief model,
which relate directly to this point, will be discussed in Chapter 4 of the literature review.
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The drug regimen: successful adherence to ART is associated with simpler drug regimens, daily
or twelve-hour dosing frequency, as few drugs as possible and minimal disruption to normal
routine (Evian, 2003 :286).
Side effects: the degree to which the patient is willing to tolerate the sometimes severe side
effects of ART is related to a number of factors including the nature of the side effect, how it
interferes with the patient's day-to-day life and the patient's belief that the regimen is likely to be
effective (Urquhart, 1996 in Saag, 2003:373).
Patient characteristics and lifestyle: possibly the only consistent predictor of poor adherence in
the research literature, across many chronic conditions, is depressed mood and mental health
problems (the prevalence of depression in people with HN/AIDS has been estimated to be as
high as between 20% and 52%) (Loveday, 2003:384). In addition, the abuse of substances or
alcohol may be significant factors in an inability to cope with complex drug regimens that
require a high degree of organisation (Joint Health and Treasury Task Team, 2003:45).
Health care providers: The qualities of the healthcare provider play a vital role in the adherence
of patients to ART (Loveday, 2003:385), with the relationship between patient and clinician
being an important predictor of adherence (Joint Health and Treasury Task Team, 2003:45).
Nurses and/or doctors, for example, are typically responsible for the following: the decision-
making process associated with starting or changing therapy; identifying - with patients - as to
how best integrate drug taking into daily routines; providing advice during the initial stages of
ART and providing long-term adherence support (Loveday, 2003:385).
Social support: adherence is usually most effective if the patient has stable relationships with
family or friends who can offer social, practical and emotional support (Evian, 2003:97; see also
Republic of South Africa, 2003b). Many treatment programmes encourage disclosure to at least
one family member or friend as disclosure is seen to have a positive impact on adherence
(Martinson et aI, 2002:241). Soul City and Khomanani (2004:42), for example, advise that
people on ARVs choose a "treatment buddy" who can offer support by reminding them to take
their medication and making sure that they attend regular medical checkups. If patients lack
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established social networks, the use of assigned "buddy" systems may help to support them
through the initial stages of therapy (Loveday, 2003:388).
In South Africa, the rallying of communities around people with HIV/AIDS and those on
treatment is seen as a vitally important. Dr. Liz Thomson, in a recent lecture, suggested that, in
order for a successful ARV rollout to take place, every sector of society must be mobilised. She
states that the "treatment ofHIV and Aids is for everyone, not just doctors and nurses ...We need
to create a society where students can sms one another and say 'have you taken your medicine
today?"'(Witness reporter, 2004; see also Thomson, 2004). In the South African context,
however, it is important to note that the fear of stigma and discrimination may prevent people on
ART from seeking much needed social support (Soul City, 2003:10). Thus, addressing issues of
stigma and discrimination may be a vital component of promoting adherence to ART.
Other factors: other factors such as level of education and socioeconomic status are generally
poor predictors of adherence (Chesney et aI, 2000 in Saag, 2003:373). In the South African
context, however, hunger, poverty and violence have been identified as major obstacles to
adherence (PlusNews reporter, 2004:2; see also Soul City, 2003).
According to Saag (2003:373), "Even the most dedicated and committed [AIDS] patients find it
difficult to remember to take each pill as prescribed every day over several months to years." It is
evident that adherence to antiretroviral therapies is a complex, multi-faceted process, involving
not only the individual, but also every member of society that is willing and able to help. In a
developing country like South Africa, adherence is also complicated by numerous social and
economic factors that need to be taken into consideration when developing adherence
programmes. As will be discussed later, communication and social marketing programmes have
a vital role to play in promoting adherence in the South African setting.
Complementary and alternative therapies
While there is no scientifically proven alternative to antiretroviral drugs for the treatment of the
final stages of AIDS, a wide variety of complementary and alternative therapies are currently
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used to ward off opportunistic diseases and maintain the health of the immune system for as long
as possible. Some of these therapies, however, can be considered to be more viable than others.
One of the most important features of the care of people in advanced stages of HN infection is
the prevention of opportunistic diseases. While ART is the most effective way to achieve this,
patients are usually only treated with ARVs once severe immune-deficiency has already
occurred. Thus, prophylaxis drug therapy against some of the common or severe opportunistic
infections, such as TB, is recommended to enhance the wellbeing and survival of people with
HN/AIDS (Evian, 2003: 106). In addition, to prevent opportunistic diseases patients are typically
advised to have regular medical check-ups, boil all unsafe drinking water, maintain good
hygiene, avoid raw and undercooked meat, peel fruit or wash it well before eating and avoid
exposure to contagious diseases (Soul City and Khomanani, 2004:34-35).
In a medical setting, "wellness programmes" may be used to help patients with HN/AIDS to
remain healthy for as long as possible (Evian, 2003:95). In order to achieve a healthy lifestyle
and thus strengthen the immune system, these programmes promote the following
recommendations: follow a nutritious diet, consider nutritional supplements if a balanced diet is
impossible, avoid smoking and excessive alcohol use, keep fit, have sufficient sleep, maintain a
positive mental attitude and seek early treatment for medical problems (Evian, 2003 :95-96; Soul
City and Khomanani, 2004:31-32). Stress management is considered important as the stress
associated with chronic disease can weaken the immune system and worsen the clinical course of
the disease (Robinson and Pratt, 2003 :409). The use of "immune boosting medicine" appears to
have little value in managing the disease (Soul City and Khomanani, 2004:32).
Alternative therapies - such as acupuncture, massage and traditional healing - although not
scientifically proven as valuable for individuals with HN/AIDS, can generally be considered as
supportive therapy (Evian, 2003 :96). Research estimates that up to 97% of South Africans with
HN/AIDS first use African/traditional or complementary medicine, and only resort to
biomedical alternatives when these methods fail (Republic of South Africa, 2003b:87). However,
while some traditional remedies and herbs may play a role in strengthening the immune system,
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others are known to be harmful, particularly when taken with ARVs (Soul City and Khomanani,
2004:32).
The South African Health Minister, Manto Tshabalala-Msimang, has repeatedly recommended
that patients with HN/AIDS eat "a combination of garlic, onions, potatoes and virgin olive oil"
(Sapa, 2003: online). Extensive research, however, does not appear to verify her stance on the
issue. Garlic powder, initially thought to have antiviral properties, was found to damage gastric
mucosa. Garlic supplements, given for over two months, may lengthen bleeding time and interact
with antiretroviral drugs (Evian, 2003:96; WHO, 2002:117-118). Onions and olive oil also failed
to show immune boosting properties. Large quantities of onion have been found to cause chronic
diarrhoea and intestinal distension. Onions and olive oil - when taken together - are likely to be
harmful and may even accelerate the onset of full-blown AIDS (Evian, 2003:96). The African
potato (Hypoxis) has also been acclaimed by the Minister for its immune-boosting properties.
However, the efficacy and safety study for the African potato was stopped after eight weeks
owing to the development of serious bone-marrow suppression in the majority of the patients
(Evian, 2003:96).
While there are a wide range of therapies and health behaviours that can support and promote a
healthy immune system in HN positive people, there is ultimately no substitute for antiretroviral
therapy. Once the immune system is sufficiently weakened, ART is necessary to decrease the
viral load and strengthen the immune system. In South Africa, however, it is only recently that
ART has been made available at public health facilities, and it is still not universally accessible.
The national rollout of antiretroviral drugs
The South Mrican Government's response to HIV/AIDS and the antiretroviral issue
In August 2003, the South African Government publicly committed itself to the development of
a plan for the provision of antiretrovirals at public health facilities. Prior to this announcement,
ARVs had only been available to a fraction of those in need of them; through pilot ART
programmes in the private sector, clinical trials, medical insurance schemes and occupational
health programmes (Martinson et aI, 2002:239). Despite widespread protest, the Government had
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resisted the provision of the drugs through a national rollout; citing the potential toxicity of the
drugs and the high costs of such a rollout as justification. In order to understand the sea-change
in government policy and the circumstances leading up to the ARV rollout in 2004, a brief
history of the politics surrounding HIV/AIDS and antiretrovirals in South Africa is obligatory.
In the 1990's, the strategies and responses of the Government to the issue of HIV/AIDS,
although relatively ineffectual, lacked the blatantly obstructionist nature of recent years. In 1994,
the National AIDS Committee of South Africa (NACOSA) was formed; 1996 saw the
establishment of an HIV/AIDS and STD programme and in 1998, a national interdepartmental
committee on HIVIAIDS and a "Partnership against AIDS" was established to encourage a
multi-sectoral response (Joint Health and Treasury Task Team, 2003:6). The Beyond Awareness
Campaign, which was conducted under the auspices of the Department of Health from 1997 to
2000, focused on the promotion of the prevention and care aspects ofHIV/AIDS (see Parker, no
date). These committees and programmes suggested that the Government was prepared to offer a
comprehensive, people-led response to the AIDS issue. By 2000, however, the political will of
the Government to address the issue of HIVIAIDS seemed to have deteriorated. In that year, the
National AIDS Council (SANAC) and the National HIV/AIDS and STI Strategic Plan (2000-
2005) were announced. However, the plan's major focus, and indeed the visible response of the
Government, was more on prevention and behaviour change messages, rather than on the
antiretrovirals necessary for the survival of hundreds of thousands of South African citizens who
already had AIDS (Willan, 2004: 109-110). Critics have stated that the National AIDS Plan of
2000 lacked proper consultation, failed to address all the implications of the epidemic, had no
clear dates or targets and ignored the issue of treatment (Willan, 2004: 113).
The year 2000 also saw the beginning of the "denialism debate" led by President Mbeki, who
established a Presidential Advisory Panel to consider the causal link between HIV and AIDS in
South Africa (Willan, 2004:112). Mbeki claimed that AIDS activists and doctors who adhered to
the mainstream position on AIDS were "racist" (Mbali, 2002: online). In addition, Mbeki
resisted the provision of the drug AZT to pregnant mothers in order to prevent the transmission
of the HI virus to their unborn foetuses, claiming that the drug's toxicity was likely to do more
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harm than good (Brink, 2000) 11. Organisations associated with the President, such as the ANC
Youth League, continued to propagate this myth, labelling ARVs "highly toxic" and praising the
Government's stand on the issue (see for example Ntshangase, 2003).
In addition to the alleged toxicity of the drugs, the high cost of ARVs was cited by the
Government as justification for not providing the drugs. It is true, that, until recently, the price of
antiretrovirals has been beyond the reach of most developing countries. International agreements
on trade-related intellectual property rights (TRIPS) give pharmaceutical companies 20 years'
exclusive rights to a drug, which is invariably put on the market at a high price to recoup
development costs (Pellowe, 2003:424). However, a number of local and international initiatives
to reduce the price of patent-protected ARVs, as well as an increase in production of generic
copies of many ARVs, have greatly increased the affordability of ART in developing countries,
including South Africa (Joint Health and Treasury Task Team, 2003:41). Sadly, the recent
introduction oflaws that prohibit the manufacture of certain generic ARVs in India - the world's
leading manufacturer of generic ARVs - may affect the future affordability of the drugs (Clarke,
2005:14). Besides the issue of cost, however, the South African Minister of Health, Manto
Tshabalala-Msimang, and President Thabo Mbeki have until recently continued to express
doubts about the safety of AZT and argued, in addition, that South Africa did not have the
infrastructure to distribute ARV drugs (Stastny, 2004:77).
On 19 November 2001, the TAC, together with medical and policy specialists and activists,
issued "The Bredell Consensus Statement" (TAC, 2001: online). The statement emphasised the
necessity of the national provision of antiretrovirals and called on the Government to change its
stance on the issue. In April 2002, a legal challenge on the issue of the provision of ARVs for
pregnant women was won by the TAC. Consequently the Constitutional Court declared that the
National Plan had to be extended to include treatment for all pregnant, HIV positive women in
order to prevent mother to child transmission of the disease (Willan, 2004: 11 0). In a Cabinet
statement on 17 April 2002, the Government stated that, in future, its policies would be based on
the assumption that HIV causes AIDS (Republic of South Africa, 2002a: online). It also




conceded that ARVs could be beneficial if administered in specific stages of the disease in
accordance with international guidelines - but that these drugs were too costly for universal
access. The Government reported that it would continue to work on lowering the costs of ARVs.
Although this Cabinet statement can be considered an important turning point in the South
African Government's response to the antiretroviral issue, it also highlighted the Government's
overwhelming focus on awareness campaigns, alternative treatments for HN/AIDS - including
immune-boosting supplements and the treatment of opportunistic infections - rather than on any
kind of commitment to a national rollout of ARVs.
On 9 October 2002, the Cabinet statement of 17 April 2002 was updated to suggest that the
Government was actively engaged in lowering the cost of ARVs and creating conditions which
would make it feasible and effective to use ARVs in the public health sector (Republic of South
Africa, 2002b: online). However, despite this promising development, the Government's attitude
to the issue of ARVs was still clearly ambivalent. Citizens who challenged the Government on
the treatment issue were labelled as "unpatriotic" and peaceful protestors of the TAC civil
disobedience campaign of March!April 2003 were sprayed with water canons and beaten
(Willan, 2004:113; see also TAC, 2003). Shortly after the chainnan of the TAC, Zackie Achmat,
called off the campaign, the Government publicly acknowledged that as many as 1.7 million
South Africans needed antiretrovirals to survive, and that it would supply the drugs to 50 000
AIDS patients by March 2004 (Willan, 2004: 113).
The findings of the Joint Health and Treasury Task Team, established in July 2002 and entrusted
with investigating the costs and benefits of an ARV programme, were embargoed until 8 August
2003. The report showed, in considerable detail, the impact that a national rollout of ARVs
would have on controlling the HN/AIDS epidemic, and set out comprehensive guidelines as to
how this could be achieved (see Joint Health and Treasury Task Team, 2003). When the findings
were released the Government announced that, owing to new developments with regards to the
pricing of drugs and the availability of budgetary resources, it was now able to consider such a
programme. Therefore, it stated, the Department of Health had been asked by the Cabinet to "as
a matter of urgency develop a detailed operational plan on an antiretroviral treatment
programme" (Republic of South Africa, 2003a: online). On 19 November 2003, the Cabinet
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publicly announced approval of the Operational Plan for Comprehensive HN and AIDS Care,
Management and Treatment for South Africa (Republic of South Africa, 2003c: online).
The key features of the Operational Plan (see Republic of South Africa, 2003b) include the
recognition that ARV medications play a critical role in the treatment of people with HN/AIDS,
and the recommendations that ARV drugs should be made available at public health facilities
and that the Operational Plan should be urgently implemented. The Operational Plan provides for
the identification and establishment of HN service points, at which people with HN/AIDS will
be offered a wide range of health services to manage their disease. These include: counselling for
the prevention ofHN, VCT, ongoing counselling and support, treatment of sexually transmitted
diseases, treatment to prevent the transmission of HN from mother to child, post-exposure
prophylaxis for rape and needlestick injuries, treatment of opportunistic infections, nutritional
assessment and support, monitoring of CD4 count and viral load in order to determine eligibility
for ART and finally, antiretroviral therapy if required.
Why, then, the shift in policy? Political observers have attributed the change primarily to an
increased pressure - both domestically and abroad - on the Government to facilitate a national
rollout (see Willan, 2004). Domestically, the lobbying of civil rights groups such as the TAC for
universal access to ART and the media frenzy surrounding the issue swung public opinion
against the Government, thus playing a significant role in pressurising the Government to roll out
ART on a national scale. There was also ongoing international pressure; calls for the South
African Government to express its political commitment to fighting the epidemic and
developments of the World Trade organisation meeting in September 2003 that increased
opportunities for poor countries to access cheaper drugs through the "parallel importation" of
generic drugs (Willan, 2004:115). On the 22 September 2003, WHO committed itself to the "3 x
5" plan - that is having 3 million people on ARV treatment by 2005 - and encouraged leaders of
developing countries to support the plan (see WHO, 2003). Thus, because of these domestic and
international developments, it would have been almost impossible for the Government to




Evaluation of the ARV rollout thus far
Although the Government's about-face on the issue of a national rollout has been welcomed, the
initial implementation of the Operational Plan has not been without its difficulties. A report by
the Aids Law Project (ALP) and the TAC (2004:3) highlighted the fact that although hospitals
and clinics have had enormous pressure to provide the treatment service, they have not been
provided with the additional capital and human resources the Operational Plan promised. Other
reports show that the current demand for ART at public health facilities far outweighs capacity,
due in part to severe human resources shortages in clinics and hospitals across the country (Joint
Civil Society Monitoring Forum, 2004:4). Even prior to the rollout, observers noted that a lack of
capacity and operational weaknesses undermined the ability of the public health system to
deliver even basic care to patients (Martinson et aI, 2002:241). There have also, until recently,
been numerous problems with drug supplies, due to a large extent to the delay in finalising the
formal drug procurement and tender process (Joint Civil Society Monitoring Forum, 2004:5). By
April 2005, however, the tender to provide supplies of ARV drugs had been awarded to seven
companies - a sign that the weaknesses in the national rollout may be beginning to be ironed out
(Weekend Witness Reporter, 2005:4). The latest figures available estimate that approximately 29
332 individuals were on ART at public health facilities at the end of December 2004 (TAC,
2005: online), and that by April 2005, the Department of Health had established at least one
service point in all 53 districts in the country (Weekend Witness reporter, 2005:4). Nevertheless,
it is unlikely that the target announced by President Mbeki of 53 000 people on treatment by 31
March, 2004 (and later extended to 31 March, 2005) has been met12.
A national rollout of ART at public health facilities is not a simple matter; the management
systems required to deliver the intervention and achieve high levels of patient adherence to the
treatment are complex (Joint Health and Treasury Task Team, 2003:33). Expert opinion suggests
that the successful implementation of ART in South Africa depends on a variety of interlinked
factors including the availability of funds, affordable medication, adequate health infrastructure,
human resources with the required skills, political will and a strong partnership across society
(Joint Health and Treasury Task Team, 2003:81). Perhaps most importantly for the purposes of
the present project, the antiretroviral rollout must be accompanied by a comprehensive
12 These figures are not yet available.
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communication campaign to all sectors of society. Before addressing this issue, it is necessary to
briefly discuss the rollout of ART at the University of KwaZulu-Natal.
The rollout at the University of KwaZulu-Natal
In April 2004, the University of KwaZulu-Natal publicly announced that it would facilitate the
provision of treatment, including ART, to all students who required it. This Treatment
Programme, first implemented in 2003, forms part of the University's Comprehensive Student
HN/AIDS Prevention, Treatment and Care Policy. The policy has four key components:
prevention, voluntary counselling and testing, the care of HN positive students at the campus
health clinics (including the treatment of opportunistic infections and the monitoring of CD4
cells), and referral to a preferred provider for specialised care, including ARVs, for students with
a CD4 count below 200 (UKZN, 2004: online). While the patient is a registered student at
UKZN, the University's AIDS Treatment Fund contributes to the cost of specialised treatment
(UKZN, 2004: online)13. Students pay R50 per month to access comprehensive HN/AIDS care,
including ARVS14 (UKZN, 2004: online).
Once a student has undergone VCT and has been discovered to be HIV positive, a CD4 count is
obtained. Students with CD4 counts above 200 are offered primary health care and an HN
counsellor15 develops an individual wellness programme with the student. The wellness
programme includes the treatment of opportunistic infections, CD4 count monitoring, vitamin
supplements, nutritional education and supportive counselling. Students with CD4 counts below
200 are referred to service providers who specialise in the management of HN/AIDS. The
service providers undertake a clinical assessment of these students and, if indicated, place the
students on ART (Mitchell, 2004a:7). McCord Hospital is, at present, the recognised service
provider for the Howard College, Medical School, Edgewood and Westville Campuses and Dr
Peter Appelt (a private general practitioner) is the service provider for the Pietermaritzburg
campus. HN counsellors at the campus clinics are trained in adherence assistance and work
13 Each student at UKZN has R30 taken offhislher fees as a contribution to the Fund and the University also
provides money for the purpose.
14 The average montWy cost for treatment - ARVs, other medication, blood tests, counselling and doctor's
consultations - is approximately R800 (Mthethwa, 2004: online).
15 HIV c?~seIIors are professional nurses employed to provide VCT, support, care and welIness management of




closely with students on ART; offering them support and encouragmg strict adherence to
medications (Interview 1, 2004:84-88). Approximately 190 HN positive students are being
managed according to primary health care at the campus health clinics and, since October 2003,
13 students have been referred to service providers for specialised care (Mitchell, 2004a:7). One
of the major challenges now faced by the University according to the Vice-Chancellor, Professor
Makgoba (2004: online), is that of encouraging uptake of the comprehensive facilities and
services available to students affected and infected by HN/AIDS.
The Treatment Programme is aimed at creating a generation of graduates that are healthy enough
to apply the skills and knowledge they have gained during their tertiary education (Makgoba,
2004: online). The provision of ARVs allows students sickened by AIDS to continue their
studies and remain productive for longer, encourages students to undergo VCT and, for students
in the early stages of HIV, allows them to come to terms with their status knowing that treatment
is available when they need it (Makgoba, 2004: online). As with the Government rollout,
however, massive communication campaigns will need to be undertaken at the University's
campuses in order to inform and educate students and staff about these services.
Communication and antiretrovirals
The Clinton Foundation, which has been asked to advise the Government on the national rollout,
has recommended that a communications plan on the topic of antiretrovirals be developed "as a
matter of urgency" (Munusamy, 2003: online). The Joint Health and Treasury Task Team
(2003:23) have stated that a substantial education and communication campaign will be essential
to maximise the implementation of the rollout. Similarly, a comprehensive communication
campaign will be necessary to accompany the rollout ofARVs at UKZN.
There is no doubt that the rollout of ARVs provides complex communication challenges, both at
a national and an institutional level. In light of the literature reviewed in this chapter, major
issues that would need to be addressed by communication campaigns on the topic of ARVs can
be summarised as follows:
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Communicating basic information: basic information that needs to be communicated to the
general public includes: how to access ARV treatment, the benefits of knowing one's HN status,
the treatment of opportunistic infections, the fact that not all HN positive people require ARVs,
the importance of other interventions such as good nutrition before the development of AIDS
and, importantly, that ARVs are not a cure for AIDS (Joint Health and Treasury Task Team,
2003:76).
Correcting misconceptions: the politicisation of the HN/AIDS and antiretroviral issues in South
Africa, and the accompanying media attention, is likely to have created a number of
misconceptions among the general population. As the President and his Health Minister have not
publicly retracted their statements on the relationship between HN and AIDS and the toxicity of
ARVs, many South Africans have been left confused and uncertain about these issues.
Nomfundo Dubula, an AIDS activist notes that "The Government's stand that AZT is not safe
and that there is no direct link between HN and AIDS caused a lot of confusion among the
people" (Stastny, 2004:77). Michelle Mitchell (Interview 1, 2004:111-113), former AIDS
Programme Co-ordinator at UKZN, concurs that the rumours and myths that abound in the South
African context, suggesting that ARVs are toxic, may contribute to the reluctance of some
students at UKZN to be placed on ART. Willan (2004:12) suggests that this ambiguity and
resultant questioning of medical science has major implications for communication campaigns
developed in this country. In addition, the intense political activism around the issue of ARVs,
by groups like the TAC, may have created false expectations about the drugs and their
capabilities (Munusamy, 2003: online). It is important, therefore, that communications on the
topic, in addition to communicating basic facts about ARVs and clearing up misconceptions
about the safety of the drugs, stress the complexity and life-long nature of the ART regimen.
Encouraging adherence: it has been noted that the health authorities have a "formidable task" in
educating patients about the need to adhere strictly to the ARV drug regime (PlusNews reporter,
2004:2). There is the danger that people may stop taking the drugs when they begin to feel better
or experience unpleasant side effects, or that they may continue to practise unsafe sex and infect
others with the virus (Munusamy, 2003: online). In South Africa, it has come to light that some
patients with HN/AIDS are sharing their ARV drugs with others, a dangerous practice that has
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been attributed to poverty, stigma and lack of education (see Sookha and Packree, 2004). For
those individuals who require ART, therefore, these issues must be addressed, with key basic
messages like the importance of strict adherence to ARV regimens and the advisability of
disclosing one's status to family or friends in order to gain emotional and practical support being
communicated (Joint Health and Treasury Task Team, 2003:76).
Encouraging social mobilisation: the Joint Health and Treasury Task Team (2003:65) have
stated that the use of community networks and general social mobilisation will be vital to
accompany the rollout of ARVs and will be essential to its success. Members of the general
public, including those who are not HN positive themselves, can serve as effective and powerful
information, education and communication channels (Joint Health and Treasury Task Team,
2003:65). However, stigma and discrimination against those with HN/AIDS is still prevalent in
South Africa and will need to be addressed by communication campaigns (Republic of South
Africa, 2003a: 175). Research conducted at UKZN showed that the low uptake of VCT at the
campus health clinics was at least partly due to a fear of stigma and discrimination (Mitchell,
2004b:3), and this factor may also play a role in the relatively low uptake of the care and
treatment programmes at the University.
Stimulating demand: although, at present, the demand at public health facilities for ARVs far
exceeds available capacity, it may be necessary in the future to stimulate demand for the service.
In some high-prevalence settings, the uptake of ART has been lower than anticipated,
necessitating the mobilisation of demand (WHO, 2003: 17). In addition, a recent survey of 77
South African private medical schemes showed that 90% of these schemes offered some form of
ARV benefits but that uptake of these benefits was typically lower than expected (Joint Health
and Treasury Task Team, 2003:52). UKZN has, in relation to its predicted infection rates, a
relatively low uptake of health services like VCT and ART, and thus stimulating demand may
well be necessary.
At a national level, the Operational Plan (Republic of South Africa, 2003b) makes provision for
extensive information, education and communication, and social mobilisation campaigns to
address the issue of HN/AIDS as well as many of the antiretroviral-related issues discussed
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above. The proposed communication strategy involves a wide range of government sectors and
NGO's at national, provincial and local levels (Republic of South Africa, 2003b: 174). Specific
aims of the communication plan will be to ensure that all relevant government programmes,
health care providers, people with HN/AIDS, families, caregivers and stakeholders are aware of
the key provisions of the plan and the care, treatment and support resources available. The
promotion of health services like ARVs and treatment for opportunistic infections will also be
undertaken.
The communication strategy will involve a market segmentation approach, whereby different
groups are targeted differently in terms of the method used and the content communicated
(Republic of South Africa, 2003b: 176). There are three components to the proposed
communication plan: mass communication campaigns and small media material to educate
people about various aspects of ART, and social mobilisation to ensure that people with
HN/AIDS have adequate support structures in their communities. These campaigns are aimed at
encouraging health-seeking behaviour and the adoption of caring attitudes towards people
seeking assistance from health care services (Republic of South Africa, 2003b: 179-180).
However, like many aspects of the Operational Plan, it appears that the communication plan
designed to accompany the national rollout has barely been implemented. According to the TAC
and the ALP (2004:3), communication about and popularisation of the Operational Plan has been
weak in most provinces. While the lists of some accredited sites where eligible individuals can
receive ART have been made available to intemet users and the media, the list and the contact
details of the actual sites that are providing treatment are not available to ordinary people with
some access to radio, television and/or newspapers. Thus, the TAC and the ALP (2004:3) have
asked the National Department of Health to inform its provincial counterparts that they have a
constitutional duty to educate the public about the ARV rollout. Although television
advertisements about ART aired briefly, these are no longer showing and anecdotal evidence
suggests that this was on the orders of the Minister of Health (TAC and the ALP, 2004:3).
However, a booklet - "HN and AIDS: Prevention, Care and Treatment" - produced by Soul
City and the Department of Health's Khomanani (2004), has been widely distributed. The
booklet contains essential information about HN/AIDS and ART as well as useful contact
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numbers, although not a list of accredited treatment sites. The Health Minister, Manto
Tshabalala-Msimang (2004:34), has named the distribution of 11 million copies of the booklet
"the largest public health education drive of its kind". Nonetheless, the report by the TAC and
the ALP (2004) suggests that a greater effort to promote the national ARV rollout and educate
the general public, as well as individuals with HIV/AIDS, about ART must be made. On 4
November 2004, in a memorandum to the Minister of Health and provincial MEC's for health,
the TAC requested that radio and television be used to promote the use of ARVs for the
treatment ofHIV/AIDS (TAC, 2004: online).
At an institutional level, UKZN uses a variety of communication channels to inform and educate
students about HIV/AIDS and accessing VCT and ART. Small media such as brochures,
pamphlets, reports and posters have been developed and distributed on all five campuses
(UKZN, 2004: online). Campus-specific brochures have been developed for the Edgewood,
Howard College, Pietermaritzburg and Westville campuses on the "How's, Where's and Why's
of Getting to know your HIV Status and accessing treatment". The brochures include campus-
specific telephone numbers of the various services as well as geographic-specific referral sources
(Mitchell, 2004a:5).
A number of targeted HIV/AIDS-related campaigns are held throughout the academic year. The
topic ofHIV/AIDS, particularly VCT, is incorporated into all Orientation Programmes for first
year students (Mitchell, 2004a:4). Other HIV/AIDS related campaigns in 2004 included the
"Access HIV Treatment - A Stigma Free UKZN" campaign at the Howard College and
Pietermaritzburg campuses aimed at informing students about VCT and accessing treatment; the
"Unmask AIDS" campaign at the Westville Campus aimed at exploring staff and students'
attitudes, prejudices and beliefs about HIV/AIDS and the "Hope and Healing" Campaign across
all campuses aimed at dealing with the negative notion of HIV as a death sentence (Mitchell,
2004a:5-6; see also Mitchell, 2004b).
Media exposure has also contributed to awareness about the care and treatment services offered
by UKZN. Since the beginning of 2004, the University has received significant media attention
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around its Treatment Programme through channels such as Safm, Sunday Tribune, Fair Lady
Magazine, Drum Magazine, Sunday Times and the Chronicle of Higher Education (Mitchell,
2004a:6). Michelle Mitchell comments that the Government rollout of ARVs, and the media
attention around that, has created a window of opportunity to again attract students' attention on
the issue of HIV/AIDS, and encourage them to seek more information on the topic (Interview 1,
2004: 35-38).
As well as making use of small and mass media, UKZN employs a variety of dialogue-oriented
and participatory strategies to allow staff and students to engage with the issues surrounding
HIV/AIDS and treatment. The use of word of mouth sources or "social networking" is seen by
Michelle Mitchell as vital in spreading correct information and knowledge (Interview 1,
2004:53-54). Members of the Student Orientation Executive Committee and Orientation mentors
are encouraged to act as role models in terms of knowing one's HIV status (UKZN, 2004:
online). In 2004, the university-wide peer education programme was introduced. The aim of the
programme is to equip those students who attend the workshops with the necessary information,
skills and understanding of HIV/AIDS to implement behaviour changes and engage in dialogue
with their peers (UKZN, 2004: online). As academic staff often deal with students who are HIV
positive, and can act as important referral nodes, a need for staff to be informed about the
University's HIV/AIDS-related programmes and services has been identified (Mitchell,
2004a: I 0). To this end, workshops with various departments and faculties have been undertaken
and a staff peer educators project is in the planning phase. The student counselling centres also
offer support groups for those infected/affected by HIV, with individual supportive counselling
from student counselling centres (UKZN, 2004: online). Although a variety of activities are
undertaken by the University to address the issues surrounding RN/AIDS, available information
does suggest that much of the focus is still on prevention and VCT, rather than on treatment.
Whether or not students require additional information on ARVs is the topic of the present
project and will be explored in subsequent chapters.
Conclusion
ARV therapy is a vital component of a comprehensive response to HIV/AIDS, although second
to preventative behaviour change as the definitive means of controlling the epidemic. In South
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Africa, ARV drugs have recently been rolled out at public health facilities and, in addition, the
University of KwaZulu-Natal has announced that it will facilitate access to ART for all students
who require it. Due to the complexity of ARV drug regimens, and the politicisation of the issue
in the South African context, however, extensive accompanying communication campaigns are
necessary at both a national and an institutional level to inform the general public of various
aspects of ART and to encourage changes in beliefs, attitudes, and behaviour where required. In
the following chapter, one method of achieving these goals - social marketing - will be critically
discussed as a viable means of communicating to audiences on the topic of antiretrovirals.
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Chapter 4: Social marketing
"Why can't you sell brotherhood like you sell soaps?"
(Wiebe, 1951-2 in Jha, 1999:31)
The rollout of antiretrovirals - both nationally and at an institutional level - raises issues around
communication that are complex and challenging to address. One approach that is capable of
influencing the kinds of changes in knowledge, attitudes, beliefs and behaviour that will be
required for a successful rollout is social marketing. Social marketing offers a strategic
framework that ensures that social change programmes are run on business lines, and thus it
increases the likelihood of successful change amongst the target audience. In this final chapter of
the literature review, social marketing will be discussed within the context of development
communication approaches, and its link to marketing in the commercial sector will be analysed.
A brief introduction to the tools and techniques of social marketing will be given, including a
discussion of the strategic planning process, the importance of segmentation, the marketing mix,
and the use of research in the marketing process. Finally, three behaviour change models that are
particularly relevant to the project at hand will be outlined and a brief overview of the criticisms
directed at the field will be presented.
The field of social marketio2
Although campaigning for voluntary behaviour change is by no means a new societal trend -
consider for example efforts to secure the vote for women or abolish apartheid - the
development of social marketing as a discipline in its own right is relatively recent. In 1971, the
term "social marketing" was first used by Kotler and Zaltman in a pioneering article in the
Journal ofMarketing (Piotrow et aI, 1997: 19). Social marketing can be defined as:
the application of commercial marketing techniques to the analysis, planning,
execution, and evaluation of programmes designed to influence the voluntary behaviour
of target audiences in order to improve their personal welfare and that of their society
(Andreasen, 1995:7; see also Kotler and Roberto, 1989; Kotler, Roberto and Lee; 2002;
Weinrich, 1999).
Social marketing can be applied to a wide range of social issues, in both First and Third World
contexts. In the area of public health specifically, it has been used to create awareness of health
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issues, problems and solutions; create demand for health services and legislative action; teach
skills; and encourage and reinforce positive behaviour change (D.S. Department of Health and
Human Sciences, 1989 in Elder, 2001: 19). It has been applied to a variety of health issues
including family planning, HN/AIDS, malnutrition and excessive population growth
(Andreasen, 1995 :32). In Uganda and Haiti, Population Services International (PSI) and
AIDSMark have used social marketing techniques to develop programmes for the prevention of
mother to child transmission of HN/AIDS; including the promotion of antiretrovirals for this
purpose (AIDSMark, 2004: online). In South Africa, social marketing techniques have been
applied to the promotion of Lovers Plus condoms (Parker et aI, 1998:8).
Social marketing has been used by government agencies like the Center for Disease Control and
Prevention, the U.S. Agency for International Development and the U.S. Department of
Agriculture, as well as NGO's such as the American Cancer Society, the Academy for
Educational Development and the Futures Group (Andreasen, 1995:33). The World Bank and
UNAIDS have also utilised social marketing principles in some of their programmes and
campaigns (Kotier et aI, 2002: xi-xii).
Although social marketing methods have been adopted by a variety of different organisations in
order to successfully accomplish social change goals, their potential is still largely untapped -
particularly in the South African context. South Africans, like most citizens of the global village,
are influenced daily by commercial marketing techniques. Persuading people to try new products
or services, or switch brands, is all in a day's work for the commercial marketer. As social
marketing uses many of the same powerful principles, it too has the potential to effect far-
reaching changes on society. Before elaborating on these principles, however, some of the ways
in which social marketing is both similar and dissimilar from its commercial cousin will be
discussed.
Social marketing in relation to commercial sector marketing
Social marketing is not dissimilar to marketing in the commercial sector. Central to all types of
marketing is the fundamental principle of a customer orientation: a focus on the customer in
order to understand the needs and wants of the target audience so as to better influence behaviour
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change (Weinreich, 1999:6-7; see also Andreasen, 1995; Kotler et ai, 2002). Many of the
challenges faced by commercial and social marketers are also similar. In both fields the ultimate
objective is to influence the target market's behaviour; target behaviours compete with
alternatives; community pressures may make it difficult to bring about change; and supporting
agencies (be it the national government or local retailers) must co-operate if the programme is to
succeed (Andreasen, 1995:5).
Nevertheless, there are also fundamental differences between social and commercial marketing.
Commercial marketing is concerned primarily with the selling of goods and services, while
social marketing is used to "sell" ideas, practices and, in some cases, accompanying tangible
objects (Kotler and Roberto, 1989:25). Although both commercial and social marketers seek to
gain the greatest returns on their investment of resources, their primary aims and objectives
differ. The main goal of commercial marketers is almost always to benefit the organisation
through increased profits, and not, as is the case with social marketing, the target audience or
broader society (Weinreich, 1999:4). While an important objective of both fields is to identify
and position offerings in relation to those of the competition, competitors differ. For the
commercial marketer, the competition is defined as all other organisations that are offering
similar goods and services, or that satisfy similar needs. For the social marketer, in contrast,
competition is the current or preferred behaviour of the target market and the perceived benefits
associated with that behaviour (Kotler et ai, 2002:10). Thus, one of the major tasks of the social
marketer is to identify and examine the behaviour the target market would prefer over the one
that is being promoted. Finally, social marketing is generally more difficult than commercial
marketing. In contrast to the immediate pleasure the consumer experiences after the purchase of
a consumer item like a book or motor car, social marketers can rarely promise a direct benefit or
immediate payback in return for the proposed behaviour change. Indeed, most changes proposed
by social marketers to their target markets - such as giving up smoking or using condoms - are
downright unpleasant. Thus, social marketing is a particularly challenging profession because it
relies on voluntary compliance to elicit behaviour change and not legal, economic or coercive
forms of influence (Kotler et ai, 2002:5).
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While many similar principles are utilised by both commercial and social marketers, commercial
marketing and advertising are not the only disciplines which have had a significant influence on
the field of social marketing. Weimeich (1999:4) notes that social marketing has also been
directly influenced by such theoretical traditions as health education, anthropology and social
psychology. In addition, it is not the only discipline applying itself to the conjoined problems of
social and behaviour change. Andreasen (1995 :9) cites a lengthy list of behaviour change
approaches, including: health education (Glanz, Lewis, and Rimer, 1990); health
communications (Backer, Rogers and Sopory, 1992); health promotion (McElroy, Gottlieb and
Burdine, 1987); mass communications (Atkin and Wallack, 1990); media advocacy (Wallack,
1990; Wallack, Darfman, Jernigan, and Themba, 1993); public advertising (Deutsch and
Liebermann, 1985); public communications (Rice and Atkin, 1989; McGuire, 1984); social
advertising (Kotler and Roberto, 1989; Weibe, 1951-2) and social mobilisation (Minkler, 1990;
Glanz, 1990). While these approaches are used to address similar social issues to those tackled
by social marketing, and may include useful concepts, they generally adopt a narrower focus
than social marketing. Promotion or communication to the public is generally paramount, with
other aspects of the marketing mix ignored. Like many of these approaches, however, social
marketing falls under the larger umbrella of development communication, an association which
is briefly discussed in the section that follows.
Social marketing and development communication
Notwithstanding its roots in the world of business, academic authors and theorists generally
locate social marketing within the broader field of development communicationl6. Development
communication is informed by two distinct theoretical approaches: 1) the diffusion/mechanistic
model and 2) the participatory/organic model (see Servaes, 1995).
Social marketing is mainly, although not exclusively, informed by the diffusion or mechanistic
model. This paradigm is largely based on Rogers' (1962) diffusion of innovation model _
discussed in greater detail elsewhere in this chapter - which is concerned with the process of
diffusion in a society and the adoption of innovations in an organised manner. Linney (1995 in
16 While communication theorists may view social marketing as one approach to communication, social marketers
would of course argue that communication is simply one aspect of social marketing (see Piotrow et aI, 1997).
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Parker, 1997:53) describes the key attributes of messages and campaigns developed within this
paradigm: they disseminate solutions to problems, are addressed to target audiences, use pre-
testing and generally do not involve local communities or encourage critical awareness. In
general, positivistic research methodologies (usually quantitative and empirical) are utilised.
Although current approaches that fall into the diffusion/mechanistic category of development
communication may not necessarily view communication as a one-way, linear process as their
predecessors did, there are still limitations associated with this paradigm. Parker (1997:52) notes
that health communications based on this model tend to reflect the viewpoints and preferences of
the communication professional rather than the target audience as the two groups usually come
from quite different socio-economic contexts. Parker (1997:53) concludes that while campaigns
utilising this approach may achieve results, they are limited in terms of the degree of
audience/community involvement.
The participatory or organic model, in contrast, emphasises the value of the cultural identity of
the local communities and of participation at all levels (Servaes, 1995:45). Participatory
communication has its foundations in Paulo Freire's notion of dialogical pedagogy (see Freire,
1972) and in the concepts of access, participation and eventual self-management discussed in the
Unesco debates of the 1970's (Servaes, 1995:46). Thus, communications developed within this
paradigm generally do not only include, but emanate from the target audience or community,
thus facilitating empowerment. Information exchange, rather than persuasion, is emphasised
(Servaes, 1995 :46). Research methodologies, thus, are always participative and generally
ethnographic and qualitative. Nevertheless, this paradigm too has its limitations. Kerr (1997:68)
notes that participatory cultural projects do not always result in empowerment of local
communities as messages and materials generated may simply perpetuate oppressive stereotypes.
In addition, there may be unintentional effects on the community involved. Participants selected
for materials development workshops may be envied by those who were not chosen - with
potentially negative consequences - and the participants' interpretation of the community's
culture may simply reflect what they believe the facilitators expect (Kerr, 1997:70).
It would be inaccurate to suggest that every communication approach with social change goals
necessarily falls into only one of the two paradigms associated with development
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communication. Social marketing programmes, for example, may include a great deal of
audience participation in the design and evaluation of messages. Likewise, essentially
participatory techniques may utilise tools such as product definition or segmentation which are
generally associated with a more mechanistic paradigm. Soul City, the South African
entertainment-education vehicle, is an excellent example of a programme that has managed to
bridge the two paradigms, "elaborating excellent social marketing strategies and combining them
with participatory components that promote dialogue, challenge power structures and provide
community-based action" (Tufte, 2001 :26).
Fundamentals of social marketing
The discussion above has shown that social marketing is by no means the only approach
designed to influence the behaviour of target audiences. Nevertheless, due to its widespread
adoption by both governmental and non-governmental organisations; its application of sound
business principles to social problems; and its proven ability to effect change (as well as my
personal interest in the field), it is the foremost theoretical approach adopted for the purposes of
the present project. As the major tenets of social marketing will be heavily drawn on in both the
design of the primary research, and the discussion of results, a brief elaboration of these will be
undertaken in the next few sections of this chapter.
The strategic marketing planning process
The strategic marketing planning process is particularly relevant to the empirical component of
this dissertation, as a needs analysis is associated with the planning stages of the social marketing
process. As in the business world, the development of a social marketing programme or
campaign is ideally a strategic process, consisting of a number of ordered steps. Kotler et al
(2002:34-43) outline the process as follows:
1) Conduct a situation analysis: once the programme focus has been determined and the
campaign purpose identified, an analysis of strengths, weaknesses, opportunities and threats
(SWOT) 17 is conducted. A review of similar programmes/campaigns could also prove useful.
17 In the ~~siness context, strengths and weaknesses refer to the internal environment of the organisation, while
opportunItIes and threats are found in the external environment.
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2) Select target audiences: the estimated size, demographics, geographical location and any
unique characteristics of the intended target audience are researched and described. The overall
market is segmented and one or more targets are chosen.
3) Set objectives and goals: objectives may be behavioural, or knowledge- or belief-oriented.
Goals, however, are quantifiable and measurable, and are more specific than objectives.
4) Analyse target audiences and the competition: the current knowledge, beliefs, and behaviours
of the target audience/s - relative to the objectives and goals - are researched. An effort is also
made to understand competition, perceived benefits, and barriers to action.
5) Develop the marketing strategy: the marketing mix - product, price, place and promotion - is
designed in relation to the previous steps.
6) Develop a plan for evaluation and monitoring: questions such as what will be measured and
how, when the measurements will be taken, and to whom they will be reported are addressed.
7) Determine budgets and find funding sources: the costs associated with various strategies are
assessed and potential additional funding sources identified.
8) Devise an implementation plan: the campaign is divided into phases if necessary and
decisions concerning what will be done, who will be responsible, when it will be done, and how
much it will cost are made.
The importance of the social marketing planning process is illustrated by its inclusion in other
seminal social marketing texts, including those by Andreasen (1995:72), Kotler and Roberto
(1989:39), Weinreich (1999:21-22), and others. Although the description of the strategic
planning process above is rather sketchy, a more detailed analysis of those principles most
relevant to the present project will be undertaken in the next few pages ofthis chapter.
Segmentation of markets
Segmentation of target markets is an important step in the planning process described above. In
addition, one of the research questions of this dissertation involves the possible segmentation of
UKZN's student population in order to better deliver antiretroviral-related messages, and thus
this concept needs to be explored further. Walker et al (2003: 151) define market segmentation as
"the process by which a market is divided into distinct subsets of customers with similar needs
and characteristics that lead them to respond in similar ways to a particular product offering and
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marketing program". Borrowed from commercial practice, segmentation is one of the central
features of social marketing which distinguishes it from typical public education programmes -
which generally treat targets as mass markets (Andreasen, 1995:17).
How, then, does the segmentation process work in practice? Once the total market for a social
product has been described, it is segmented in such a way that members of a segment share
similar characteristics that determine the behaviour under consideration, and that permit tailoring
of messages or interventions to those members (Slater, 1995: 187). In addition, members of a
segment can be reached through similar media, organisational or interpersonal channels (Slater,
1995:187). The most common approach to segmenting markets is demographic; distinguishing
segment members by variables such as race, gender, ethnicity, income or age (Slater, 1995: 188).
While the basels used for segmentation often depend on the particular market and the available
information, the variables chosen must be correlated with those factors that directly influence
behaviour. Once segmentation of the market has taken place, one or more segments are chosen
for targeting (Kotler et aI, 2002: 116-117), and tailored marketing strategies are then developed to
appeal to the unique needs of each segment.
Market segmentation and subsequent targeting offer a number of strategic advantages, including
increased likelihood of social change, increased effectiveness and efficiency, a basis for resource
allocation, and input for developing strategies (Kotler et aI, 2002: 117). As segmentation
necessitates an in-depth understanding of various sub-groups in the target audience, it is also
likely to result in an audience-focused marketing programme (Weinreich, 1999:52).
Segmentation allows social marketers to develop a set of marketing strategies and tactics that
meet the needs, wants and perceptions of specific sub-groups rather than approaching the entire
market with one general strategy that does not target anyone well (Andreasen, 1995:177).
Although there is a great deal of empirical support for the segmentation technique, two research
studies - see Morrison (2003) and Yun et al (2001) - are worth mentioning for their focus on
young populations in the KwaZulu-Natal region. Both studies concluded that segmentation was




Unlike some of the other approaches to social change that have been mentioned, social marketers
do not rely on only one or two programme elements to achieve results amongst target audiences.
Based on experience in the commercial sector, four strategic elements (the so-called "4 P's") are
considered when developing a social marketing programme. The social marketing product is the
behaviour or offering to be adopted by the target audience. The product may fall anywhere along
a continuum ranging from physical products, to services, to practices, to more intangible ideas
(Weinreich, 1999:10). The price of adopting a particular social product or behaviour may be
monetary, but it is more likely to be an intangible cost, such as time, effort, or previous habits
that must be given up (Weinreich, 1999:12). The place is where the target audience will perform
the new behaviour, acquire any tangible objects, receive services associated with the programme,
and gain access to the programme's messages (Kotler et aI, 2002:41). Promotion includes the
message to be communicated (Kotler et aI, 2002:42), and the means by which the social product
is promoted to the target adopters (Kotler and Roberto, 1989:44).
Each of these four strategic elements - product, pnce, promotion, and place - may be
manipulated by the social marketer in order to make the final offering more attractive to the
target audience. As the empirical research of the present project consists of a needs analysis for
the promotion of the antiretroviral rollout at UKZN, the promotional component of the marketing
mix will be discussed in some detail in the section that follows.
Promotion
Promotion is an important part of the marketing mix, and a consideration in the broader strategic
marketing planning process. The development and implementation of a promotion
(communication) programme consists of the following steps (Andreasen, 1995:200; Jha,
1999:57-68):
1) Determine objectives: specific, time-bound promotional objectives that are consistent with the
overall campaign objectives, and that emerge from a thorough analysis of the target audience,
need to be developed. Objectives may include one or more of the following: create awareness,
facilitate knowledge, encourage preference/liking for the behaviour, encourage conviction,
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develop the intention to perfonn the behaviour, or facilitate perfonnance of the behaviour
amongst the target audience (lha, 1999:59). While good use of promotion can help in creating
awareness, knowledge and preference, behaviour generally cannot be changed by promotion
alone (Jha, 1999:59)18. Thus, the most effective campaigns set fairly modest but attainable goals
in tenns of behaviour change (Backer et aI., 1992, in McGrath, 1995:208).
2) Decide on the promotion mix: the major elements of the promotion mix include advertising,
personal selling, publicity, and sales (Elder, 2001 :21). A careful evaluation of the advantages and
disadvantages of each element should be undertaken in order to select a promotion mix that is
relevant to the message and target audience.
3) Develop messages: choosing a message to communicate to the target audience depends on an
analysis of their characteristics, the benefits they seek, and the meaning and affect they associate
with different words and images (lha, 1999:64). In order to produce messages that have long-
tenn effects on target audiences, experts suggest that a well tested theory/theories of behaviour
change be used as the underlying framework for message development (Andreasen, 1995:141;
Kotler et aI, 2002:169; Weinreich, 1999:91). Some important behaviour change models will be
examined in a later section of this chapter.
4) Select channels of communication: effective communication vehicles and channels, to which
the target audience will respond and deem credible, must be selected (Salmon et aI, 1996:136).
Channels of communication can be divided into two broad categories: mass media, such as
visual, audio and print media, and interpersonal media, such as personal presentation and direct
mail (lha, 1999:66). The choice ofmedia depends on a number of factors including: the nature of
the target audience and its media habits, promotion objectives, the message and its execution, the
cost and availability of the media, and impact (credibility of the media with the target audience)
(Jha, 1999:66).
18 The effects of the mass media particularly are limited in achieving behaviour change. For a comprehensive
analysis of the limited effects of the mass media in effecting behaviour change, and the evolution of the perceived
role of the mass media in health promotion, see Naidoo and Wills (1988).
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5) Pretest messages: pretesting of the promotional aspects of the campaign with the target
audience is an essential component of a successful social marketing programme (Weinreich,
1999: 123). It ensures target audience comprehension, detects unforeseen interpretations,
facilitates the refinement of messages and materials, and allows for the selection of the most
effective approach (Weinreich, 1999:126).
6) Implement the promotion programme
7) Evaluate outcomes: promotion activities need to be periodically monitored and systematically
evaluated using social marketing research (Jha, 1999:67-68). Research is the focus of the next
section of this chapter.
Promotion, then, is a vital component of social marketing campaigns. However, it should be
reiterated that communication alone is unlikely to result in behaviour change among a target
audience. In addition to a focus on the other "P's" of the marketing mix, interventions at the
interpersonal and community levels should be considered to ensure the members of the target
audience have the skills and support necessary to perform the desired behaviour (Elder, 2001: 18-
19).
The importance of research
Research is an essential pre-requisite for each of the steps described in the strategic marketing
planning process. According to Kotler and Roberto (1989:62), "Research is what differentiates
the marketing approach to social change from earlier impressionistic efforts to influence changes
in social ideas and practices". While research may be rare for most health communication
campaigns (Atkin and Freimuth, 1989 in Nowak and Siska, 1995:171), as the foundation of
social marketing, sound research offers a scientific basis for making strategic decisions. Social
marketing campaigns can only be effective among their target audiences if the specific needs,
desires, beliefs, and attitudes of target adopters are used to inform them (Lefebvre et aI,
1995:218). Thus, marketing research has a role to play at every stage of the social marketing
process, including planning, implementation and evaluation.
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Based on the stage in the social marketing process at which it occurs, three types of basic
research can be identified. Firstly,formative research is used to guide the initial development of
the programme or campaign (Weimeich, 1999:27). Formative research is conducted to analyse
the marketing environment, select and segment target markets, and develop preliminary
strategies to address chosen markets (Andreasen, 1995:106). Secondly, pre-test research is used
to evaluate alternative strategies and tactics before they are implemented, and refine possible
approaches so that they can effectively address the specific needs and wants of the target
audience (Andreasen, 1995:120). Thirdly, monitoring and evaluation research is used to assess
projects after their implementation so that, if necessary, they can be adjusted to improve their
efficiency and effectiveness. Monitoring typically refers to an ongoing measurement of
programme outcomes, while evaluation is usually a single final assessment of a project or
programme (Andreasen, 1995:127). A useful framework for understanding the type of research
necessary at each programme or campaign phase is presented in Appendix A, and will be
referred to again in Chapter 5.
Models of behaviour change
Social marketers typically borrow theories and models of behaviour change from a variety of
other fields, including health psychology, anthropology and commercial marketing. These are
considered vital tools in creating social marketing programmes that effect real social change.
There are a wide variety of behaviour change models available to choose from, but as these have
been extensively described and evaluated elsewhere I9, a comprehensive review will not be
attempted in this chapter. Instead, three models that have informed the assumptions of the
empirical component ofthe present project will be briefly described.
Diffusion of innovations model (Rogers)
The ability of social marketers to plan and manage the diffusion or spread of adoptions to the
largest possible target population requires both an understanding of individual behaviour, and of
the mechanisms by which new ideas and practices are spread to target adopters (Kotler et aI,
2002:171). In this regard, the diffusion of innovations model, developed by Everett Rogers




(1962) from a synthesis of previous diffusion research studies in diverse fields, is particularly
useful. In addition to its applicability to both the commercial and social marketing fields, the
model has influenced a plethora of approaches to development communication - as noted earlier
in this chapter.
Rogers (1962:17-18) distinguishes between the adoption process - the adoption of a new idea or
practice by one individual- and the diffusion process, which deals with the spread of new ideas
in a social system. There are five stages in the adoption process (Rogers, 1962:81-100):
1) Awareness: the individual is exposed to the innovation20 but lacks complete information about
it and is not yet motivated to seek further information.
2) Interest: the individual is interested in the new idea and searches for additional information
about it. S/he favours the innovation in a general way but has not yet judged its usefulness in
terms of her/his specific situation.
3) Evaluation: the individual mentally applies the innovation to her/his present and anticipated
future situation in order to decide whether or not to try it. If the individual feels that the
advantages of the innovation outweigh the disadvantages, s/he will decide to try it.
4) Trial: if possible, the individual uses the innovation on a small scale to determine its
applicability to her/his own situation.
5) Adoption: the individual decides to continue full use of the innovation.
Elaborating on his concept of the adoption process, Rogers (1962:99) suggests that impersonal
information sources, such as mass media, are most important at the awareness stage, while
personal sources are more important at the evaluation and trial stages. In general, the model
presents personal influence as extremely important in the adoption process. Personal sources are
more likely to influence behaviour and the transfer of ideas than mass communications which,
rarely affect decisions directly (Rogers, 1962:100). This is because personal influence is better
able to overcome the barriers of selective exposure, perception and retention that can inhibit the
effectiveness of mass media campaigns (Rogers, 1962:225).
20 An innovation is defmed as an idea perceived as new by the individual (Rogers, 1962: 13).
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Rogers (1962:169-170) proposes that individuals in a society can be allocated to one of five
adopter categories (or segments) on the basis of their degree of innovativeness: innovators, early
adopters, early majority, late majority, and laggards. Rogers (1962:209) also suggests that not all
individuals in a social system play equivalent roles in diffusing ideas and practices; some
adopters are active in influencing others to adopt while others play a passive role in spreading an
innovation after their own adoption decision is made. Individuals with a high degree of
influence, from whom others seek information and advice, are known as opinion leaders or
gatekeepers (Rogers, 1962:16). In general, individuals who fall into the "early adopter" segment
tend to possess the highest degree of opinion leadership in a social system (Rogers, 1962:169).
Change agents, professionals who attempt to influence adoption decisions in particular
directions, may also have a high degree of influence in adoption decisions (Rogers, 1962:17).
Importantly, Rogers (1962: 124-132) also proposes a set of determinants of the speed and extent
of adoption and diffusion in a social system. These determinants include:
• Relative advantage: the degree to which an innovation is better, easier and simpler than
the currently available options.
• Communicability: the degree to which the results of the innovation may be diffused to
others.
• Compatibility: the degree to which the innovation fits into people's lifestyles, cultural
beliefs and practices, and self-images.
• DiVisibility: the degree to which the innovation can be tried before making a final
commitment.
• Complexity: the relative difficulty of the innovation to understand and use.
The model's set of inter-related concepts - those of the adoption and diffusion processes, adopter
segments and the determinants of adoption and diffusion - can be applied by the social marketer
in a variety of contexts. In practice, an understanding of the adoption process for a particular
social product or behaviour allows social marketers to set objectives and goals for campaigns,
and manipulate the marketing mix to meet the needs of adopters in different stages of the
process. Empirical evidence suggests that the concept of stages in the adoption process is valid
(Rogers, 1962:95). Lending further weight to Rogers' work is the fact that his conceptualisation
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of the adoption process is echoed in another, more recent, stage model often used by social
marketers: the transtheoretical model (see Prochaska and DiClemete, 1983 in Kotler et aI, 2002).
Although Rogers' model of the adoption process has been praised for its simplicity, some
authors suggest that it does not adequately reflect the full complexity of adoption. Specifically, it
does not acknowledge the possibility of a needs recognition stage prior to the awareness stage; it
does not allow for potential evaluation and rejection of a new product after each stage; and it
does not include a post-adoption evaluation stage (Schiffman and Kanuk, 2000:425).
However, recent research, suggesting relatively limited effects of the mass media and the
importance of interpersonal communication in behaviour change, supports Rogers' assessment of
the role of personal sources in the adoption process (for example Tones and Tilford, 1994, in
Naidoo and Wills, 1988:248). The concept of opinion leaders has been used to advance both
commercial and social goals (for example Schiffman and Kanuk, 2000; Stroebe, 2000) and has
entered the vernacular of the social marketing and health promotion fields. In commercial and
social marketing, the set of proposed determinants of the speed and extent of adoption and
diffusion can be a useful tool in anticipating consumers' reactions to products, as well as in
developing promotional strategies that can compensate for the deficiencies of a particular
product (Schiffman and Kanuk, 2000:414).
As the analysis above - and the earlier discussion around development communication -
indicates, the diffusion of innovations model has been criticised by a number of authors, both in
terms of the components of the model, and with regards to the health promotion approaches it
has spawned. Nevertheless, the model's tenets have a great deal of applicability to social
marketing. The model is also relevant to the specific areas of public health and health promotion;
in which the dissemination of new prevention, early detection, and treatment methods to target
adopters is a major challenge (Glanz and Rimer, 1995:28). In addition, the diffusion of




Health belief model (Rosenstock)
The health belief model is one of the more commonly used theories amongst public health
practitioners and many of its major tenets have been incorporated into social marketing projects
(Lefebvre, 2001 :507). The model was originally designed to explain why individuals did not
participate in programmes to prevent or detect diseases.
The health belief model proposes that an individual will take action to prevent, screen for, or
control a disease or condition based on the following factors (Kotler et aI, 2002: 170; Rosenstock
et aI, 1988:177):
1) Perceived susceptibility: the subjective perception of the likelihood of experiencing or
developing a condition that will adversely affect one's health.
2) Perceived severity: the belief of the individual about the seriousness of the consequences of
developing a specific health problem.
3) Perceived benefits: beliefs about the effectiveness of various actions that might reduce
susceptibility and severity.
4) Perceived barriers: the extent to which the treatment or preventive measure may be seen as
expensive, inconvenient, unpleasant, painful or upsetting.
5) Cues to action: bodily or environmental events that trigger action. Cues to action may be
internal cues like a bodily symptom, or external cues like a mass media campaign.
Thus, once an individual perceives a threat to their health and is simultaneously cued to action,
and the perceived benefits outweigh the perceived costs, the individual is likely to undertake the
recommended health action. More recently, the health belief model has been amended to include
self-efficacy as another predictor of health behaviours, especially more complex ones that
necessitate long-term lifestyle changes (see Rosenstock et aI, 1988).
There is considerable empirical support for the health belief model. A review of a number of
studies, conducted across a variety of health behaviours (such as using seat belts, adherence to
medication regimens and conducting breast self-examinations), found substantial support for the
tenets of the model (Janz and Becker, 1984 in Lefebvre, 2001:507-508). However, the model has
been criticised as it assumes a rational decision-maker (Freimuth, 1992, in Airhihenbuwa and
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Obregon, 2000:7). It also postulates that a change in beliefs automatically results in a change in
behaviour (Andreasen, 1995: 10), and ignores the influence of social influence variables on
individual behaviour (Stroebe, 2000:21). As the health belief model is an abstract theoretical
framework, it has to be operationalised in the context of a particular health behaviour and target
audience (de Wit and Stroebe, 2004:56).
Lefebvre (2001:516) proposes that the health belief model can be best utilised by social
marketers in designing and implementing the promotion component of the marketing mix. Social
marketers can benefit from conducting research to determine the target audience's perceptions of
susceptibility, severity, benefits and barriers as well as cues to action before developing
campaign strategies (Kotler et aI, 2002:171). Decreasing the perceived barriers and increasing
the perceived benefits of a health behaviour are common objectives pursued by social marketing
programmes (Lefebvre, 2001 :508). In addition, such programmes implicitly constitute the cues
to action component of the model (for example mass media interventions designed to motivate a
particular behaviour) (Lefebvre, 2001 :508).
The communication-persuasion model (McGuire)
While McGuire's (1974) communication-persuasion model only examines one of the strategic
elements considered important in social marketing programmes - promotion - it is included in
this discussion as much of the literature on the development of promotional messages is
implicitly or explicitly based on this model (Andreasen, 1995:205). The most recent version of
the model (see McGuire, 2001) presents an input-output matrix to describe the stages leading to
behavioural change (outputs), and how progress through these stages is aided by communication
in its various forms (inputs). Inputs are those qualities of the communication message that can be
manipulated and controlled by the social marketer. Outputs, on the other hand, are those
information-processing steps that must be stimulated in those receiving the message.
Inputs include the following factors (McGuire, 2001 :23-35):
The source: the communicator of the message. Characteristics like age, gender, ethnicity,
credibility and socio-economic status may influence the persuasive impact of the source.
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The message: the infonnation communicated to the target audience. Factors that detennine the
effectiveness of the message include delivery style, content organisation, length and repetition.
The channel: the mode of communication. This may be face-to-face, print and/or broadcast.
Audience characteristics: factors like age, education, intelligence and demographic variables.
The destination: the targeted behaviours and issues to be considered, including long-tenn versus
short-tenn change and specific versus general behaviours.
Outputs are the stages of change from the initial exposure to communication to the long tenn
maintenance of change within the intended receiver. There are twelve output steps necessary for
pennanent behaviour change to occur: exposure; attention; liking; comprehension; skill-
acquisition; attitude change; memory storage; infonnation search and retrieval from memory;
decision based on retrieval; behaviour in accordance with the decision; reinforcement; and
consolidation (McGuire, 2001 :32; Elder, 2001: 17).
The model has made a significant contribution to the field of public health communication,
especially in the use of mass media (Elder, 2001: 18). It is particularly relevant to the design of
the promotional component of social marketing programmes, as well as the evaluation of specific
components of the communication effort, as it offers both an understanding of the behaviour
change process and of the ways in which this can be manipulated by the social marketer. It is
also useful in nations with large rural populations where mass media is relied on to a greater
extent than in urban areas where populations can be more easily reached through personal
contact (Elder, 2001: 18).
McGuire (2001:41) himself, however, points out some of the limitations of the model: many of
the steps in the behaviour change process may be eliminated in some contexts and the steps may
not always occur in the proposed order. de Groot (1980:63) in his analysis of an early version of
the model, criticises it for its "linear sequential" nature - its assumption of a causal sequence of
communication effects. The notion that an individual considers communication messages in a
rational, step-by-step manner can be considered to be problematic, a point with which
Airhihenbuwa and Obregon (2000:12) concur in their more general assessment of theories of
behaviour change. Nevertheless, the similarity of McGuire's output steps to the stages described
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in Rogers' adoption process as well as the hierarchy of effects model typically used in marketing
- in which the proposed steps are awareness, knowledge, liking, preference, conviction, and
purchase (Etzel et aI, 2001 :502) - confirms the durability of this kind of model of
communication.
Behaviour change models, such as the three discussed above, offer important principles and
concepts that can be utilised by social marketers in the design of social change programmes.
However, no model is complete in itself and thus as Weinreich (1999:92) points out, a synthesis
of theories relevant to a specific programme is generally more useful than a strict adherence to
anyone framework. Each of the models discussed above has been chosen for its applicability to
the present project and will be further utilised in later chapters of this dissertation.
Criticisms of the social marketing approach
Before concluding this chapter, it would be politic to present a brief synthesis of criticisms of the
social marketing paradigm. While social marketing can have a significant influence on some
types of social problems, it is acknowledged that it may not be as effective for complex problems
with many contributing or confounding factors, problems not under individual control, or
addictive disorders (Weinreich, 1999:4). A number of authors (see for example Buchanan et aI,
1994:53; Goldberg, 1995:348) problematise social marketing's focus on changing individual
behaviour, suggesting that social change programmes also need to concentrate on changing the
negative social structural influences (such as policy or environment) on the individual. As a
consequence of this limitation, Goldberg (1995:347) advocates a move away from a conservative
structural-functional tradition in the social marketing approach towards a more radical critical
theory paradigm21. Hastings and Haywood (1994:62) counter-argue that social marketing does
not necessarily ignore environmental factors, but rather works on changing these when possible
(for example, social marketers have campaigned against tobacco advertising in America), and
when this is not feasible, programmes and campaigns are planned around these constraints.
Montazeri (1997: 117) criticises the use of social marketing in the field of health as simply too
expensive - in money, time, and human resources - to be used in already overburdened public




health systems. (However, in the same article the author cites a study that praised social
marketing as a cost-effective strategy for preventing unwanted pregnancies).
In a seminal article, Buchanan and colleagues (1994:51) attack social marketing as a health
promotion tool, questioning the assumptions of central tenets of the field. They criticise the
relevance of the "product, place, and price" components of the marketing mix in social contexts,
as these are not as easily manipulated as in commercial marketing; and write scathingly about the
applicability of the consumer orientation, as the "needs" of the target audience are rarely
perceived as such by anyone other than the social marketer. In their reply, Hastings and
Haywood (1994) manage to debunk each of their critics' arguments, ultimately exposing a faulty
understanding of social marketing as the root of the problem. In relation to the latter of the
criticisms detailed above, Hastings and Haywood (1994:60) explain that the consumer
orientation of social marketing views consumers as "active participants in the search for a
mutually beneficial outcome", and not merely as passive recipients of the marketer's message.
As the debate described above illustrates, a negative perception of social marketing - particularly
by professionals in the development and public health fields - is perhaps the greatest hindrance
to the widespread acceptance of the discipline. It is what Buchanan and his colleagues (1994:56)
express as a "vague discomfort with the growing enthusiasm for social marketing"; a sense that
marketing is a somewhat sleazy and manipulative endeavour, best confined to the commercial
arena if it has to be used at all. It might perhaps be prudent, therefore, to apply the tools and
techniques of social marketing to the formidable task of convincing professionals in similar
fields of the validity of the approach.
Conclusion
Although social marketing is not without its critics, it has nevertheless been recognised as an
approach capable of addressing a variety of social problems, including public health issues. As
an approach that can be contextualised within the broader field of development communication,
social marketing's central tenet of a customer orientation contributes to its success. This analysis
of the field has concentrated on the literature dedicated to the planning stages of the social
marketing process, due to the focus of the research questions of this dissertation. In addition, a
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critical review of three behaviour change models that are particularly applicable to the project at
hand has been conducted. The next chapter will layout the methodology for the empirical
component of this dissertation.
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Chapter 5: Research methodology
As the previous three chapters constitute a review of the relevant literature in the fields of
RN/AIDS, antiretrovira1s and social marketing, they have served as a background to the primary
research conducted as part of the present project. The primary research was divided into three
stages, each of which is discussed in detail in the sections that follow. Prior to this discussion, the
type of research, statement ofthe problem and research questions will be clarified.
Type of research
The primary research is of a descriptive nature. Durrheim (1999a:39) explains that descriptive
studies "aim to describe phenomena accurately". By conducting a needs analysis among the
general student population, the research aims to describe students' knowledge, attitudes and
beliefs surrounding the topic of ARVs as well as the sources that have influenced them in this
area. The research is not designed to provide causal explanations, but rather to discover, and
provide insight into, the ARV-re1ated needs of students that can be addressed by appropriate
promotional campaigns.
In terms of the stages of social marketing research discussed in Chapter 4, the primary research
undertaken for this project can be considered to be formative research (see Andreasen, 1995). It
aims to address many of the issues highlighted in the strategic planning, needs assessments and
target audience research stages of the framework provided in Appendix A.
Statement of the problem and research questions
In light of the complicated nature of antiretrovira1 therapy, the politicisation of the issue in the
South African context and the resultant media hype, as well as the necessity of community
support for the patient on ARVs, the communication needs of different target popu1ations are
likely to be diverse and complex. Nevertheless, at both a national and an institutiona11eve1 there
is a pressing need for appropriate communication about ARVs in order to influence the
knowledge, attitudes and behaviour of RN-infected individuals, individuals with AIDS and the
general public. The present project will examine this issue in the context of the ARV rollout by
UKZN. In conducting a needs analysis among the general student population, the present project
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will probe the students' current knowledge, attitudes and beliefs about ARVs. Such research is
an essential component of social marketing and a necessary precursor to the development of
effective, audience-driven promotional materials around the subject22 .
The primary research will attempt to answer three major research questions:
1) What are the sources and content of the knowledge, attitudes and beliefs23 of the
general student population concerning antiretrovirals?
2) Are there significant differences in the knowledge, attitudes and beliefs of sub-
groups within the general student population that may justify audience
segmentation when delivering messages?
3) What are the promotion-related needs of the general student population
concerning the topic of antiretrovirals?
Research design
In an endeavour to answer the research questions of this dissertation, three distinct phases of
primary research were designed (although only two of the phases were eventually implemented).
These phases consisted of an expert interview, questionnaires, and depth interviews. Each of the
phases is detailed in the sections that follow.
Expert interview
According to Flick (2002:89), the expert interview is a form of semi-structured interview,
designed to elicit very specific kinds of information from an expert in a particular field. In order
to gain additional knowledge about aspects of the ARV rollout at UKZN that were not available
via secondary sources, Michelle Mitchell was interviewed on 6 October 2004. Michelle Mitchell
was the AIDS Programme Co-ordinator for UKZN in 2004 (she has since left the University).
22 Although the research has been designed in line with the social marketing paradigm, only one element of the
marketing mix has been addressed by the primary research: promotion. This is due to time limitations, the fact that
the product and place components of antiretroviral therapy are mostly beyond the control of the University, as well
as the focus on communication of the department in which this research has been conducted (Culture,
Communication and Media Studies).
23 The terms "knowledge", "attitudes", and "beliefs" are commonly used in a variety of disciplines, including social
marketing. For the purposes of the present project, knowledge can be defmed as "what is known...person's range of
information" (Allen, 1984: 406-407), beliefs are "perception(s) held about factual matter" (Kotler and Roberto,




Although a list of questions was compiled prior to the interview, the interview was also allowed
to develop naturally in order to explore relevant and interesting issues that arose during the
course of the conversation. Where applicable, information obtained from this interview has been




The largest and most important component of the primary research consisted of a questionnaire
designed to assess the ARV-related promotional needs of the general student population (see
Appendix C). A questionnaire design was chosen for a number of reasons. Knowledge, attitudes,
practices and beliefs (KAPB) surveys, such as this one, are common research tools in the social
marketing environment and are widely used in the area of health (Andreasen, 1995: 109). Also,
questionnaires are: the most convenient way to elicit information from large groups of
respondents; relatively cheap to produce; time-efficient in terms of data collection and analysis
and ensure a homogenous stimulus.
The questionnaire, after expert consultation and pre-testing, consisted of a sixteen question, two
page, back-to-back format. All of the questions, with the exception of questions 3, 5, 6 and 7,
required quantitative answers. A funnel approach was used, in that questions were arranged from
the general to the particular and followed a logical order. Also, the format was designed to be as
easy to complete as possible, in order to gain the cooperation of respondents and ensure
straightforward data analysis. A brief description of each question and the motivation behind it is
available in Appendix D.
A reliability analysis statistical test - Cronbach's coefficient alpha - was conducted in order to
determine the reliability of the questionnaire as a measurement instrument. Durrheim (1999b:88)
explains that reliability refers to the dependability of the measurement instrument; the extent to
which the questionnaire will yield similar results on different occasions. The alpha test indicated
an alpha value of 0.8953 for the entire questionnaire. As this is greater than 0.75, the
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The target population sampled for the questionnaire phase of the primary research consisted of
all students currently studying at the University of KwaZulu-Natal: Howard College and
Westville campuses. Students were chosen as the target population for three reasons. Firstly, as
noted elsewhere, students fall within the most vulnerable age category for new HN infections,
and thus demonstrate a relatively high prevalence of HN/AIDS. Thus, it is likely that a
significant proportion of students may need ARV drugs in the future, or may know friends or
family members who need support in this area. This group is thus likely to be a major target
audience for future communication campaigns on this subject, both as members of the University
community and as South African citizens, and thus their communication needs must be
identified. Secondly, as antiretroviral drugs have recently been rolled out at UKZN, it is essential
that the communication needs of students around this issue are well understood in order to
develop appropriate promotional materials. Thirdly, students are an easily accessible group, and
thus convenient to sample.
Only two campuses out of the five campuses that now form UKZN were selected in order to
increase the feasibility of the present project: the Howard College and Westville campuses.
These particular campuses were chosen as they differ in two notable aspects. As a university
intended for Indian students in the apartheid era, the Westville campus has been traditionally
attended by poorer students of colour (both Indian and Black African) and in this respect it
differs from the Howard College campus, which is a historically more privileged institution and
still has a high proportion of White students24. Another reason for the choice of campuses was
24 In terms of race, in 2004 the Westville Campus student population was 54% Black African, 41% Indian, 2%
White, 2% Coloured and 1% other. In contrast, the Howard College Campus student population was 45% Black
African, 33% Indian, 19% White, 4% Coloured and less than 1% other (percentages rounded off to nearest whole
number). Statistics for 2005 are similar (see http://www.ukzn.ac.za/dmi/ukznstats/students cam.asp). While no
figures are available to compare the fmancial means of the two campuses prior to the merger, anecdotal evidence
and a clear physical difference visible between the two campuses in terms of resources, suggest that substantial
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that as Westville had not had a nurse trained for HN Counselling until September 2004, the
rollout of antiretrovirals was not advertised at that campus until October of the same year
(Mitchell, 2004: personal correspondence). Thus, Westville served as a control group, which
could be usefully compared to Howard College, where the rollout has been extensively
advertised since the first semester of 2004. It is possible, therefore, that the disparities between
the two campuses may have influenced differences in the ARV-related knowledge, attitudes and
beliefs of students at the two campuses, and thus the choice of campuses is considered
justifiable.
Sampling method:
For the questionnaire, quota sampling - a type of non-probability sampling - was used to obtain
a sample as representative of the general student population in certain aspects as possible
25
. Non-
probability samples rely heavily on personal judgement and thus are only representative of the
target population if the researcher is sufficiently skilled (Loubser, 1999b:253). In a quota sample,
steps are taken "to obtain a sample similar to the population in some pre-specified
characteristics" (Loubser, 1999b:254). In this case, two characteristics were considered when
sampling: 1) the campus at which the respondent studied and 2) the respondent's race. The
present project employed this sampling method because it was hypothesised that these two
variables may have resulted in any differences in ARV-related knowledge, attitudes and beliefs
within the general student population. Thus, these variables may be useful for future audience
segmentation exercises. As discussed above, fundamental differences between the two campuses
may have resulted in differing responses to the questionnaire. In addition, race is still considered
a valuable differentiating factor in South Africa and has been used in development surveys like
The Nelson MandelalHSRC Study ofHN/AIDS (see HSRC, 2002). The previous government's
policy of apartheid resulted in varying degrees of access to resources for different race groups
and thus, economic, social and cultural differences are still visible among the races.
differences did and still do exist. For a more detailed history of the two former universities, see
http://www.homestead.comlleader/fileslDurban doc.pdf
25 Altho~gh stratified sampling - the probability sampling equivalent of quota sampling - was originally proposed as
a samplmg method, the logistical impossibility of randomly sampling students was soon realised and thus this
method was ultimately not considered feasible.
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After consultation with lecturers at the two campuses, the questionnaires were distributed in
classes that were considered to have a relatively representative racial composition of students.
This was done to ensure that the racial demographics of the sample replicated those of each
campus as closely as possible. However, owing to the fact that the questionnaires were
distributed in lectures in order to maximise the response rate, it was not possible to obtain a
sample that exactly mirrored the racial characteristics of each campus. In order to ensure that
students at each of the two campuses were adequately represented in the total sample, an
approximately equal number of questionnaires were handed out on each campus26 .
Sample size:
It was decided to use a sample size of approximately 300 (150 on each campus). At the end of
the data collection period, a total of 324 questionnaires had been handed out, of which 302 were
returned and usable (a response rate of 93%). The sample size was small owing to time and
financial constraints, as well as the logistics involved in trying to liaise with lecturers to hand out
questionnaires in their classes at the end of a term. However, the sample size was considered
large enough to reveal broad trends in awareness, knowledge, attitudes and beliefs among the
general student population.
Expert evaluation and pre-testing ofthe questionnaire
Once the initial questionnaire was designed, it was submitted to Arnold Shepperson (a tutor in
Culture, Communication and Media Studies) and Lynn Dalrymple of the NGO DramAidE for
evaluation. Dalrymple pointed out that this version of the questionnaire used the term
"antiretrovirals" generically and thus was likely to be misconstrued by students as antiretrovirals
have a number of uses in connection with HNIAIDS. In order to rectify this, Question 4 was
added to focus the students' attention on the fact that ARVs are used for a number of purposes.
As the remaining questions were changed, where appropriate, so that ARVs were always
mentioned in connection with the treatment of HIVIAIDS (and thus not as a prophylactic), it was
hoped that the students would answer the questions in line with what they knew, believed and
26
As of 16 September 2004, the Howard College campus had a total of20250 students while the Westville campus
had a stude~t bo~y of 12443 (http://www.ukzn.ac.zaldmilukznstats/students cam.asp). Theoretically therefore,
fewer q~estlOnnalTeS should ha~e been handed out at Westville. However, due to the already small sample size it
was deCIded to hand out approxImately equal numbers of questionnaires at the two campuses.
64
Callen MorrisonlMasters Dissertation
thought about ARVs for the treatment of HIVIAIDS. Once these changes had been made, the
questionnaire was also submitted to Michelle Mitchell, formerly of UKZN's AIDS Programme,
for her comments.
Before pre-testing the questionnaire, it was submitted to Professor Johan Jacobs, then Head of
the School of Graduate Studies, Faculty of Human Sciences, for ethical approval and to Dr. Devi
Rajab, Dean of Student Development, for approval to hand out on the two campuses. Approval
was granted in both cases.
Pre-testing of a questionnaire is essential to ensure that it is able to perform the functions for
which it was designed (Loubser, 1999a:232). In a pre-test, respondents from the target
population are asked to complete the questionnaire as it exists at that time, point out features of
the questionnaire that may need to be changed and suggest questions that may need to be added
(Bourque and Fielder, 2003:84).
In order to pre-test this questionnaire, a convemence sample of eight students (one Black
African, two Indian and five White students) from the Howard College campus was used. The
students were asked to complete the questionnaire and then give feedback as to the clarity of the
questions, any difficulties they experienced and any suggestions they had to improve the
questionnaire design. In general, the students found the questionnaire easy to understand and
answer. However, the following issues came to light as a result of the pre-test:
• One student noticed that the term "HN/AIDS" was used for some questions, while the
terms "HN" or "AIDS" was used for others. This inconsistency was rectified except for
Question 12 ("If! knew someone who was sick with AIDS ...") as once a person becomes
sick as a result of the disease, they are medically classified as having AIDS.
• One student mentioned that Question 4 ("In which context have you heard of
antiretrovirals?") was confusing until he read the options available to choose from. As
this point was not raised by any other student, it was decided to leave the question as it
stood.
• Question 5 ("What do you think are the main benefits of antiretroviral drugs when used to
treat HIVIAIDS?"- italics added) was misunderstood by one student. She answered that
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the main benefit of the drugs was to prevent mother-to-child transmission of HN/AIDS.
As the other students in the pre-test did not have this problem and every attempt has been
made to clarify the issue (particularly through the addition of Question 4), the question
was not adjusted. However, it was recognised that the question may be open to some
misinterpretation.
Data collection
The questionnaires were distributed and collected on the two campuses from 11 October 2004
to 5 November 2004. As mentioned above, the questionnaires were distributed and collected
during a lecture slot in order to maximise the response rate. An attempt was made to
distribute the questionnaires across faculties and years of study in order to minimise bias and
to obtain as representative a sample as possible. Prior to the questionnaire being handed out,
instructions were given to the students. The voluntary nature of the questionnaire was
emphasised and the students were assured that their responses would be anonymous in order
to ensure their cooperation and the completion of the questionnaire. It was stressed that every
respondent needed to complete the demographic question (Question 16) even if they
answered "no" to the first question. While the questionnaire was being completed by the
students, every effort was made to ensure that they did not discuss the questionnaire with
their peers, as this could have produced inaccurate results. I was present throughout the time
to answer any questions that the students had.
Data analysis
Data editing:
According to Martins (1999:295), editing "entails a thorough and critical examination of a
completed questionnaire in terms of compliance with the criteria for collecting meaningful data
and in order to deal with questionnaires not duly completed" For the purposes of this research
study, each questionnaire was scrutinised for compliance with the following criteria:
• Completeness: if a high number of questions were unanswered or the demographic
questions had not been answered and thus the questionnaire was unable to be analysed, it
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was discarded. If only a few questions were left unanswered, these were coded as "no
answer".
• Legibility and comprehensibility: these criteria were especially important when
analysing the qualitative responses to Questions 5, 6 and 7 of the questionnaire. When
answers were illegible or incomprehensible, they were coded as "no answer".
• Relevance: this criterion was particularly important for open-ended Questions 5, 6 and 7
as respondents are more likely to have misunderstood these questions than the questions
with structured responses, and thus are more likely to have given irrelevant answers. As
this may point to a need for further information on ARVs, this was taken into account
when coding these answers. When answers were not relevant to the question, they were
coded as "incorrect answer".
Data coding:
The coding system used for the questionnaires can be seen in Table 5.1 below:
Table 5.1: Coding of data for the questionnaire
Question/s Coding
All questions: o= no answer or incomprehensible/illegible answer
Questions 1, 14, 15: 1 = yes, 2 = no
Questions 2 and 4: For each option, 1 = yes (tick) and 2 = no (no tick)
Question 3: For the options AZT, Nevirapine and other ARV brand
name, 1 = yes (mentioned) and 2 = no (not mentioned)
Question 5: For each of the categories (biological advantages, social
advantages, incorrect answer, other) 1 = yes
(mentioned), 2 = no (not mentioned)
Question 6: For each of the categories (side effects, lifelong
treatment, careless sexual behaviour, adherence, access,
incorrect answer, other), 1 = yes (mentioned), 2 = no
(not mentioned)
Question 7: For each of the categories (safe sexual behaviour,
exercise, healthy eating/vitamins, alternative therapies,
incorrect answer, other, none) 1 = yes (mentioned),
2 = no (not mentioned)
Question 8, a, band c: 1 - true, 2 = false
Question 9-13: 5 = strongly agree, 4 = agree, 3 = neutral, 2 = disagree,
1 = strongly disagree
Question 16 (campus): 1 = Westville, 2 = Howard College
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Question 16 (faculty)L : I - Commerce and Management/Management Studies, 2
= HumanitiesIHuman Sciences, 3 = Science, 4 =
Engineering,S = Law, 6 = Education, 7 = Health
Sciences, 8 = Community and Development Disciplines
(CADD)
Question 16 (sex): 1 - female, 2 - male
Question 16 (race): I - Black/African, 2 - White, 3 Indian, 4
Coloured,S = Other
Question 16 (background): 1 - urban, 2 - rural
For Questions 3, 5, 6, and 7, the thematic categories used to code the answers were only
determined once data collection had taken place. A number of the questionnaires were perused
so as to determine the most common and relevant themes that could be used to categorise the
qualitative data.
Data capturing:
The data was captured onto the computer for analysis, using the SPSS computer programme.
Data analysis:
For all questions: frequency distributions and percentages were calculated for the answers to all
questions, both for the overall sample, and for each campus and racial group. The use of
percentages allowed data to be represented in pie-charts and/or bar graphs. Descriptive statistics
(mean, median, mode, standard deviation and variance) were also calculated for each question.
Although frequency distributions, percentages and descriptive statistics are useful in presenting
the answers of the sample to the questions, they are not sufficient to determine whether any
differences that exist between sub-groups of the sample are due simply to chance or to
fundamental differences in knowledge, attitudes or beliefs among different populations. Thus,
statistical tests have been used to determine whether any differences that exist between students
from different campuses or races are statistically significanes and therefore noteworthy. Before
27 When faculties across the two campuses are similar, but had different names in 2004, they have been coded as one
category. However, both names are given here where applicable, with the faculty name of the Westville campus
being given fIrst, followed by that of the Howard College campus. In 2005, faculty names were standardised across
all the campuses.
28 If the differences are "statistically signifIcant", then the differences between sub-groups of the sample are too




describing the statistical tests used, it should be noted that the explanation of the tests assumes
some basic statistical knowledge on the part of the reader.
For questions 1-8, 14 and 15: as the data obtained from these questions is nominal, the chi-
square (non-parametric) test was used to test for significant relationships between each
dependent variable and race/campus. If the probability (or p) value29 is less than 0.0530, then the
chi-square value is significant and there is a significant association between the two variables.
Cross-tabulations that included expected counts for each category of each variable were also
utilised in order to identify patterns or trends in the data.
For questions 9-13: in order to discover whether there were significant differences between
students from different race groups in their response to these questions, the Kruskal-Wallis test
has been used. As the data obtained from these questions is ordinal, a non-parametric procedure
must be used to test for differences between multiple groups (Loubser, 1999c:340). The Kruskal-
Wallis test is the non-parametric alternative to one-way analysis of variance. Where significant
differences between the races are indicated by a small p-value (less than 0.05), a Mann-Whitney
U test has been used to perfonn pair-wise comparisons, in order to find out where the differences
lie.
In order to test for significant differences between students from the two campuses in their
response to these questions, the Mann-Whitney U test was used. This is the non-parametric
alternative to the t-test for two independent samples (Loubser, 1999c:339).
Depth interviews
In order to gain a deeper, more qualitative understanding of the ARV-related promotional needs
of the general student population, depth interviews with students already on ARVs were planned.
The target population for this phase of the research would have been all students at the
University of KwaZulu-Natal, on any of the five campuses (due to the small number of students
on ARVs under the supervision of the campus clinics, sampling only two campuses would have
2~ T~e p-val~e is "the chance that that there is no relationship between variables in the population, or that there is no
~~gruficant dIfferences between groups" (Durrheim, 1999c: 118).
The significance level has been set at 0.05 for all of the tests used.
69
Callen MorrisonlMasters Dissertation
been unlikely to elicit sufficient numbers of respondents). According to Bennett (1999:134-135),
depth interviews are particularly useful when the issue under investigation is complex and
involves attitudes, beliefs and feelings. As students on ARVs under the auspices of the campus
clinics are essentially "success stories", their insight into various issues would have been
valuable in determining the steps that the University needs to take to move other students
towards the same point. The depth interview questions were designed to complement the
information obtained from the questionnaire (see Appendix E for the covering letter to students
and the depth interview outline).
Unfortunately, although ethical clearance was applied for well in advance, the bureaucratic
nature of the University's new ethical review system resulted in a lengthy delay in obtaining
ethical clearance. Thus, there was insufficient time before the due date of this dissertation to
recruit students and conduct the depth interviews. It is acknowledged that these interviews would
have formed a valuable addition to the information obtained from the other two phases of the
primary research.
Conclusion
This chapter has laid out the methodology of the primary research, which has been conducted in
line with the tenets of the social marketing approach. The main purpose of the research is to gain
insight into the ARV-related knowledge, beliefs and attitudes of the general student population;
thus allowing an analysis of the students' future promotional needs. The type of research,
statement of the problem, and the research questions have been elucidated in order to lead the
reader into the research design. Thereafter, each of the three phases - expert interview,
questionnaires and depth interviews - has been described in detail. Chapter 6 will present the
results of the questionnaire phase of the primary research, while Chapter 7 will critically discuss




This chapter will present the findings of the questionnaire phase of the pnmary research
(information obtained from the expert interview has been included in other chapters where
appropriate). Although the data generated from the questionnaire is substantial, space limitations
prevent a lengthy description of each and every possible level of analysis. Thus, only the most
pertinent findings have been described, with other interesting but less important data available in
the appendices.
Caveats
The findings related to the questionnaire have been grouped according to the knowledge,
attitudes and beliefs of respondents that they represent, rather than in the order in which the
questions were asked. Not only is this more interesting and reader friendly, it is also the format
which will be used in the discussion of results. Before delving into the findings, a few points
should be noted. Firstly, due to space limitations, only the frequency distributions for the total
sample have been discussed. Where there are statistically significant relationships between
dependent variables and race or campus, these will be described. Otherwise, tables of frequencies
that indicate the responses of students from different races and campuses to the questions are
available in Appendix F, as are measures of central tendency and dispersion. The results of the
statistical tests used can be found in Appendix G, as can important details pertaining to the tests.
Secondly, only where the non-response rate for a question is more than 5% will this statistic be
given and discussed. Otherwise, it can be assumed that the proportion of respondents who did
not answer a question is less than 5%. Thirdly, as Coloured respondents constituted only 2.6% of
the total sample and "Other" respondents only 0.7%, these race groups have not been included in
the statistical tests used. However, they do form part of the frequency distributions given for the
overall sample. Finally, the results of the statistical tests have been presented in standard
statistical language in this chapter. In Chapter 7 they will be interpreted and discussed in a
manner more accessible to the layman.
71
Callen MorrisonlMasters Dissertation
Description of the sample
(Question 16: In order to statistically analyse this questionnaire I require some demographic
information from you.)
Campus
As planned, the sample was fairly evenly split between the two campuses surveyed, with 53% of
respondents studying at the Westville campus and 47% at the Howard College campus. The





• t-bw ard College
Faculty
Commerce and Management/Management Studies students (47%) and HurnanitiesIHurnan
Sciences students (46.7%) formed the bulk of the sample. The remainder of the respondents were
from the Science (2.6%), Law (2.3%), Health Sciences (0.7%), Engineering (0.3%) and CADD













The majority of students (75.8%) were female and only 24.2% of the total sample was male (in
the general student population, 55% of students were female and 45% were male in 200431 ). This
outcome was unintended and, unfortunately, not a variable that was controlled for. The sex of the





In the overall sample, the majority of students were Black (51.7%), followed by Indians (33.1 %),
Whites (11.9%), Coloureds (2.6%) and "Other" (0.7%). Of the students sampled from the
Westville campus, 66.9% were Black, 31.3% Indian, 1.3% Coloured, 0.6% White and none were




"Other" (compared to a total 2004 Westville student population of 54% Black Africans, 41 %
Indians, 2% Whites, 2% Coloureds and 1% "Other"). Out of the students from the Roward
College campus, 35.2% were Indian, 34.5% were Black, 24.6% were White, 4.2% were
Coloured and 1.4% were "Other" (compared to a 2004 Roward College total student population
of 45% Black African, 33% Indian, 19% White, 4% Coloured and less than 1% "Other,,32). The
difficulties of obtaining an entirely representative sample have been discussed in Chapter 5, but
nevertheless the samples obtained from the two campuses were, in general, fairly representative
of the racial composition of the two student populations. The racial composition of the overall



















As can be seen in Figure 6.5 below, the majority of students (80.5%) came from an urban
background, while only 18.9% came from a rural background. It is noteworthy that a higher
percentage than the average of Blacks and Westville students came from rural backgrounds:
32.1 % and 28.1 % respectively.





Knowledge-related questions (Questions 1,3,4, 8, 14)
Awareness of antiretrovirals
(Question 1: Have you ever heard of"antiretrovirals" or "ARVs"?)
Awareness of antiretrovirals was extremely high among the sample, with 98% of all respondents
having heard of antiretrovirals or ARVs and only 2% unaware of the drugs. The results are
illustrated in Figure 6.6 below:
Figure 6.6: Awareness of antiretrovirals
2%
98%
Chi-square tests were conducted in order to determine whether there are statistically significant
relationships between race and/or campus and awareness of antiretrovirals. The results indicate
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that there is no significant relationship between awareness of ARVs and race (p=O.947), or
between awareness of ARVs and campus (p=O.132).
Awareness of University rollout
(Question 14: Are you aware that the university provides access to cheap antiretroviral
treatmentfor students and statfwith HIVIAIDS?)
In contrast to a general awareness of ARVs, awareness of the rollout at UKZN was extremely
low. The majority (82.5%) of the sample was unaware that the University provides access to
cheap antiretroviral treatment for students and staff with HN/AIDS, and only 15.2% were aware
of this fact. The distribution of answers is illustrated in Figure 6.7 below:





Chi-square tests do not reveal a statistically significant relationship between awareness of the
university rollout and race (p=0.253). However, the results do indicate a significant relationship
between awareness of the university rollout and campus (p=O.024). A statistically significantly
larger proportion of Howard College students, and a smaller proportion of Westville students,
were aware of the rollout than would have been expected had campus and awareness of the
rollout not been associated.
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Knowledge of antiretroviral names
(Question 3: Ifyou know the names ofany antiretrovirals, please write them here.)
The majority (72.2%) of the total sample did not answer this question, presumably because they
did not know the names of any antiretroviral drugs or were not prepared to give a written answer.
However, 15.2% mentioned AZT and 14.2% mentioned Nevirapine (or Virimune, a brand name
for the same drug). 2.3% stated the names of other ARVs, including Stocrin, 3TC and d4T. The
sample's knowledge of the names of ARVs is illustrated in Figure 6.8 below:















The results of the chi-square tests conducted indicate that there are no significant relationships
between knowledge of AZT, Nevirapine or any "other" ARV name and race (p=0.259; p=O.235;
p=O.252 respectively). However, the tests do show significant relationships between each of the
dependent variables (AZT, Nevirapine and "other") for this question and campus (p=O.002 for
each variable). In each case, a higher proportion ofWestville students, and a lower proportion of
Howard College students, recalled the names of ARV drugs than would have been expected if
knowledge of ARV names and campus had not been associated. Also, more Westville students,
and less Howard College students, did not recall AZT, Nevirapine or an "other" ARV than
would have been expected had there been no association between variables. Thus, for this
question, the trend in the data is not particularly clear.
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Knowledge of different contexts in which antiretrovirals are used
(Question 4: In which context have you heard ofantiretrovirals?)
The majority (79.5%) of respondents had heard of antiretrovirals in the context of preventing
mother to child transmission of HN; 68.9% in the context of treating adults and children with
HN/AIDS; 52.3% knew about their use as a precaution after rape and 34.4% were aware that the
drugs could be taken after a needlestick injury as a prophylactic measure. Less than 1% had
heard of the drugs in a context other than those mentioned. The sample's knowledge of different
contexts in which antiretroviral drugs are used is illustrated in Figure 6.9 below:












Chi-square tests performed to assess the relationship between knowledge of different contexts for
ARV use and race did not yield statistically significant results for the variables rape (p=O.074);
prevention of mother to child transmission (p=O.382); treatment of HN/AIDS (p=O.097) or
"other" (p=O.145). However, the results do indicate a statistically significant relationship
between knowledge of ARVs in the context of needlestick injuries and race (p=O.OOl). A higher
proportion of White and Indian students, and a lower proportion of Black students, were aware
of this context for ARV use than would have been expected ifthere were no association between
the variables.
Similarly, the tests do not reveal statistically significant relationships between campus and
students' knowledge of antiretrovirals used in the contexts of rape; the prevention of mother to
child transmission; the treatment of adults and children with HN/AIDS or "other" contexts
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(p=0.078; p=0.416; p=0.352 and p=0.138 respectively). However, there is a statistically
significant relationship between knowledge of antiretrovirals used in the context of needlestick
injuries and campus (p=O.OOO). A higher proportion of Howard College students, and a lower
proportion of Westville students, were aware of this context than would have been expected if
there were no relationship between the variables.
Knowledge of antiretrovirals and access (Question 8)
In general, respondents had a good grasp of the basic facts concerning ARVs and access to the
drugs. For statement 8a ("When used as a treatment for HN/AIDS, antiretrovirals are a cure for
HN/AIDS") the majority of students (86.1 %) stated correctly that this was false. 7% answered
that the statement was true, while another 7% did not answer the question.
For statement 8b ("When used as a treatment for HN/AIDS, antiretrovirals are taken for the rest
of a person's life"), most respondents (79.5%) answered correctly that this was true. 12.3%
stated that this was false, while another 8.3% did not answer the question.
For statement 8c ("When used as a treatment for HN/AIDS, antiretrovirals are given to anybody
who asks for them"), most of the students surveyed (74.2%) again answered correctly, stating
that this was false, while only 14.6% believed that the statement was true. 11.3% did not answer
the question. A visual summary of the responses to these three statements is provided in Figure
6.10 below:
















Chi-square tests do not reveal a significant relationship between statement 8a, 8b or 8c and race
(p=0.316; p=0.527 and p=0.374 respectively). Similarly, the results do not indicate a significant
relationship between any of the three statements and campus (p=0.074; p=0.679 and p=0.727
respectively).
Belief-related questions (Questions 5, 6, 7)
Beliefs about the benefits of antiretrovirals
(Question 5: What do you think are the main benefits ofantiretroviral drugs when used to
treat HIVIAIDS?)
The majority of respondents (64.2%) discussed the biological advantages of ARVs in their
answers to this question. Although not all answers were absolutely correct from a technical
viewpoint, most respondents noted that ARVs allowed people with HIV/AIDS to live longer,
healthier lives and that the drugs dramatically improved the strength of the immune system.
Three answers that typify the response to this question are reproduced below:
"The mam benefit IS that it helps you fighting disease and boosting your Immune
system".
"It would improve the general well-being of people suffering from HIV/AIDS and would
lengthen their lives."
"They reduce the speed of the virus and increase the CD4 cells."
The remainder of the responses to this question were as follows:
• A very small percentage (5.3%) of respondents pointed out the social advantages of the
drugs. Answers that fell under this category included those that mentioned that ARVs
allowed the infected individual to stay with his or her loved ones for longer, and those
that discussed how the use of ARVs could reduce the negative effects of the virus on the
individual's community.
A large proportion (21.9%) of the sample gave an incorrect answer for this question,




in relation to ARVs used to prevent mother to child transmission of RN or those used
after rape.
A high percentage of students (17.5%) did not answer this question, presumably because
they did not know enough about ARVs to do so, or did not want to take the necessary
time and effort to answer.
The sample's beliefs about the benefits of antiretroviral drugs for the treatment of RN/AIDS
have been summarised in Figure 6.11 below:













Chi-square tests indicate that there is a significant relationship between a biological answer and
race (p=O.OI0); between a social answer and race (p=O.OI7); between an incorrect answer and
race (p=O.005) and between an "other" answer and race (p=O.003). A larger proportion of Black
and White students, and a smaller proportion of Indian students, mentioned the biological
benefits of ARVs than would have been expected if there were no association between race and
this variable. A larger proportion of Black and White students, and a smaller proportion of
Indians, than would have been expected were there no association between the variables, did not
mention the social benefits of ARVs. More Blacks and Whites, and less Indians, did not give an
incorrect answer for this question than would have been expected had there been no relationship
between the variables. A larger proportion of Black and White students, and a smaller proportion
of Indian students, than would have been expected if there were no relationship between the
variables did not mention "other" benefits of ARVs.
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Statistical tests show that there is no statistically significant relationship between a biological
answer and campus (p=0.104); between an incorrect answer and campus (p=0.327) or between
an "other" answer and campus (p=0.136). However, there is a statistically significant association
between a social answer and campus (p=0.014). A higher proportion ofWestville students, and a
lower proportion of Howard College students, gave a social answer than would have been
expected had there been no association between the two variables.
Beliefs about the disadvantages of antiretrovirals
(Question 6: What do you think are the main disadvantages ofantiretroviral drugs when used
to treat HIVIAIDS?)
This question was a particularly interesting one, with a variety of answers being gIven, as
illustrated by the following examples:
"Side effects, need to be taken in conjunction with a healthy balanced diet few infected
people can afford. No guarantee they will work."
"People may use it as an excuse to not be careful when it comes to AIDS. It can often
also be seen as a definite cure."
"Because it is not a cure [and] not many disadvantaged people can afford nor have access
to the drugs."
The breakdown of answers to Question 6 is described below:




17.5% of respondents mentioned difficulties in accessing the drugs as a major drawback;
either because of the expense involved or because of government policies that result in
only relatively few individuals being able to access treatment.
10.3% of the sample discussed possible problems with adherence; some stating that
people may not know how to use the drugs correctly, others mentioning that poor people




• 9.3% saw the fact that ARVs are a life-long treatment and/or not a cure for AIDS as a
drawback.
• 4.3% believed that the provision of ARVs could encourage careless sexual behaviour,
either before or after contracting RN. Some respondents discussed how RN negative
individuals might indulge in reckless behaviour knowing that they would be given ARVs
if they contracted the virus. Others expressed their concern that ARVs would allow RN
positive individuals to live longer and that they would then continue to practise risky
sexual behaviour.
• Quite a large percentage (17.2%) of students gave an answer that could not be placed into
any of the categories above. Responses that fell under "other" were diverse and creative.
Some respondents wrote that it was likely that people would have false expectations or
misconceptions of what ARVs could really do; others questioned the drugs' efficacy and
some suggested that the drugs could even cause death. One student mentioned that the
drugs had not been advertised extensively. A few respondents mentioned the expense of
the drugs to the Government and the economy as well as the individual taxpayer. Some
respondents also voiced their concern that the drugs, or fake replicas of the drugs, would
be sold on the black market.
• 4.3% gave an incorrect answer, again because most of these respondents misunderstood
that the question was only about ARVs when used to treat RN/AIDS, and not in other
circumstances.
• A sizeable proportion of respondents (34.8%) did not answer the question at all; this may
have been because they did not believe that there were any disadvantages to the drugs, or
because they did not feel like preparing a written answer to the question.
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The students' responses to the question are illustrated in Figure 6.12 below:



















The chi-square tests reveal significant relationships between each of the dependent variables for
this question (side effects, lifelong treatment, careless sexual behaviour, adherence, access,
incorrect answer, other) and race (for each of the tests, p=O.OOO). A higher proportion of Black
students, and a lower proportion of White and Indian students, discussed the side effects of
ARVs, the lifelong nature of treatment, the issue of adherence, an "other" disadvantage and gave
an incorrect answer than would have been expected had there been no relationship between the
variables in each case. A larger proportion of Blacks and Whites, and a smaller proportion of
Indians, than would have been expected had there been no association between the variables
mentioned careless sex in their answers. A larger proportion of White students, and smaller
proportions of Black and Indian students, mentioned the problem of access than would have been
expected were there no relationship between the variables.
The chi-square tests show that there are no statistically significant relationships between any of




Beliefs about other options to treat HIV/AIDS
(Question 7: What other options do you know ofto treat HIVIAIDS?)
Many of the major themes expressed by students in their responses to this question are summed
up in the answer of one student, below:
"Eating healthy, exercIsmg, not smoking or drinking, drinking immune boosters and
being healthy mentally."
The breakdown of answers is presented below:
• A large proportion of students (29.1 %) stated that they knew of no other options (i.e.:
other than ARVs) to treat RN/AIDS, although many then went on to describe
complementary practices that should be adopted by people with RN/AIDS.
• 19.2% discussed the importance of eating healthily and/or taking vitamins.
• 18.2% wrote about safe sex, including abstinence. Most respondents mentioned safe
sexual practices in terms of a preventative action so as not to contract RN in the fIrst
place. The remainder stated that even after contracting the virus, safe sex should still be
practised.
• 10.9% mentioned that individuals with RN/AIDS should exercise regularly.
• 6.3% of the sample mentioned alternative therapies as an option to treat RN/AIDS; the
therapies described were mainly traditionaVAfrican healers, but prayer and immune-
boosting medications were also mentioned. It is noteworthy that while only 4% of
respondents discussed African/Zulu/traditional medicines or healers in their answer to
this question, 83.3% of these answers were from students from the Westville campus,
while only 16.7% were from Roward College campus students. Most of the respondents
who discussed traditional medicines were Black (83%) and from rural backgrounds
(75%).
• 14.9% of the sample gave answers that did not fall into the categories mentioned above.
Some mentioned the importance of avoiding cigarettes, alcohol and drugs, while others
talked more generally about living a healthy lifestyle. A number mentioned the
importance of a healthy mental attitude and/or living "positively", while others discussed
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the value of getting support from family and friends and going for counselling if
necessary. A few students talked about the importance of prevention and early detection;
a couple mentioning the role of awareness campaigns and one student stating the
importance of knowing one's RN status.
• 1% of the sample answered the question incorrectly, giving outlandish answers that did
not fit into any of the other categories.
• The majority of students (32.5%) did not answer the question, presumably due to lack of
knowledge on the topic or an unwillingness to write an answer.
Respondents' beliefs about other options to treat RN/AIDS are summarised in Figure 6.13
below:










Chi-square tests reveal significant relationships between each of the dependent variables (safe
sex, exercise, healthy eating/vitamins, alternative therapies, incorrect, other and none) and race
(p=O.004; p=O.OOO; p=O.OOO; p=O.003; p=O.005; p=O.012 and p=O.OOO respectively). A larger
proportion of Black students, and a smaller proportion of White and Indian students, mentioned
safe sex, exercise, healthy eating/vitamins, alternative therapies and "other" options than would
have been expected had there been no association between the dependent and independent
variables in each case. More Blacks, and less Whites and Indians, did not give an incorrect
answer and did not mention that they knew of no other options to treat RN/AIDS than would
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have been expected had there been no relationship between the dependent and independent
variables in each case.
The results indicate that there are no statistically significant relationships between the variables
safe sex and campus (p=O.660); exercise and campus (p=O.628); healthy eating/vitamins and
campus (p=O.976); alternative therapies and campus (p=0.365); incorrect and campus (p=O.891)
or "other" and campus (p=O.561). However, there is a significant association between campus
and the variable "none" (p=O.025). Fewer Westville students, and more Howard College
students, than expected had there been no association between the variables stated that they knew
of no other options to treat HN/AIDS.
Attitude-related questions (Questions 9, 10, 11, 12, 13)
Attitudes towards UKZN's ARV rollout (Question 9)
The majority of students held a positive attitude towards the provision of ARYs by UKZN. For
the statement "The university should supply cheap antiretrovirals to students and staff with
HN/AIDS", 73.2% either strongly agreed or agreed with the statement, 15.6% were neutral, and
8.9% strongly disagreed or disagreed.
Attitudes towards those with HIV/AIDS (Question 10)
Most respondents did not express attitudes of stigma or discrimination towards people with
HN/AIDS (PWHA). For the statement "Most people with HN/AIDS have sinned and do not
deserve treatment", 91.7% strongly disagreed or disagreed with the statement, 4.3% were
neutral, and only 2% strongly agreed or agreed.
Attitudes towards VeT (Question 11)
Most students had a positive attitude towards voluntary counselling and testing. For the
statement "If I had a friend who thought they might be infected with HN/AIDS, I would advise
them to go for voluntary counselling and testing (YCT)", the majority of students surveyed
(91.4%) strongly agreed or agreed with the statement, 4.6% were neutral, and only 2% strongly
disagreed or disagreed with the statement.
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Attitudes towards ARV treatment (Question 12)
The majority of respondents had a positive attitude towards antiretroviral treatment. A high
percentage (84.4%) either strongly agreed or agreed with the statement "If I knew someone who
was sick with AIDS, I would advise them to get antiretroviral treatment"; while 9.6% of
respondents chose to remain neutral and 3.3% strongly disagreed or disagreed with the
statement.
Attitudes towards supporting those on ARVs (Question 13)
The overwhelming majority of students surveyed indicated that they would be prepared to offer
support to an individual on antiretroviral drugs. 91.4% strongly agreed or agreed with the
statement "If I knew someone on antiretrovirals for the treatment of RN/AIDS, I would be
prepared to offer them support (for example by reminding them to take their medication)". A
mere 1.6% strongly disagreed or disagreed with the statement, while 5% were neutral.
Figure 6.14 illustrates the sample's attitudes towards the issues discussed above:
























Kruskal-Wallis tests, used to search for significant differences between groups, reveal that there
are no statistically significant differences between the race groups for Question 10 (p=0.053);
Question 11 (P=0.100); Question 12 (P=0.869) or Question 13 (P=0.353). There are only
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statistically significant differences between the race groups for Question 9 (attitudes towards
UKZN's ARV rollout). In this case, p=0.048. The Mann-Whitney U test indicates that for this
question the differences lie between Black and Indian students. The Mann-Whitney U tests show
that there are no significant differences between the two campuses for any of the variables in this
section (p=0.716; p=0.172; p=0.089; p=0.968 and p=0.064 for Questions 9 to 13 respectively).
Other questions (Questions 2 and 15)
Sources of information on antiretrovirals
(Question 2: From which sources have you heard about "antiretrovirals" or "ARVs"?)
The sample's response to the question was as follows:
• Television: 90.7% of all respondents had gained information on ARVs from television,
while 7% did not acknowledge it as a source.
• Radio: 80.1 % of all respondents cited radio as one of the sources of their knowledge on
ARVs, while 17.5% did not.
• Newspapers: a large proportion of respondents (81.1 %) cited newspapers as a source of
ARV-related information, while a much smaller proportion (16.6%) did not.
• Friends/Family: a little more than half of the sample (57.9%) had heard about ARVs
from friends or family, while 39.7% had not.
• Politicians/Activists: approximately half of all respondents (49%) had heard about ARVs
from politicians or activists, while 48.7% had not.
• DoctorslNurses: 47.4% of the sample had gained ARV-related information from doctors
or nurses, while a slightly larger percentage (50.3%) had not.
• Posters/Flyers on campus: the majority of respondents (65.6%) had not gained
information about ARVs from posters or flyers on campus, while only 32.1 % had.
• Billboards: only 22.5% of the sample had learnt about ARVs from billboards, while a
much larger proportion (75.2%) had not.
• Other: only 7% of respondents indicated that another source had provided them with
information about ARVs. Examples of other sources mentioned included school, peer
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educators (at Howard College campus), university lecturers, HN/AIDS audio tapes from
the University and HN/AIDS conferences or workshops.
Figure 6.15, below, shows the sources cited by students in the sample:
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Chi-square tests do not indicate statistically significant relationships between the variables TV
and race (p=0.460); radio and race (p=0.336); billboards and race (p=0.098); newspapers and
race (p=0.140); posters/flyers on campus and race (p=0.365) or "other" and race (p=0.460).
However there are significant associations between the variables friends/family and race
(p=0.030); politicians/activists and race (p=0.047) and doctors/nurses and race (p=0.000). More
Blacks and Whites, and less Indians, than would have been expected had there been no
association between the variables mentioned friends/family and politicians/activists as sources of
information about ARVs. A significantly larger proportion of Black students, and a smaller
proportion of White and Indian students, mentioned doctors/nurses as a source than would have
been expected had there been no association between this variable and race.
The tests did not reveal statistically significant relationships between billboards and campus
(p=0.332); politicians/activists and campus (p=0.383); newspapers and campus (p=0.203);
posters/flyers on campus and campus (p=0.183) or "other" and campus (p=0.663). However, the
results do indicate significant associations between the variables TV and campus (p=0.024);
friends/family and campus (p=0.047); radio and campus (p=0.001) and doctors/nurses and
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campus (p=O.OOO). More Westville students, and less Howard College students, than expected
had there been no association between the variables cited TV, radio and doctors/nurses as
sources of information. A larger proportion of Howard College students and a smaller proportion
of Westville students than expected had there been no relationship between the variables
mentioned friends/family as a source.
Perceived need for more information on the rollout
(Question 15: Do you think that the university shouldprovide the general student population
with more information on the provision ofantiretrovirals for the treatment ofHIVIAIDS?)
Most students expressed a need for more information on the rollout. 95% of all respondents
indicated that they thought that the University should provide the general student population with
more information on the provision of ARVs for the treatment ofHIV/AIDS. Only 3% did not see
the need for more information on the topic. This distribution of frequencies is illustrated in
Figure 6.16:






The statistical tests performed do not indicate a statistically significant relationship between




Summary of statistical tests
Table 6.1, below, summarises the fmdings of the statistical tests by indicating the questions for
which statistically significant associations between at least one of the dependent variables and
race/campus were found:
Table 6.1: Summary of statistical test findings
Question: Significant association with race? Significant association with
campus?
Knowledf!e-related Questions
Awareness of ARVs (Ql) No No
Awareness ofUKZN rollout (Q14) No Yes
ARV names (Q3) No Yes
Contexts in which ARVs used (Q4) Yes Yes
Knowledge about ARVs and access No No
(Q8)
Belief-related Questions
Benefits (Q5) Yes Yes
Disadvantages (Q6) Yes No
Other options (Q7) Yes Yes
Attitude-related questions
UKZN's ARV rollout (Q9) Yes No
People with mY/AIDS (QI0) No No
VCT (Qll) No No
ARV treatment (Q12) No No
Support (Q13) No No
Other Questions
Sources of information (Q7) Yes Yes
Perceived need for more info (Q15) No No
Conclusion
This chapter has presented the findings of the primary research in terms of the ARV-related
knowledge, beliefs and attitudes of the general student population, as well as the sources from
which they have obtained information. The response of the total sample to each question has
been detailed, with accompanying graphs where appropriate. Significance tests have been used to
indicate any associations between the dependent variables and race or campus. Chapter 7 will




Chapter 7: Discussion of results and conclusions
The overriding objective of this dissertation has been to conduct a needs analysis for the
promotion of the antiretroviral rollout at the University of KwaZulu-Natal. The process of
determining the needs of a target audience is an early, and vital, step in the development of
any social marketing campaign or promotional message. This chapter, then, is an attempt to
bring together relevant theory and the findings of the primary research in a meaningful way,
so that the promotion needs of students concerning antiretrovirals are made apparent. Thus,
the discussion of results has been organised under each of the first two primary research
questions. It should be noted that conclusions concerning the third research question (What
are the promotion needs of the general student population concerning the topic of
antiretrovirals?) can only be drawn after a discussion of results relating to the first two
research questions. Thus, this question will not be discussed separately, but rather within the
framework of the other two research questions. Within each section, important results are
discussed in relation to theory; conclusions are made; and the implications for future
promotion campaigns on antiretrovirals are pointed out. Finally, the limitations of the primary
research and suggestions for further research on the topic are considered.
Research Question 1: What are the sources and content of the knowledge, attitudes and
beliefs of the general student population concerning antiretrovirals?
Knowledge of antiretrovirals
Evaluating a target audience's awareness and knowledge of a particular idea, product or
behaviour is an important step in the initial phase of the social marketing planning process. The
knowledge and level of awareness of the target audience will influence the objectives of a
campaign as well as the messages that are ultimately designed and delivered (see Jha, 1999).
Theoretical models of behaviour change, too, regard awareness and knowledge as vital initial
steps in the change process. In the diffusion of innovations model, for example, Rogers (1962:
17-18) describes awareness as the first in a series of steps required for the ultimate adoption of
an idea or practice by the individual. Similarly, McGuire's communication-persuasion model
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sees exposure, attention, liking and comprehension - prerequisites of awareness and knowledge
- as initial information-processing steps in the behaviour change process (McGuire, 2001 :32).
Awareness and knowledge of antiretrovirals in the South African context is critical. With
approximately 400 000 South Africans in immediate need of the drugs (Soul City and
Khomanani, 2004:11), the Joint Health and Treasury Task Team (2003:76) has noted the
importance of communicating basic information about ARVs to the South African public.
Knowledge and comprehension of ART are also fundamental to communication strategies to
encourage adherence among individuals on the drugs (Martinson et aI, 2002:240). Awareness of
ARVs is thus not only essential for those individuals who need treatment, but also for members
of the general public who can act as vital channels of information, education and communication
(Joint Health and Treasury Task Team, 2003:65). In the context ofUKZN, where it is estimated
that 16.6% of students are HN positive (Mitchell, 2004b:2), ensuring a high level of awareness
of antiretrovirals and the University rollout is equally imperative.
In the case of the target population for the present project - the general student population at
UKZN - the results of the questionnaire indicate that an extremely high proportion (98%) of all
respondents were aware of antiretrovirals. It is likely that the politicisation of the HN/AIDS and
antiretroviral issues in South Africa, the lobbying for a national rollout by activist groups like the
TAC, and the accompanying media attention has contributed to this high level of awareness. This
hypothesis is given weight by the fact that the sample's three most cited sources of antiretroviral-
related information were all forms of mass media: TV (90.7%), newspapers (81.1%) and radio
(80.1 %). Interestingly, the TAC and the ALP (2004:3) have noted that planned media
communication about antiretrovirals and the national rollout has been weak in most provinces.
Thus, it is probable that the majority of information that students have received through mass
media channels was via news coverage of antiretroviral-related issues and not planned
promotional messages. Therefore, while increasing awareness of antiretrovirals among students
is not likely to be a major goal of future communication campaigns, the content of the
knowledge that students have about the drugs should be explored further.
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When asked about their knowledge of antiretroviral names, those students who answered the
question generally cited AZT (15.2%) and/or Nevirapine (14.2%). This is consistent with the
findings of Soul City in their research among the general South African population (Soul City,
2003:7). Both of these drugs have been at the centre of heated national debates: President Mbeki
and his Government debated the efficacy and safety of the drugs in preventing mother to child
transmission of RIV (see Brink, 2000) and the TAC vigorously lobbied the government to
provide ARVs such as AZT and Nevirapine to all pregnant, RN positive women. Thus, most of
the attention given by the media to AZT and Nevirapine has been in the context of the prevention
of mother to child transmission of RN, and not in the context of the treatment of adults with
RN/AIDS. Consistent with the ARV names cited by students, therefore, is the finding that the
majority of the student sample had heard of antiretrovirals in the context of preventing mother to
child transmission of RN (79.5%). Also, many students answered later questions in line with
their knowledge concerning the use of ARVs for PMTCT, and not for the treatment of
RN/AIDS as required. It can be concluded therefore, that most students had considerable
knowledge of antiretrovirals as used for the purposes of PMTCT, due in part to the extensive
media coverage surrounding the national provision of these drugs. While it is true that some
students at UKZN may require antiretrovirals for this purpose, the fact that ARVs may be used in
different ways according to the goals of therapl3 may necessitate a focus on clarifying these
distinctions in future communication campaigns.
What, then, of students' knowledge of antiretrovirals for the treatment of RN/AIDS? ARVs for
this purpose were the second most known context for ARV use (68.9% of the sample), after
PMTCT. Furthermore, most students had a good grasp of the facts surrounding treatment with
antiretrovirals, as predicted by Michelle Mitchell when she was interviewed (Interview 1,
2004:44). The majority knew that ARVs are not a cure for RN/AIDS, that they are a lifelong
treatment, and that they are not given to just anybody who asks for them. In light of experts'
concerns about misconceptions surrounding the drugs and their use in the South African context
(see Munusamy, 2003), this is an extremely positive finding. While there may be a potential for
33 It should be noted that the same antiretroviral drugs may be used for different purposes, but that the length of
treatment, dosage and combination with other ARVs will differ depending on the goal of therapy.
95
Callen MorrisonlMasters Dissertation
confusion due to the different contexts in which ARVs are used, a good understanding of ARVs
for the purposes oftreatment was evident among much of the sample.
Less encouragmg, however, was the awareness of the antiretroviral rollout at UKZN. Only
15.2% of respondents were aware of the rollout, despite the fact that the University has provided
access to treatment since 2003. This statistic is compatible with the low proportion of students
who cited posters/flyers on campus as a source of antiretroviral-related information (32.1 %); the
least cited source, bar one. In keeping with the very low awareness of the rollout at UKZN was
the high proportion of students who thought that the University should provide the student
population with more information on the rollout (95%). There is a clear need for additional
information concerning the accessing of treatment at UKZN to be provided to the general student
population.
Beliefs concerning antiretrovirals
The health belief model describes the individual's beliefs concerning the perceived benefits and
perceived barriers of treatment as two of six essential factors likely to contribute to the
performance of a health behaviour (Rosenstock et aI, 1988:177). The model proposes that the
perceived benefits of a behaviour must exceed the perceived costs in order for the individual to
act (Rosenstock et aI, 1988:177). Research in the context of antiretroviral therapy supports the
tenets of the model: individuals who believe that ARVs have significant benefits are likely to
have higher rates of adherence than those who are unsure of the efficacy of the treatment (Joint
Health and Treasury Task Team, 2003:45). A target audience's beliefs concerning the benefits
and barriers of a particular health behaviour or treatment are common issues addressed by social
marketing campaigns (Lefebvre, 2001 :508). As each target audience is likely to have a unique
set of beliefs concerning the idea or practice being promoted, these need to be well understood
by campaign developers. Promotional messages should include an emphasis on the benefits of a
course of action, and should suggest ways in which any negative aspects of the treatment can be
minimised (see Lefebvre, 2001).
When asked about their beliefs concerning the benefits of antiretroviral drugs, most students
(64.2%) discussed the physiological action of the drugs. Many demonstrated a very good
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understanding of the way in which antiretrovirals work in the human body. It is noteworthy that
the majority of students (17.9%) also mentioned unpleasant physiological side effects as a major
disadvantage of treatment with ARVs. In addition, students expressed their concern over a
number of other issues concerning ARVS, including difficulties in accessing the drugs (17.5%);
adherence (10.3%); the life-long nature of treatment (9.3%); careless sexual behaviour (4.3%);
and the efficacy of the drugs. These issues are congruent with those repeatedly discussed in the
antiretroviral literature. The doubts of some students regarding the efficacy of ARVs lends
support to Michelle Mitchell's supposition that the reluctance of some students to be placed on
ART may be due to a lingering belief that ARVs could be toxic (Interview 1,2004:111-113). It
is evident that before students can be expected to approach campus clinics for treatment, or
recommend antiretroviral therapy to friends or family, their negative beliefs concerning ARVs
will have to be addressed by promotional campaigns.
The concerns of students regarding access and the efficacy of ARVs are essentially issues that
can be tackled with correct information. Promotional messages that advertise the rollout at
UKZN and that present a realistic picture of what antiretrovirals can and cannot do are vital,
particularly in light of the vast array of misinformation in the South African environment. The
remaining issues are complex, but will also need to be dealt with for this target audience.
Rogers (1962:124-132) concludes that two of the factors that typically influence whether or not a
particular practice is adopted are complexity of the practice and compatibility with the
individual's lifestyle, beliefs and self-image. Promotional messages concerning antiretrovirals
will need to emphasise the ways in which the side effects of the drugs can be dealt with; the
regimen adhered to and careless sexual behaviour avoided. In line with Rogers' findings, these
messages should increase the audience's perceptions of the simplicity and practicability of the
antiretroviral regimen, as well as ways in which treatment can be successfully integrated into the
individual's current lifestyle.
Students' beliefs concerning other options to treat RN/AIDS have significant implications for
future promotion campaigns on the topic of antiretrovirals. Competition is an essential
consideration in both commercial and social marketing; in the case of the latter, competition
refers to the activities preferred by the target market over those being promoted (Kotler et aI,
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2002:10). Rogers (1962:124-132) suggests that the relative advantage of the product being
promoted over other available options determines whether or not it is adopted by members of the
target audience. Once the competition has been identified, the way in which the social product
should be positioned for the target audience can be established.
Current mainstream literature concludes that there is no competition for antiretrovirals in the
final stages ofHN/AIDS; ARVs are the only effective means ofrestoringlmaintaining immune
function in HN positive individuals for significant periods of time (see Southern African HN
Clinicians Society, 2002). However, experts do suggest a range of complementary therapies that
can be adopted to maintain the health of the immune system and ward off opportunistic
infections for as long as possible. These recommendations include nutritious eating, exercise, a
positive mental attitude and the avoidance of cigarettes and alcohol (Soul City and Khomanani,
2004:31-32). The majority of students surveyed expressed beliefs that correspond with the
literature: 29.1 % stated that they knew of no other options to treat HN/AIDS with many then
going on to describe the complementary practices recommended by experts. Students discussed
the benefits of healthy eating and taking vitamins (19.2%); exercise (10.9%); a positive mental
attitude; and avoiding cigarettes and alcohol. It is encouraging that not a single student
mentioned any of Health Minister Tshabalala-Msimang's controversial and much publicised
remedies; that is garlic, onions, olive oil and the African potato - all ofwhich have been found to
do more harm than good (see Evian, 2003; Sapa, 2003).
The use of traditional/African healers was mentioned by some students (4%) - most of whom
were Black students from the Westville campus - as an option to treat HN/AIDS. This low
proportion is in contrast to Government's findings that up to 97% of HN positive people first
use traditional or complementary medicines in an attempt to treat the disease (Republic of South
Africa, 2003b: 87). The handful of students who mentioned traditional medicines, as compared
to the many who discussed mainstream recommendations, suggests that this population is
somewhat different to that described by the Government's research. It is probable that as the
majority of students surveyed came from urban backgrounds (80.5%), and are being educated at
a Westernised university, they are more likely to subscribe to "scientific" thought on the causes
and treatment of diseases than to more traditional ways of thinking. While there is no doubt that
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some traditional remedies can be helpful in strengthening the immune system, others may be
harmful to the health of an HIV positive individual (Soul City and Khomanani, 2004:32). Thus,
the issue of traditional medicine may need to be specifically addressed among this sub-section of
the general student population.
In general, then, it can be concluded that those students who answered the question on other
options to treat HIV/AIDS had a very good understanding of the complementary practices that
should be used by HIV positive people, as well as those taking antiretrovirals, to maintain the
health of their immune systems. Most also knew that there is no substitute for antiretrovirals in
the treatment of the final stages ofHIV/AIDS. Very few students mentioned practices that could
be dangerous to the health of HIV positive individuals. For this group, then, future promotional
messages simply need to reinforce and reiterate their current beliefs concerning other options to
treat HIV/AIDS. This would include the relative advantage of antiretrovirals over any other
treatments available. However, 32.5% of students did not answer this question. While some of
these students may simply have been too lazy to do so, others may be unaware of those practices
recommended for HIV positive individuals. Messages, therefore, directed at the general student
population, may need to bring these practices to the attention of those individuals who are
currently unaware of them.
Attitudes concerning antiretrovirals
Social marketing practitioners generally regard the development of positive attitudes towards a
particular idea, product or behaviour as a primary objective of any promotional campaign (Jha,
1999:59). In the diffusion of innovations model, the second and third stages in the adoption
process are interest and evaluation of the product at hand; stages that implicitly involve the
formation of a positive or negative attitude towards the product (Rogers, 1962:17-18). McGuire's
communication-persuasion model, too, sees attitude change as an essential pre-requisite to
behavioural change (McGuire, 2001 :32).
The majority of students (73.2%) expressed a pOSItive attitude towards the rollout of
antiretrovirals at UKZN. It has been stated elsewhere that stimulating demand for campus health
services such as VCT and ART may well be necessary. To this end, general goodwill towards the
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rollout is an excellent starting point for future campaigns on the issue. It should be noted,
however, that a few students took the time to write additional comments on their questionnaires
next to this question; all stated that they agreed that the University should supply ARVs to
students and staff with HIV/AIDS but only if every student's fees were not increased34. These
comments should not be taken lightly, and it may well be necessary for future promotional
messages to explain to students exactly where their money is going for the rollout, and why.
The high levels of stigma and discrimination directed towards individuals with HIV/AIDS in
South Africa has been noted by a number of authors (see Caldwell, 2000; Soul City and
Khomanani, 2004; UNAIDS, 2003). Mitchell (2004b:3) concluded that the low uptake ofVCT at
the campus health clinics was at least partially due to a fear of stigma and discrimination.
Consequently, many of the campus HIV/AIDS campaigns have focused on the issues of stigma
and discrimination against HIV positive students; including the "Access HIV Treatment - A
Stigma Free UKZN" and the "Unmask AIDS" campaign, both in 2004 (Mitchell, 2004a:5-6). It
is remarkable, then, that 91.7% of the students surveyed strongly disagreed or disagreed with the
statement "Most students with HIV/AIDS have sinned and do not deserve treatment". Obtaining
accurate representations of attitudes of stigma and discrimination through questionnaires is
notoriously difficult, and thus it seems likely that this statistic should be treated with a certain
amount of caution. As a part of broader South African society, it is possible that there are still
high levels of stigma and discrimination directed against individuals with HIV/AIDS in the
University context. These attitudes will need to continue to be addressed by promotional
messages and campaigns.
Most students surveyed (91.4%) agreed that they would advise a friend who thought they might
have HIV/AIDS to go for voluntary counselling and testing (VCT). In addition, a high proportion
(84.4%) of respondents agreed that they would advise a friend who was sick with AIDS to get
antiretroviral treatment. These positive attitudes towards recommending VCT and ART to
others, and the positive attitudes towards VCT and ART that are implicit, are promising. The
diffusion of innovations model- among others - recognises the importance of social influence in
34 As noted previously, each student at UKZN has a proportion of his/her fees deducted as a contribution to the
AIDS Treatment Fund. In 2004, this amounted to a contribution ofR30 per student per year.
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changing an individual's attitudes or behaviour (Andreasen, 1995:157-158). The Joint Health
and Treasury Task Team (2003:65) have pointed out the role that community networks and
social mobilisation can play in informing, educating and communicating antiretroviral-related
information to those who need it. Michelle Mitchell, too, has noted the need for correct
information and knowledge to be spread among the student population through word of mouth
sources or "social networking" (Interview 1, 2004:53-54). Thus, students who have a positive
attitude towards VCT and ART can serve as powerful referral nodes, and important sources of
information, for other students who may need to make use of these health services. These
positive attitudes should continue to be reinforced through communication campaigns.
An overwhelming majority of students indicated that they would be prepared to offer support to
someone on antiretrovirals (91.4%). This is an optimistic finding, considering the vital role that
social support plays in encouraging adherence to ART (see Evian, 2003). Soul City and
Khomanani (2004:42) even recommend the use of a "treatment buddy" who can offer practical
and emotional support to individuals on ART. Similarly, students who receive their treatment
through McCords Hospital are obliged to appoint a "treatment buddy" to whom they can disclose
their status and who can offer them support (Interview 1, 2004:61-63). Thus, this result gives
credence to the "treatment buddy" strategy, as it indicates that many students would be prepared
to play such a role. Future promotional messages on the topic need to maintain these positive
attitudes expressed by students, and may need to pay attention to educating the general student
population about the ways in which they can offer friends on ART practical and emotional
support.
Sources of information on antiretrovirals
Selecting the appropriate channels of communication for a particular target audience is a vital
component in developing a successful promotion campaign (Salmon et aI, 1996:136). An
examination of the media habits of the target audience is essential in order to make such a
choice.
In the general sample, the top three cited sources of ARV-related information were all forms of
mass media: TV (90.7%), radio (80.1%) and newspapers (81.1%). As discussed previously, an
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analysis of the results suggests that the mass media have played an important role in increasing
the awareness and general knowledge of students regarding antiretrovirals. However, such
channels can clearly not be used by the University, due to their high cost and untargeted nature.
Small media, such as posters and flyers, on campus were poorly attended to by the sample, with
only 32.1% of respondents citing this medium as a source of ARV-related information.
Furthermore, the very low awareness of the ARV rollout among students suggests that posters
and flyers are not reaching their intended audience in an effective manner. Posters and flyers,
and other types of small media, are relatively cheap and potentially effective ways of
communicating with a geographically concentrated target audience. However, they need to be
better utilised by the University as a means of communicating with the student population.
Rogers (1962:99) suggests that impersonal information sources (such as mass and small media)
are most important at the awareness stage of the adoption process, with personal sources more
important at the evaluation and trial stages. Personal sources are also seen as more likely to
influence behaviour change than mass communications (Rogers, 1962:100). Personal sources
were well attended to by the sample, with 57.9% of students receiving antiretroviral-related
information from friends or family and 47.4% of students receiving such information from
doctors or nurses. It appears that these two sources could be utilised for the purposes of future
communication campaigns, particularly for achieving the objectives of deeper attitude and
behaviour change. The role that students in the general student population can play as conduits of
knowledge and information has been discussed in detail elsewhere. Peer educators, who are
trained by the University, are an extension of this concept and could serve as "opinion leaders"
(see Rogers, 1962) in changing the attitudes and behaviour of students. Doctors and nurses, and
particularly nurses at the campus clinics, already act as important sources of practical and
emotional support for students on ART (Interview 1,2004:84-88). Their brief should continue to
include providing information and advice on the topic of antiretrovirals to students with whom
they come into contact and who could benefit from such information.
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Research Question 2: Are there sienificant differences in the knowledee, attitudes and
beliefs of sub-groups within the eeneral student population that may justify audience
segmentation when delivering messages?
Segmentation of markets is a central tenet of the social marketing paradigm. Market
segmentation and targeting has a number of advantages over undifferentiated or mass marketing;
specifically it allows a particular set of marketing strategies and tactics to be developed in order
to meet the unique needs of a certain group (Andreasen, 1995: 177). Strictly speaking,
segmentation is not currently used by the University in their campaigns or messages, although
different campaigns may be organised for different campuses and campus-specific brochures on
the topic of antiretrovirals have been developed (see Mitchell, 2004a). Segmentation on the basis
of demographic variables such as race and geographic location is probably the most common
technique used by social marketers (Slater, 1995: 188). My own, earlier work concerning the
influence of the 10veLife AIDS awareness campaign on students at the Pietermaritzburg campus
ofUKZN concluded that segmentation on the basis of race was indicated among this group (see
Morrison, 2003). What, then, of the segmentation possibilities among the student population
surveyed for the purposes of the current research?
The results of the questionnaire did not reveal an overwhelmingly clear pattern as to the
differences between students from different campuses or races; however statistical tests did
confirm that there are associations between campus and/or race and the dependent variables in a
number of cases. These associations have been detailed in the previous chapter, and will not be
repeated here. Rather, an attempt will be made to interpret and analyse the important findings in
the paragraphs that follow.
In general, there were very few remarkable differences between the campuses in their
knowledge, attitudes or beliefs concerning antiretrovirals, or the sources from which they had
obtained information. The most noteworthy finding is that a statistically significant association
was found between campus and awareness of the University rollout, indicating that Westville
students had a significantly lower awareness of the rollout than those from Roward College.
Also, there are significant associations between campus and some of the sources of ARV-related
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information. Westville students paid more attention to TV, radio and doctors/nurses as sources of
information than Howard College students, while the latter saw friends and family as a more
important source than their Westville counterparts.
These findings suggest that segmentation on the basis of campus, for all campaIgns and
messages, is not indicated. However, a great deal more attention must be paid to promoting the
ARV rollout among Westville students. In addition, it may be necessary to utilise the personal
sources of doctors/nurses and friends/family in different ways on the two campuses. As doctors
and nurses are particularly important sources to Westville students, it should be ensured that the
medical staff at the campus clinic have the necessary resources to act as conduits of ARV-related
information. On the Howard College campus, the role of "friends" (in the form of peer educators
or other students) in communicating ARV-related information and promoting the rollout should
be emphasised. This is not to say that both of these personal sources should not be made use of
on the two campuses, but rather that they may need to be prioritised in a slightly different way
for each campus.
In a number of instances, pertinent statistical associations between race and the dependent
variable were found. For each of the questions concerning the beliefs of students, significant
associations were found between campus and every one of the dependent variables in each case.
However, there were no clear patterns in terms of the differences between the races. Black and
White students showed a greater tendency towards describing the biological benefits of ARVs
than Indian students; and were less likely to describe the social benefits or give an "other" or
incorrect answer to the question than Indian students. For the question concerning the
disadvantages of ARVs, Black students differed from White and Indian students in some cases;
in others Blacks and Whites differed from Indians; and in still others White students differed
from Black and Indian students. Regarding other options to treat HN/AIDS, Black students
differed from White and Indian students in the pattern of their responses. Black and Indian
students differed in their attitudes toward the ARV rollout at UKZN, with significantly more
Black than Indian students expressing a positive attitude towards the rollout. These findings
indicate that in many instances, students from different races did differ on ARV-related
variables; particularly in the areas of beliefs and attitudes. Notably, while different groupings of
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races are evident for various variables, Black and Indian students differ from each other in
almost every case.
Thus, general segmentation on the basis of race is not indicated across the board, for all
campaigns and messages. However, the different beliefs and attitudes of different races may
require segmentation and targeting on the basis of race when messages or campaigns related to
these particular topics are designed. This segmentation is likely to be particularly valuable on the
Westville campus, where the overwhelming majority of students are still Black and Indian. Thus,
the consistent differences between these race groups can justifiably be used for the purposes of
segmentation. On the Howard College campus, segmentation on the basis of race needs to be
used only in those cases where the needs of different race groups do not overlap.
Slater (1995:187) notes that members of a segment should be able to be reached through similar
media or interpersonal channels. The three most cited sources by students from all races were, in
order: TV, newspapers and radio. However, a significantly larger proportion of Black and White
students cited friends/family and politicians/activists as sources than Indian students and more
Blacks than Whites or Indians mentioned doctors/nurses as a source. These findings indicate that
should segmentation on the basis of race occur, Black and White students may respond better to
information imparted by fellow students and politicians or activists (who could be invited to give
presentations or lectures at UKZN) than Indians. Also, doctors and nurses from the campus
clinics may be utilised as channels of information for Black students particularly.
While segmentation is a powerful tool in ensuring that the promotion needs of particular target
audiences are met, it is not always a simple technique to execute. The discussion above indicates
that there is some basis for segmentation of the general student population by race and/or campus
- but only for some antiretroviral-related issues. It appears that the use of a combination of
segmenting variables - campus and race - is likely to achieve the most effective and efficient
communication results. In addition, other bases for segmentation of the general student
population may need to be investigated in the future.
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Limitations of the research
This section will briefly discuss the limitations of the research in terms of the sample and
questionnaire design. Limitations in terms of time and space have necessitated a relatively brief
investigation into the promotion needs of students on the topic of the antiretroviral rollout at
UKZN. Thus, suggestions for ways in which the research design could be improved, and taken
further, have also been given.
Sample limitations
The sample used for the questionnaire phase of the research represents a very small proportion of
UKZN students35 . The small sample size means that the results should be treated with due
caution when generalising to the larger student population.
As a probability sampling method could not be utilised, the sample composition was not
particularly representative of the student population for those variables that were not controlled
by the research design. Disparities in the availability of classes to be surveyed among the
different faculties resulted in an overwhelming proportion of respondents from the Commerce
and Management/Management Studies and RumanitiesIHuman Sciences Faculties. In addition,
the majority of students surveyed were female; most probably owing to the faculties from which
students were sourced.
As only one White student from the Westville campus was surveyed, it was not feasible to
conduct statistical tests to look for associations between the dependent variables and race within
each campus. This could very well have yielded some interesting and informative results.
Questionnaire design limitations
A major limitation of the questionnaire design in general is the reliance on the self-reporting of
respondents, particularly with regard to sensitive topics such as RN/AIDS. The answers given,
especially to the questions concerning the beliefs and attitudes of respondents, may well have
35 This is j~st less than 1% of the combined student populations of the Howard College and Westville campuses in
2004. AvaIlable: http://www.ukzn.ac.za/dmiJukznstats/students cam.asp
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reflected what they perceived to be correct or socially acceptable answers, rather than strictly
accurate responses.
Questions 5 and 6, which required respondents to discuss their beliefs about the advantages and
disadvantages of ARVs respectively, were misinterpreted by an unusually high proportion of
students. These students did not understand that these questions only applied to "antiretroviral
drugs to treat HIV/AIDS". This distinction should have been emphasised to a greater extent, or
the questions re-worded so as to have been clearer to students.
A high proportion of questions were not answered by a large number of students, particularly
those that required written answers. This may have been because students could not think of an
answer to the question, or more likely, that they did not want to take the time and energy
required in answering the question. This "questionnaire fatigue" on the part of students is not
uncommon and is difficult to overcome.
Suggestions for further research
Extensions of the current research could consider the following suggestions in order to expand
and improve the study:
1) A comparison between students on all five of the University's campuses, instead of just two,
would increase the value of the results.
2) A larger sample size, as discussed above, would be greatly advantageous in increasing the
generalisability of the research and would allow a wider range of statistical tests to be performed
on the data. In addition, a greater effort to control demographic variables so as to obtain a more
representative sample would increase the generalisability of the results.
3) Further research could also focus on the other "P's" of the marketing mix, and in addition
could go on to develop an entire strategic social marketing programme for antiretrovirals at the




An earlier discussion, in Chapter 3 of the literature review, proposed five key issues that would
need to be addressed by any antiretroviral-related communications programme. These were:
communicating basic information; correcting misconceptions; encouraging adherence;
encouraging social mobilisation; and stimulating demand. The critical discussion presented in
this penultimate chapter has come to remarkably similar conclusions. Future promotional
messages and campaigns directed at the general student population will need to focus on the
following issues: clarifying the distinctions between different contexts of ARV use; increasing
the awareness of the rollout at UKZN as a prerequisite to stimulating demand; addressing
negative beliefs and misconceptions regarding ARVs; emphasising complementary practices to
be used by individuals with RN/AIDS; addressing issues of stigma and discrimination; and
encouraging students to act as sources of support and information for other students. In addition,
small media and personal sources need to be utilised more effectively by the University. In the
case of certain messages, segmentation - on the basis of race and campus - may result in a more
effective dissemination of information to the target audiences. Limitations of the research
conducted for the purposes of this dissertation have also been briefly discussed in this chapter,
with suggestions for further research being outlined. The final chapter will summarise the




In the complex environment of modem life, educational institutions no longer have the luxury of
separating themselves from the concerns and problems of the societies in which they are located.
The University of KwaZulu-Natal is no exception to the rule; as a part of South African society,
its students and staff have not remained unaffected by the HN/AIDS epidemic that has had such
a devastating impact on the country. It is for this reason that the institution announced in 2004
that it would provide access to antiretroviral drugs for the treatment of HN/AIDS to all students
and staff members who require it.
However, in order for this rollout to be successful, a number of concerns have to be urgently
recognised and addressed through promotional messages and campaigns, including: the
politicisation of the antiretroviral issue in South Africa, the rumours and myths on the topic that
abound among the general population, the complicated nature of antiretroviral therapy and the
necessity of social support for those on the drug regimen. Thus, the empirical component of this
dissertation has consisted of a needs analysis for the promotion of the antiretroviral rollout at
UKZN. The major objectives of the research were to understand the knowledge, attitudes and
beliefs of the general student population, the sources to which they attend, and any differences
between sub-groups within this population, so that the antiretroviral-related needs of students
that can be addressed by future promotional campaigns could be identified.
As a background to the primary research, a literature review was undertaken. HN/AIDS in the
South African context was critically discussed in order to show the necessity of a national
provision of antiretroviral drugs to ameliorate at least some of the impact of the epidemic. The
topic of antiretrovirals was discussed in some detail, so that the complexity of a national rollout
and subsequent promotion campaigns on the topic could be explored. The final chapter of the
literature review examined the social marketing paradigm - a set of tools and techniques that can
be utilised to effect social change. Social marketing has informed the assumptions, research
design and research questions of the present project. In addition, it has been argued that this
approach is capable of effecting the kinds of changes in individual knowledge, attitudes and
beliefs that will be needed for successful national and institutional rollouts.
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After the methodology of the primary research was described, the results of the questionnaire
distributed to a sample of students from the Westville and Roward College campuses of UKZN
were presented. Subsequently, these findings were interpreted in the light of the literature
reviewed. It was concluded, finally, that future promotional campaigns on the topic of
antiretrovirals at UKZN will need to do the following: clarify the distinctions between different
contexts of ARV use; increase awareness of the rollout at UKZN as a prerequisite to stimulating
demand; address negative beliefs and misconceptions regarding ARVs; emphasise
complementary practices to be used by individuals with RN/AIDS; address issues of stigma and
discrimination and encourage students to act as sources of support and information for other
students. In addition, small media and personal sources need to be utilised more effectively by
the University. In the case of certain messages, segmentation - on the basis of race and campus -
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Appendix A: Types of research by campaign phase
Source. adaptedfrom Nowak and Szska (1995.172).
Phase Research necessary Explanation
Pre-campaign: strategic planning research Research used in the initial design of
campaigns or messages to identify
potential problems, target audiences,
campaign ideas, and possible media
channels or message vehicles.
needs assessments Research to collect information on
what is needed (such as social
support, skills, money or
information) to solve the defmed
problems of a target audience/so
Campaign/message development: target audience analysis Research used to select, segment,
and/or describe the target audience/s
that the campaign aims to address.
formative evaluation Research undertaken to compare
alternative campaign
strategies/messages and/or improve
a specific strategy. Includes idea
generation, concept testing,
positioning, copy/ message testing,
and test market research.
message efficacy/response research Research to determine if a
campaign, messages, and/or
produced materials are likely to have
the desired impact.
Post-campaign: process evaluation Research to ascertain when, to
whom, where and, how often,
campaign materials are being
disseminated.
outcome/effectiveness evaluation Research to determine the effects of
a campaign/campaign materials, and
to compare this to previously set
objectives.
Ongoing: exploratory research Research to investigate issues as
they arise.
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Appendix B: Interview with Michelle Mitchell,
AIDS Programme Co-ordinator1
Conducted: 6 October 2004, 2pm, Howard College Campus, Durban
Ql: What forms of communication are used to reach students on the topic of
antiretrovirals?
l.Michelle explains that it is mostly external media that are used to communicate infonnation
2.about the University's ARV programme. There have been articles concerning the topic in
3.newspapers such as the Sunday Times and The Mercury; in magazines like Fair Lady and
4Drum; on websites like eHea1th; and interviews have been conducted and aired on SAFM and
5.on SABC 1 and 3. This use of the mass media is, she feels, very important to get the attention
6.and buy-in of the top executives of the University, as well as to gain the attention of students.
7.0n the campuses themselves, tools that have been used to disseminate infonnation about the
8.rollout include the use of peer educators, campaigns like the Hope and Healing Campaign and
9.ta1ks arranged by HIVAN2 and the campus health clinics and often given by people with
lo.HN/AIDS (the use of the latter serves also as an attempt to decrease stigma and
ll.discrimination against people living with HN/AIDS). Flyers, posters and infonnation on
12.UKZN's innerweb provide students, staff and other interested parties with infonnation about
13.the AIDS Programme. The Orientation Programme at the beginning of each year for first year
14.students contains a large HN/AIDS component. Michelle says that they rely on these sources
15.of infonnation to gain the attention of the students, and make them aware that cheap
16.antiretrovira1s and treatment are available, and it is then the responsibility of the student to
17.find out more infonnation from the health clinics or other sources.
I Michelle Mitchell has reviewed this transcript and has approved it as an accurate representation of the
conversation.
2 HIVAN is the Centre for HIV/AIDS Networking and is located on the Howard College campus ofUKZN.
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18.A recent Hope and Healing Campaign was held across the campuses of UKZN, in order to
19.encourage a more positive attitude about the disease among students. Michelle says that
2o.students are tired of talks, as they have to attend lectures all the time, and so need to be
21.engaged by something different. The campaign allowed the students to interact with various
22.events for just ten minutes at a time; between lectures for example. One such event was a Wall
23.of Courage where students who knew their HIV status could have their picture taken and have
24.it displayed on the wall. However, Michelle notes that a campaign such as this has few visible
25.indicators of success, and so is difficult to evaluate.
26.Michelle also explains that they have started educating staff about the options available for
27.HIV positive students. Staff are the often the first to know a student's HIV status, as they may
28.be confided in after the student has missed lectures or tests or is falling behind in coursework
29.as a result of poor health. She says that staff can thus act as important referral nodes by
3o.advising the students of where they can go for help. While many staff a few years ago were
31.reluctant to get involved with the issue of HN/AIDS, saying that their job was to lecture the
32.students only, now that some staff have had students die of AIDS, they are more willing to get
33.involved. Staff members now want to be empowered in this arena and be given the necessary
34.skills and resources to deal with students who are HIV positive.
35.Michelle says that she sees the Government rollout of ARVs and the media attention around
36.that, as having created a window of opportunity to gain people's attention again about the
37.issue ofHIV/AIDS, and encourage them to read and find out more about the topic of ARVs
38.and other HN/AIDS related topics. It is an interesting issue, so it serves to create renewed
39.concem around the general topic.
Q2: Are communication strategies on this topic different on the five campuses? Why/why
not?
40.The basic communication strategy in terms of ARVs is the same for each campus, with the
41.exception of Westville. Michelle explains that although they started to put students on ARVs
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42.as early as May of last year, they didn't advertise the service on the Westville campus as they
43.only recently appointed a nurse who is responsible for handling HIV positive students.
Q3: Do you think that students in general have adequate knowledge about ARVs? For
example, do they understand that ARVs are not a cure for AIDS and that the medicine
regimen is complex and must be strictly adhered to?
44.Michelle believes that, in general, students have good knowledge about HIV/AIDS and ARVs,
45.but still may subscribe to certain myths about the disease and its treatment, and thus may be
46.confused. She believes that this awareness about ARVs is due, at least in part, to the media
47.hype in South Africa about treatment for HIV/AIDS. She says that students tend to have a
48.reactive knowledge; that is they only want to know the information after the fact - for
49.example where to go and what to do when they find out they are HIV positive - and are not
5o.particularly interested in prevention information.
51.Michelle says that the focus of communication messages about treatment for HIV/AIDS
52.should be holistic in nature. She feels that it is important to focus not just on ARVs, but rather
53.on all the components of "wellness management". There is a need to spread correct
54.information and knowledge through word of mouth sources or "social networking". One way
55.to do this is to use peer educators, who are respected by other students and act as opinion
56.leaders, as well as health promoters. Health promoters are people living openly with
57.HIV/AIDS, who can give lectures and workshops to students. Michelle feels that there is a
58.need to normalise HIV/AIDS. Unfortunately, by having an "AIDS Programme", she feels that
59.this marginalises those with the disease and makes them different. She feels that it is very
6O.important to normalise HIV/AIDS; at least within the university context.
Q4: What role do you see other students (not necessarily HIV positive) playing in
encouraging and supporting students on ARVs?
61.Michelle explains that students who are attached to the treatment programme at McCords are
62.obliged to have a "treatment buddy" to whom they disclose their status and who can offer
63.them support. This buddy mayor may not be a fellow student. Staff involved in the AIDS
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64.Programme initially thought that peer educators, trained by the University, could act as
65.treatment buddies. However, students didn't want their treatment buddy to be someone they
66.didn't know; rather they wanted to choose someone who they knew and trusted. The staff also
67.thought of offering students on ARVs assistance with other issues (such as transport to the
68.treatment venues), but in general, students were reluctant to accept offers of help. Michelle
69.believes that this is part of the empowerment process; students don't want to be pushed into
70.the victim role, but rather want to have some agency in this matter.
Q5: Does the University have any role in encouraging adherence among students on ARVS
(eg: through support groups, mentors)?
71.Michelle explains that different campuses have different kinds of support groups for students
72.infected and affected by HN. The Howard College Campus has a support group for students
73.affected by, although not necessarily infected with, HN/AIDS. The group is organised by the
74.Student Counselling Centre, but hasn't really got off the ground. In Pietermaritzburg, the
75.support group on campus is good; with six students meeting regularly to support and
76.encourage each other. At the Edgewood Campus, the SRC president has started a very
77.successful, informal support group. Michelle feels that this model of support, where the group
78.is organised by a role model and University leader, is probably the most successful, as it helps
79.to normalise the disease, rather than making people who have it feel marginalised. Michelle
80.believes that the staff of the Programme can then facilitate the process by offering the SRC
81.President assistance and relevant skills when necessary, while allowing her to lead the
82.process.
83.Michelle says that adherence to the ARV regime is complicated as you have to take at least
84.three pills twice a day. However, she says that the nurses at the campus clinics are trained in
85.adherence assistance and thus try to help the students to develop tricks and ways of
86.remembering to take their medication (for example putting their pills under their pillow so that
87.they remember to take them at night before going to sleep). Students tend to develop close
88.relationships with the nurses and use them as a form of support.
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89.0n the topic of adherence, Michelle notes that in Pietermaritzburg, the treatment of students
9o.who need ARVs is handled by a private GP. Although this doctor does not insist on disclosure
91.for his patients, their adherence rate is, in general, higher than those students on the
92.programrne at McCords. Michelle believes that this is because the students form a personal
93.relationship with the doctor, and feel that they are accountable to him for their adherence to
94.the medication, and thus don't want to disappoint him.
Q6: Do you find any students resisting the use of ARVs even when they are in need of the
drugs?
9s.Michelle says that some students, who have needed ARV treatment and have been advised of
96.this, have refused treatment. In Durban, for example, up to June of this year, fifteen students
97.were referred to McCords Hospital for ARV treatment. Two students died, due to extremely
98.low CD4 counts, one never arrived for his/her appointment and one refused treatment. She
99.doubts that lack of funds could be the reason for this, as the University subsidises the
IOO.treatment, with students being asked to contribute R50 a month towards the cost. However,
IOl.students who are not able to pay this fee are aided by the University. Michelle says that many
I02.students, when told they have AIDS, go into a state of crisis, with their first instinct being to
I03.deny the whole situation. Thus, many refuse to go for counselling to manage their illness.
I04.Some have the feeling that agreeing to go on antiretrovirals is an acknowledgement that you
los.have AIDS and are going to die. Many are also worried about the reactions of their families
I06.and friends when they discover they are on the drugs; friends and family may see the student
I07.taking the pills and start to ask questions. Thus, many are afraid to disclose. Another reason
I08.for refusing to take ARVs, according to Michelle, could be traditional and cultural beliefs.
l09.Some students may believe that RN/AIDS is a curse that has been placed on them and thus
l1o.they would rather seek the help of a traditional healer to deal with the disease, not a medical
111.doctor. And fmally, the rumours and myths that abound in the South African context,
112.suggesting that ARVs are toxic, may contribute to the reluctance of some students to be
113.placed on the medication.
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Q7: What about when students leave UKZN? Does the University continue to play any role
in providing ARVs or encouraging maintenance of the treatment and adherence?
114.Michelle says that once the students leave university, they shouldn't have a problem
lls.accessing the drugs. McCords will soon be offering free treatment, so students who are
116.presently receiving treatment there can simply move on to that programme. In
117.Pietermaritzburg, the students will be linked to Grays Hospital when they leave university
118.and can receive their medication there. Michelle says that the problem comes in when
119.students leave the area in which they studied. Hopefully, though, as the Government's
120.programme becomes more established, the students can move onto other programmes in an
12l.area that is convenient to them. Adherence to the treatment is then encouraged by the service
122.provider only, and the University no longer plays a role.
Q8: Is UKZN's ARV rolIout in any way related to that of the National Government?
123.The rollout of ARVs by the University is not linked in any way to that of the National
124.Government (they did not have to obtain permission from the Government to roll out).
125.However, the medication with which the students are treated, and the guidelines for the
126.treatment, are the same as those used by the Government. This ensures that, once they leave
127.UKZN, students can move onto Government programmes easily. For example, students are
128.put on ARVs once their CD4 count is lower than 200, as occurs in the Government
I 29.programme.
Additional information given by MichelIe
• 13o.About 16.6% of students are estimated to be HN positive at UKZN. Michelle
13l.explains that this estimate was based on modelling (using, in part, figures from antenatal
132.surveys, to arrive at this percentage). She believes that this figure is accurate as it
133.corresponds with the percentage of students who are HN positive when they receive VCT at
134.campus clinics.
• 135.A recent survey showed that 30% of first-year students knew their HN status before
136.coming to University, although half of these knew their HN status because they had never
137.had sex.
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• 138.Michelle says that the logistics of handling an ARV rollout at UKZN are complicated
139.and difficult. However, the staff involved in the AIDS Programme felt that it was necessary
140.to roll out as soon as possible, and iron out the kinks on the way, rather than wait until things





This questionnaire forms part of a study that concerns the antiretroviral rollout at UKZN. The study is being conducted
by the researcher for a Masters degree. It would be appreciated if you would take a few minutes to fill in the
questionnaire. Please note the following:
• The questionnaire is voluntary. If you would rather not take part in the research, please return the
questionnaire to the researcher.
• The questionnaire is anonymous. Please do not write your name on the questionnaire.
1) Have you ever heard of "antiretrovirals" or "ARVs"? Please tick: IYES INO
IF NO, YOU ARE NOT REQUIRED TO ANSWER ANY OF THE REMAINING QUESTIONS.










3) If you know the names of any antiretrovirals, please write them here (don't worry about spelling):
4) In which context have you heard of antiretrovirals? Please tick as many as apply:
As a precaution after a needlestick injury
As a precaution after rape
To prevent mother-to-child transmission ofHIV
To treat adults and children with HIV/AIDS
Other (please specify):
5) What do you think are the main benefits of antiretroviral drugs when used to treat HIV/AIDS?
6) What do you think are the main disadvantages of antiretroviral drugs when used to treat HIV/AIDS?
7) What other options do you know of to treat HIV/AIDS?
8) When used as a treatment for HIV/AIDS, antiretrovirals are .. .Please tick:
a) a cure for HIV/AIDS
I TRUE I FALSE
I FALSEb) taken for the rest of a person's life I TRUE
I FALSEc) given to anybody who asks for them I TRUE
Please tick your response to the following statements:
9) The university should supply cheap antiretrovirals to students and staff with HIV/AIDS.
Strongly Agree Agree Neutral Disagree Strongly Disagree
10) Most people with HIV/AIDS have sinned and do not deserve treatment.
Strongly Agree Agree Neutral Disagree Strongly Disagree
11) If! had a friend who thought they might be infected with HIV/AIDS, I would advise them to go for
voluntary counselling and testing (VCT).
Strongly Agree Agree Neutral Disagree Strongly Disagree
12) If! knew someone who was sick with AIDS, I would advise them to get antiretroviral treatment.
Strongly Agree Agree Neutral Disagree Strongly Disagree
13) If! knew someone on antiretrovirals for the treatment ofHIV/AIDS, I would be prepared to offer them
support (for example by reminding them to take their medication).
Strongly Agree Agree Neutral Disagree Strongly Disagree
14) Are you aware that the university provides access to cheap antiretroviral treatment for students and staff
with HIV/AIDS? Please tick:
15) Do you think that the university should provide the general student population with more information
on the provision of antiretrovirals for the treatment of HIV/AIDS? Please tick:
16) In order to statistically analyse this questionnaire I require some demographic information from you.





Do you come from an urban or rural background?
------
THANK YOU FOR YOUR TIME!
Appendix D: Questionnaire design
The questionnaire consisted of a number of questions, each of which is described and justified
below:
Informed consent: on the first page of the questionnaire, before the presentation of the questions,
respondents were informed of its basic purpose as well as the voluntary and anonymous nature of
the questionnaire. This is in accordance with the ethical guidelines of the University of
KwaZulu-Natal and with the suggestions of Professor Johan Jacobs (Head of the School of
Graduate Studies, Faculty of Human Sciences in 2004) to whom the questionnaire was submitted
for ethical approval.
Question 1: this was a structured, dichotomous question with a structured yes/no answer. It was
designed to assess respondents' awareness of antiretrovirals. The question also acted as a filter as
those respondents who answered "no" to the question would not have been able to answer the
remaining questions and thus, were informed that they were not required to answer the rest of the
questionnaire. After the questionnaires had been printed, it was realised that in order to analyse
the data effectively, it was necessary to have the demographic details of all of the respondents
(question 16) - even those who had answered "no" to this question. Thus, this request was made
verbally to all respondents before handing out the questionnaire.
Question 2: this question was a structured, multiple-choice question with multiple answers,
designed to ascertain the sources from which respondents had obtained information about
antiretrovirals. There were nine possible answers; three of which were personal sources from
which respondents may have obtained information, and five of which were types of media. An
"other" option was also included in order to identify alternative sources of information. The data
likely to be obtained from this question was considered useful both in order to identify future
channels of communication for this audience and in order to gain an idea of which types of
information about ARVs, with which types ofbiases, respondents had access to.
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Question 3: this structured question requiring an unstructured response was another awareness
question; this time assessing respondents' top-of-mind awareness of brand names of
antiretrovirals. This question was adapted from one used by Soul City (2003: 18) in their
audience research among the general public. It was expected that most respondents who
answered this question would mention AZT and/or Nevirapine, as these two antiretrovirals have
been extensively discussed in the South African media. The negative perceptions of
antiretrovirals that respondents may have as a result of the controversy associated with these
ARVs may need to be addressed by communication campaigns. The citing of other brand names
by the respondents could suggest that they were either using the drugs themselves or were
familiar with someone who was.
Question 4: Question 4 was a structured, multiple-choice question with multiple answers. As
antiretrovirals are not only utilised for the purposes of treating people with HIV/AIDS, but also
as a prophylactic measure, Question 4 was designed to assess the context in which respondents
had heard of the drugs. This may well have affected the information and beliefs they have about
ARVs in general, despite the fact that ARVs for different purposes may be used and distributed
in different ways. This question was also designed to focus respondents' attention on the fact that
although ARVs can be used in different contexts, the remaining questions applied to only one of
the categories mentioned: ARVs "to treat adults and children with HIV/AIDS".
Question 5: this question was a structured one, requiring an unstructured, qualitative response. It
aimed to discover respondents' beliefs about the benefits associated with ARVs for the treatment
ofHIV/AIDS.
Question 6: Question 6 was also a structured one, requiring an unstructured, qualitative response.
It aimed to assess respondents' beliefs about the major disadvantages associated with ARVs for
the treatment ofHIV/AIDS.
Question 7: Question 7 was a structured question, requmng an unstructured, qualitative
response. It was designed to assess respondents' beliefs about possible competing products or
132
practices that they perceived could be used in place of, or together with, ARVs for the treatment
ofHIV/AIDS.
Question 8: Questions Sa, b and c were knowledge questions, designed to assess the accuracy of
respondents' knowledge about certain basic facts concerning antiretrovirals. Each question was a
structured, dichotomous one, requiring a structured true/false answer.
Question 9-13: Questions 9 through 13 were scaled questions, requiring an answer to be selected
from a five point Likert Scale. Each of these five questions was designed to assess the
respondents' attitudes about a particular issue related to antiretroviral therapy. Question 9 aimed
to assess students' attitudes towards UKZN's provision of subsidised ARVs to students and staff;
Question 10 to assess possible attitudes of stigma towards people with HIV/AIDS; Question 11
to analyse attitudes towards VCT; Question 12 to examine attitudes towards ARV therapy itself
and Question 13 to assess students' attitudes towards offering their support to someone on ARV
treatment. Questions 11, 12 and 13 were worded to refer to a third party in order to prevent
respondents from feeling threatened, as they may have if the questions asked them to consider
the situation as applied to themselves. According to Loubser (1999a:217), any questions that
may embarrass respondents should rather be phrased to refer to a third party. In addition, as the
advice and support of family and friends is considered to be vitally important in the adoption of,
and successful adherence to, ARVs, Questions 11, 12 and 13 also addressed the extent to which
respondents were willing to recommend VCT and ARV therapy to friends, and then support
them in adhering to the treatment.
When the findings for this set of questions are presented, it will be assumed that students'
responses to each ofthe five questions can be translated into a "positive", "negative" or "neutral"
attitude. Thus, a student who strongly agrees or agrees with the statement "The university should
supply cheap antiretrovirals to students and staff with HIV/AIDS" is assumed to have a positive
attitude towards the rollout by UKZN.
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Question 14: Question 14 focused specifically on UKZN's ARV Programme by assessing
respondents' awareness of the rollout at UKZN. The question was a structured, dichotomous one,
requiring a structured, yes/no response.
Question 15: Question 15 was also a structured, dichotomous one, requiring a structured, yes/no
response. It assessed the perceived need of respondents for more information about the ARV
rollout at UKZN.
Question 16: this question required five demographic indicators (campus, faculty, sex, race and
urban/rural background) to be completed by respondents. This was designed to aid the
classification and analysis of the data. The demographic questions were placed at the end of the
questionnaire, in line with recommended protocol (see Borque and Fielder, 2003).
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Re: Urgent request for help with research study.
My name is Callen Morrison and I am a Masters student with Culture, Communication and
Media Studies (CCMS), Roward College campus. I am currently involved in researching the
rollout of antiretroviral drugs at UKZN; in particular the kinds of messages that need to be
communicated to students about the drugs and how to access them.
As you are one of the few students on antiretrovirals, as part of UKZN's HIV/AIDS
Treatment Programme, I urgently need your help. I would like to chat to you about your
experiences with antiretrovirals, so that I can gain an insight into how the University can
further assist you, and other students like you. The information you give me will also be used
to assess how the University can reach students who need antiretroviral therapy, but have not
yet accessed the Treatment Programme.
I would like to interview you, at a time and place convenient to you, for approximately 30 to
45 minutes. Your participation in the research will be entirely voluntary and any information
you give me will be on a confidential basis. I have enclosed an information sheet that
provides further details of the research procedure. If you have any more questions, or you
would like to help me with my research, please contact me on 082 5381173 or email me at
callenmorrison@yahoo.co.uk.
Please take some time to consider my request. I believe that the research will not only be
beneficial to you as an individual, but also to the university community as a whole. I would






What is the research about?
The research is for my thesis: ·Social
Marketing and Health Service Promotion: a
needs analysis for the antiretroviral rollout
at the University of KwaZulu-Natal".
The research examines which kinds of
messages about antiretroviral drugs need to
be communicated to students; both the
general student population and those
students who are already taking
antiretrovirals.
What exactly do you have to do?
@., I would like to interview you, at a time and
place convenient to you.
The interview will consist of some simple
questions that have been approved by
UKZN's Ethics Committee, and should take
approximately 30 to 45 minutes.
I will either tape the interview or take notes
(depending on which you prefer) so that I
have an accurate record of our conversation.
Contact me...
If you would like to participate in the
research or would just like to find out more
information, you can contact me, Callen
Morrison, on 082 5381173 or email me at
callenmorrison@yahoo.co.uk.
If you would like to talk to my supervisor,
Professor Keyan Tomaselli (Culture,
Communication and Media Studies), you can
contact him on 031-2602505.
Why do I need your help?
@, As you are one of the few students on
antiretrovirals through the University's
Treatment Programme, I urgently need your
help. I would like to chat to you in order to gain
insight into your experiences with
antiretrovirals. The information you give me can
in turn be used to develop services, resources
and information campaigns so that all students
who need to know about antiretrovirals can be
reached.
What are your rights?
Participation in this research is entirely
voluntary. A decision not to participate will not
result in any form of disadvantage to you.
@, Your anonymity of person is guaranteed at
every stage in the process; I will be the only
person who will know your name. The
information that you give me is entirely
confidential. Your name will never be mentioned
in any publication, and only summarised group
information or anonymous quotations will be
included in the final thesis. Your personal
details will be kept in a safe place, separate
from the transcript of your interview (which
will be assigned a code). Once the data has been
analysed, and the thesis completed, all records
of your name and identifying details will be
destroyed.
@; You are free to withdraw from the research
study at any stage before the thesis is handed
in, even after the interview has been conducted.
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Depth interview outline
1) Before hearing about UKZN's Treatment Programme, did you know anything about
antiretrovirals? If yes, from which sources had you heard about antiretrovirals? What did you he
2) From which sources, and when, did you first hear about the University's Treatment Programr
3) Did you find it difficult to access information about antiretrovirals and/or the Treatment
Programme before you started treatment?
4) Before deciding to start antiretroviral therapy, did you try any other methods of treatment (for
example traditional healers, prayer, vitamins)?
5) When and why did you decide to start ARVs?
6) Now that you are on ARVs, what do you find to be the main benefits oftaking the drugs?
7) What are the difficulties you have experienced in terms of taking ARVs?
8) If you have told family or friends that you have AIDS and are on ARVs, have they supported:
in terms of your treatment? Do they offer you emotional and/or practical help? If you have not he
the support of family or friends, how have you coped?
9) Have you experienced any negative attitudes or behaviour directed towards you as a result of
having RN/AIDS or being on ARVs?
10) Have you found the services offered by the campus clinic to be useful? If yes, which services
were particularly helpful? Which could be improved?
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11) At any point in your treatment with ARVs (including before you started it) do you think thal
University should have provided you with more information, support or resources? If so, what iI
particular?
12) In light of your experiences with antiretroviral therapy, through UKZN's Treatment Progran
would you recommend it to someone else who had HIV or AIDS?
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Question 1-16: Descriptive statistics
Statistics
Q1AWARE Q2ATV Q2BFRIEN Q2CRADIO Q2DBILLB Q2EPOLlT
Valid 302 302 302 302 302 302
Missing 0 0 0 0 0 0
lean 1.02 1.05 1.37 1.15 1.73 1.46
ledian 1.00 1.00 1.00 1.00 2.00 1.00
lode 1 1 1 1 2 1
td. Deviation .140 .301 .531 .420 .495 .544
'ariance .020 .091 .281 .176 .245 .296
Statistics
Q2FDOC Q2GNEWS Q2HPOSTE Q210THER Q3AAZT Q3BNEVIR
I Valid 302 302 302 302 302 302
Missing 0 0 0 0 0 0
~ean 1.48 1.14 1.63 1.88 .40 .41
~edian 2.00 1.00 2.00 2.00 .00 .00
~ode 2 1 2 2 0 0
Itd. Deviation .545 .411 .529 .386 .703 .718
'ariance .297 .169 .280 .149 .494 .516
Statistics
Q3COTHER Q4ANSTIC Q4BRAPE Q4CPMTCT Q4DTREAT
J Valid 302 302 302 302 302
Missing 0 0 0 0 0
lIean .53 1.60 1.42 1.15 1.25
lIedian .00 2.00 1.00 1.00 1.00
.1ode 0 2 1 1 1
>td. Deviation .873 .549 .551 .430 .499
lariance .761 .301 .304 .185 .249
Statistics
Q4EOTHER Q5ABIOL Q5BSOCIA Q5CECON Q5DINCOR
J Valid 302 302 302 302 302
Missing 0 0 0 0 0
lIean 1.93 1.01 1.60 1.65 1.43
Jledian 2.00 1.00 2.00 2.00 2.00
Jlode 2 1 2 2 2
itd. Deviation .349 .599 .771 .762 .773
fariance .122 .359 .594 .581 .598
Pa~
Statistics
Q5EOTHER Q6ASIDEF Q6BLlFE Q6CSEX Q6DADHER
Valid 302 302 302 302 302
Missing 0 0 0 0 0
ean 1.65 1.13 1.21 1.26 1.20
edian 2.00 1.00 2.00 2.00 2.00
ode 2 2 2 2 2
td. Deviation .762 .899 .930 .944 .927
ariance .581 .808 .865 .891 .859
Statistics
Q6EACCES Q6FINCOR Q6GOTHER Q7ASAFSE Q7BEXERC
Valid 302 302 302 302 302
Missing 0 0 0 0 0
lean 1.13 1.26 1.13 1.17 1.24
ledian 1.00 2.00 1.00 1.00 2.00
lode 2 2 2 2 2
,td. Deviation .900 .944 .902 .890 .914
'ariance .811 .891 .813 .792 .835
Statistics
Q7CEAT Q7DALT Q7EINCOR Q7FOTHER Q7GNONE Q8ACURE
I Valid 302 302 302 302 302 302
Missing 0 0 0 0 0 0
'ean 1.16 1.29 1.34 1.20 1.06 1.79
'edian 1.00 2.00 2.00 2.00 1.00 2.00
'ode 2 2 2 2 2 2
:td. Deviation .886 .926 .936 .902 .841 .552
Irariance .785 .857 .877 .813 .707 .305
Statistics
Q8BLlFE Q8CANYBO Q9SUPPLY Q10SIN Q11VCT Q12ADVIS
I Valid 302 302 302 302 302 302
Missing 0 0 0 0 0 0
'ean 1.04 1.63 3.99 1.28 4.55 4.28
ledian 1.00 2.00 4.00 1.00 5.00 5.00
lode 1 2 5 1 5 5
td. Deviation .452 .678 1.251 .727 .969 1.098
'ariance .204 .460 1.565 .528 .940 1.206
Pa~
Statistics
Q13SUPPO Q14ACCES Q151NFO Q16ACAMP Q16BFACU
Valid 302 302 302 302 302
Missing 0 0 0 0 0
lean 4.45 1.80 1.01 1.47 1.69
ledian 5.00 2.00 1.00 1.00 2.00
lode 5 2 1 1 1
td. Deviation .931 .454 .223 .500 .953
ariance .867 .206 .050 .250 .907
Statistics
Q16CSEX Q16DRACE Q16EBACK
I Valid 302 302 302
Missing 0 0 0
lean 1.24 1.89 1.18
ledian 1.00 1.00 1.00
lode 1 1 1
itd. Deviation .429 1.002 .403
'ariance .184 1.004 .163
Appendix F: Tables of frequencies and descriptive statistics
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Appendix F: Tables of frequencies and descriptive statistics
Demograpbic information (Question 16)
Question 16a: Campus
Frequency Percent Valid Percent Cumulative Percent
Westvllle 160 53.0 53.0 53.0
Valid Howard College 142 47.0 47.0 100.0
Total 302 100.0 100.0
!
Black White Indian Coloured Other
Count % Count % Count % Count % Count %
Westvllle 107 68.6% 1 2.8% 50 50.0% 2 25.0%
Howard College 49 31.4% 35 97.2% 50 50.0% 6 75.0% 2 100.0%
r Question 16b: Faculty
Frequency Percent Valid Percent Cumulative Percent
Commerce and Management 142 47.0 47.0 47.0
Humanities 141 46.7 46.7 93.7
Science 8 2.6 2.6 96.4
Valid
Engineering 1 .3 .3 96.7
Law 7 2.3 2.3 99.0
HeaIth Sciences 2 .7 .7 99.7
CADD 1 .3 .3 100.0
Total 302 100.0 100.0
i
Black White Indian Coloured Other Westvllle Howard
College
Cou ,-. Cou ,-. Cou % Cou % Cou ,-. Cou ,-. Cou %nt nt nt nt nt nt nt
Commerc
eand
68 43.6 15 41.7 55 55.0 4 SO.O 76 47.5 66 46.5Managem % % % % % %
ent
Humanltl
76 48.7 21 58.3 38 38.0 4 SO.O 2 100.0 70 43.8 71 50.0es % % % % % % %
Science 4 2.6 4 4.0 7 4.4 1 .7%% % %
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Englneeri
1 .6% 1 .6%ng
Law 4 2.6 3 3.0 4
2.5 3 2.1





CADD 1 .6% 1 .7%
~ ----- ----~ ----
I Question 16c: Sex
Frequency Percent Valid Percent Cumulative Percent
Female 229 75.8 75.8 75.8
Valid Male 73 24.2 24.2 100.0
Total 302 100.0 100.0
Black White Indian Coloured Other Westvllle
Howard
College











le % % % % % % %
Male 41 26.3 10 27.8 22 22.0 36
22.5 37 26.1
% % % % %
r - --- _. -------
I Question 16d: Race
Frequency Percent Valid Percent Cumulative Percent
Black 156 51.7 51.7 51.7
White 36 11.9 11.9 63.6
Indian 100 33.1 33.1 96.7
Valid
Coloured 8 2.6 2.6 99.3
Other 2 .7 .7 100.0
Total 302 100.0 100.0
I
Westvllle Howard College
Count % Count ,-.
Black 107 66.9% 49 34.5%
White 1 .6% 35 24.6%
Indian 50 31.3% 50 35.2%
Coloured 2 1.3% 6 4.2%
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IOther I I 1 21 1.4%1
;
Question 16e: Background
Frequency Percent Valid Percent Cumulative Percent
No Answer 2 .7 .7 .7
Valid
Urban 243 80,5 80.5 81.1
Rural 57 18.9 18.9 100.0
Total 302 100.0 100.0
~~_._~.-,-_._---"_._-_. - -------------------_._---------------_.._.






% Cou % Cou %
Cou
~.
Cou .,4nt nt nt nt nt nt nt
No
1.0Answ 2 1.4% 1 .6% 1
%er
Urban 115 71.9 128 90.1 105 67.3 36 100.0 94 94.0 8 100.0% % % % % %
Rural 45 28.1 12 8.5% 50 32.1 5 5.0 2 100.0% % % %
Awareness of antiretrovirals (Question 1)
I Question 1: Awareness of ARVs
Frequency Percent Valid Percent Cumulative Percent
Yes 296 98.0 98.0 98.0
Valid No 6 2.0 2.0 100.0
Total 302 100.0 100.0
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
Ye
153 98.1 35 97.2 98 98.0 8 100.0 2 100.0 155 96.9 141 99.3s % % % % % % %
No 3 1.9% 1 2.8% 2 2.0% 5 3.1% 1 .7%
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Awareness of VKZN rollout (Question 14)
,......---------_._-------- _..
Question 14: Awareness of access to cheap ART
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Valid
Yes 46 15.2 15.2 17.5
No 249 82.5 82.5 100.0
Total 302 100.0 100.0
Black White Indian Coloured Other Westvllle HowardCollege
Cou
%
Cou % Cou ~.
Cou
~.
Cou .,4 Cou % Cou %nt nt nt nt nt nt nt
No








% % % % %






% % % % % % %
Knowledge of antiretroviral names (Question 3)
~-----------Que;tl~;:;3a: Aii------------·-----
Frequency Percent Valid Percent Cumulative Percent
No Answer 218 72.2 72.2 72.2
Valid
Yes 46 15.2 15.2 87.4
No 38 12.6 12.6 100.0
Total 302 100.0 100.0
Black White Indian Coloured Other Westvllle
Howard
College
Cou % Cou ~. Cou % Cou ~. Cou %
Cou % Cou %nt nt nt nt nt nt nt
No
























Frequency Percent Valid Percent Cumulative Percent
No Answer 218 72.2 72.2 72.2
Valid
Yes 43 14.2 14.2 86.4
No 41 13.6 13.6 100.0
Total 302 100.0 100.0
-
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
68.6 83.3 74.0 75.0 SO.O 63.8 81.7Answ 107







Yes 26 16.7 1 2.8% 15 15.0 1 SO.O 30 18.8 13 9.2%% % % %
No 23 14.7 5 13.9 11 11.0 2 25.0 28 17.5 13 9.2%% % % % %
~ - -
Question 3c: Other
Frequency Percent Valid Percent Cumulative Percent
No Answer 218 72.2 72.2 72.2
Valid
Yes 7 2.3 2.3 74.5
No 77 25.5 25.5 100.0
Total 302 100.0 100.0
.- --
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
68.6 83.3 74.0 75.0 SO.O 63.8 81.7Answ 107 30 74 6 1 102 116
er % % % % % % %
Yes 6 3.8% 1 1.0% 5 3.1% 2 1.4%
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Knowledge of different contexts in which ARVs are used (Question 4)
Question 4a: Needlestlck
Frequency Percent Valid Percent Cumulative Percent
No Answer 9 3.0 3.0 3.0
Valid
Yes 104 34.4 34.4 37.4
No 189 62.6 62.6 100.0
Total 302 100.0 100.0
~- ----._-._.- - -

















nt nt nt nt nt nt nt
No
Answ 5 3.2% 1 2.8% 3 3.0% 7 4.4% 2 1.4%
er
Yes 39 25.0 19 52.8 42 42.0 3 37.5 1
50.0 40 25.0 64 45.1
% % % % % % %





% % % % % % %
--
Question 4b: Rape
Frequency Percent Valid Percent Cumulative Percent
No Answer 9 3.0 3.0 3.0
Valid
Yes 158 52.3 52.3 55.3
No 135 44.7 44.7 100.0
Total 302 100.0 100.0
,_....- .- ----~-- ._----_._------ ,-_. --- -_._---_._------_."._" -







Cou % Cou %
Cou % Cou %
Cou
%
nt nt nt nt nt nt nt
No
Answ 5 3.2% 1 2.8% 3 3.0% 7 4.4% 2 1.4%
er
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% % % % % % %
No 79 50.6 11 30.6 44 44.0 1 12.5 78 48.8 57 40.1% % % % % %
Question 4c: Prevention of mother to child transmission
Frequency Percent Valid Percent Cumulative Percent
No Answer 9 3.0 3.0 3.0
Valid
Yes 240 79.5 79.5 82.5
I
No 53 17.5 17.5 100.0
Total 302 100.0 100.0
.--------- _._.
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou 'I. Cou % Cou 'I. Cou %nt nt nt nt nt nt nt
No
Answ 5 3.2% 1 2.8% 3 3.0% 7 4.4% 2 1.4%
er
Yes 126 80.8 30 83.3 75 75.0 7 87.5 2 100.0 128 80.0 112
78.9
% % % % % % %
No 25
16.0
5 13.9 22 22.0 1 12.5 25 15.6 28 19.7% % % % % %
~ -------------------_....
Question 4d: Treatment
Frequency Percent Valid Percent Cumulative Percent
No Answer 9 3.0 3.0 3.0
Valid
Yes 208 68.9 68.9 71.9
No 85 28.1 28.1 100.0
Total 302 100.0 100.0
----
!
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou 'I. Cou % Cou % Cou % Cou % Cou 'I.nt nt nt nt nt nt nt
No
Answ 5 3.2% 1 2.8% 3 3.0% 7 4.4% 2 1.4%
er
Yes 99 63.5 29 80.6 71 71.0 7 87.5 2 100.0 105 65.6 103 72.5% % % % % % %
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I Question 4e: OtherI
Frequency Percent Valid Percent Cumulative Percent
No Answer 9 3.0 3.0 3.0
Valid
Yes 2 .7 .7 3.6
No 291 96.4 96.4 100.0
Total 302 100.0 100.0
-.---------_.__.._.-----_.------
i











Cou 'I. Cou % Cou %
nt nt nt nt nt nt nt
No
Answ 5 3.2% 1 2.8% 3 3.0% 7 4.4% 2 1.4%
er
Yes 2 2.0% 2 1.4%





% % % % % % %
Knowledge about antiretrovirals and access (Question 8)
,---_._-- --
r Question Ba: Cure
Frequency Percent Valid Percent Cumulative Percent
No Answer 21 7.0 7.0 7.0
Valid
True 21 7.0 7.0 13.9
False 260 86.1 86.1 100.0
Total 302 100.0 100.0
r
Black White Indian Coloured Other Westvllle
Howard
College
Cou 'I. Cou 'I. Cou % Cou % Cou % Cou %
Cou 'I.
nt nt nt nt nt nt nt
No
10.0
Answ 11 7.1% 1 2.8% 9 9.0% 16 5 3.5%
er %
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True 12 7.7% 7 7.0% 2 25.0 12 7.5% 9 6.3%%
False 133 85.3 35 97.2 84 84.0 6 75.0 2 100.0 132 82.5 128 90.1% % % % % % %
Question Bb: Life-long treatment
Frequency Percent Valid Percent Cumulative Percent
No Answer 25 8.3 8.3 8.3
Valid
True 240 79.5 79.5 87.7
False 37 12.3 12.3 100.0
Total 302 100.0 100.0
--- - --
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou 'I. Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
10.0Answ 14 9.0% 1 2.8% 10
% 15 9.4% 10 7.0%er
True 126 80.8 29 80.6 76 76.0 7 87.5 2
100.0
127 79.4 113 79.6% % % % % % %
False 16 10.3 6 16.7 14 14.0 1 12.5 18 11.3 19 13.4% % % % % %
-
Question Se: Given to anybody
Frequency Percent Valid Percent Cumulative Percent
No Answer 34 11.3 11.3 11.3
Valid
True 44 14.6 14.6 25.8
False 224 74.2 74.2 100.0
Total 302 100.0 100.0
I - -----
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
11.5 14.0 12.5Answ 18
% 2 5.6% 14 % 20 % 14 9.9%er
True 26 16.7 7 19.4 10 10.0 1 12.5 24 15.0 20 14.1% % % % % %
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Beliefs about the benefits of antiretrovirals (Question 5)
Question Sa: Biological advantages
----
Frequency Percent Valid Percent Cumulative Percent
No Answer 53 17.5 17.5 17.5
Valid
Yes 194 84.2 84.2 81.8
No 55 18.2 18.2 100.0
Total 302 100.0 100.0
- --- --
I
Black White Indian Coloured Other Westvllle
Howard
College
Cou % Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No





Yes 100 84.1 25 69.4 60 60.0 7 87.5 2 100.0 94 58.8 100 70.4% % % % % % %
No 31 19.9 10 27.8 13 13.0 1 12.5 33 20.6 22 15.5% % % % % %
- - ---. - -- ._.
I Question 5b: Social advantages
Frequency Percent Valid Percent Cumulative Percent
No Answer 53 17.5 17.5 17.5
Valid
Yes 16 5.3 5.3 22.8
No 233 77.2 77.2 100.0
Total 302 100.0 100.0
I
I






% Cou 'I. Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
16.0 27.0 20.6 14.1Answ 25
%
1 2.8% 27
% 33 % 20 %er
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Yes 7 4.5% 2 5.6% 6 6.0% 1 12.5 13 8.1% 3 2.1%%
No 124 79.5 33 91.7 67 67.0 7 87.5 2 100.0 114 71.3 119 83.8% % % % % % %
Question Se: Incorrect answer
Frequency Percent Valid Percent Cumulative Percent
No Answer 53 17.5 17.5 17.5
Valid
Yes 66 21.9 21.9 39.4
No 183 60.6 60.6 100.0
Total 302 100.0 100.0
.~._-----~..
Black While Indla~ Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
16.0 27.0 20.6 14.1Answ 25 1 2.8% 27 33 20er % % % %
Yes 30 19.2 13 36.1 20 20.0 3 37.5 34 21.3 32 22.5% % % % % %
No 101 64.7 22 61.1 53 53.0 5 62.5 2 100.0 93 58.1 90 63.4% % % % % % %
---'-~----- ------- ------- -
Question 5d: Other
Frequency Percent Valid Percent Cumulative Percent
No Answer 53 17.5 17.5 17.5
Valid No 249 82.5 82.5 100.0
Total 302 100.0 100.0
I----·---~- .--------_...__._--_...__•._--
Black While Indian Coloured Other Westvllle Howard
College
Cou ." Cou "I. Cou % Cou % Cou "I. Cou % Cou %nt nt nt nt nt nt nt
No
16.0 27.0 20.6 14.1Answ 25
% 1 2.8% 27 % 33 % 20 %er
'No 131 84.0 35 97.2 73 73.0 8 100.0 2
100.0
127 79.4 122 85.9% % % % % % %
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Beliefs about tbe disadvantages of antiretrovirals (Question 6)
Question 6a: Slde-effects
Frequency Percent Valid Percent Cumulative Percent
No Answer 105 34.8 34.8 34.8
Valid
Yes 54 17.9 17.9 52.6
No 143 47.4 47.4 100.0
Total 302 100.0 100.0
._-",---_.
I
Black While Indian Coloured Other Westvllle HowardCollege
Cou ." Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No














5 13.9 12 12.0 3
37.5 25 15.6 29 20.4
% % % % % %










% % % % % % %
r "---'-'-'.--.' - ". -----_..... _._-,._-----_.._...__..- ..... - ......_----_..._.._-_..__._---
I Question Gb: Llfe-Ionglnot a cure
Frequency Percent Valid Percent Cumulative Percent
No Answer 105 34.8 34.8 34.8
Valid
Yes 28 9.3 9.3 44.0
No 169 56.0 56.0 100.0




Black While Indian Coloured Other Westvllle
Howard
College
Cou "I. Cou "I. Cou % Cou "I. Cou "I. Cou % Cou %nt nt nt nt nt nt nt
No







% 1 % 51 %
54
%er
Yes 21 13.5 2 5.6% 5 5.0% 18 11.3 10 7.0%% %
No 97 62.2 25 69.4 41 41.0 5 62.5 1 50.0 91
56.9 78 54.9
% % % % % % %
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- --- -- --- . -
Question 6e: Access
Frequency Percent Valid Percent Cumulative Percent
No Answer 105 34.8 34.8 34.8
Valid
Yes 53 17.5 17.5 52.3
No 144 47.7 47.7 100.0
Total 302 100.0 100.0
-
,.











%nt nt nt nt nt nt nt
No















4 50.0 1 50.0 86 53.8 58
40.8
% % % % % % %
Question 6c: Careless sex
Frequency Percent Valid Percent Cumulative Percent
No Answer 105 34.8 34.8 34.8
Valid
Yes 13 4.3 4.3 39.1
No 184 60.9 60.9 100.0
Total 302 100.0 100.0
r- ...- .._. ...__..- -"- -.--_.._._...._-
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
24.4 25.0 54.0 37.5 50.0 31.9 38.0Answ 38
% 9 % 54 % 3 %
1
% 51 % 54 %er
Yes 9 5.8% 3 8.3% 1 1.0% 8 5.0% 5 3.5%
No 109 69.9 24 66.7 45 45.0 5 62.5 1 50.0 101 63.1 83 58.5% % % % % % %
-----
Question 6<1: Adherence
Frequency Percent Valid Percent Cumulative Percent
No Answer 105 34.8 34.8 34.8
Valid
Yes 31 10.3 10.3 45.0
No 166 55.0 55.0 100.0
Total 302 100.0 100.0
- ----
Black White Indian Coloured Other Westvllle Howard
College
Cou
'I. Cou % Cou % Cou % Cou 'I. Cou % Cou %nt nt nt nt nt nt nt
No
24.4 25.0 54.0 37.5 50.0 31.9 38.0Answ 38
% 9 % 54 % 3 % 1 % 51 % 54 %er
Yes 21 13.5 3 8.3% 4 4.0% 2 25.0 1 50.0 21 13.1 10 7.0%% % % %
No 97 62.2 24 66.7 42 42.0 3 37.5 88 55.0 78 54.9% % % % % %
Question 6f: Incorrect answer
Frequency Percent Valid Percent Cumulative Percent
No Answer 105 34.8 34.8 34.8
Valid
Yes 13 4.3 4.3 39.1
No 184 60.9 60.9 100.0
Total 302 100.0 100.0









%nt nt nt nt nt nt nt
No





















% % % % % % %
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Question 6g: Other
Frequency Percent Valid Percent Cumulative Percent
No Answer 105 34.8 34.8 34.8
Valid
Yes 52 17.2 17.2 52.0
No 145 48.0 48.0 100.0
Total 302 100.0 100.0
._-- -- ._-













%nt nt nt nt nt nt nt
No
24.4 25.0 54.0 37.5 50.0 31.9 38.0Answ 38 9 54 3 1 51 54
er % % % % % % %








50.0 76 47.5 69
48.6
% % % % % % %
Beliefs about other options to treat HIVIAIDS (Question 7)
Question 7a: Safe sex
Frequency Percent Valid Percent Cumulative Percent
No Answer 98 32.5 32.5 32.5
Valid
Yes 55 16.2 16.2 50.7
No 149 49.3 49.3 100.0
Total 302 100.0 100.0
- ---------- -- ---_._--- - -_._--





Cou Of, Cou %
Cou % Cou %
Cou
%
nt nt nt nt nt nt nt
No
23.1 36.1 44.0 50.0 50.0 32.5 32.4Answ 36 % 13 %
44
%
4 % 1 % 52 %
46
%er
Yes 38 24.4 4 11.1 13 13.0 32 20.0 23 16.2
% % % % %
No 62 52.6 19 52.8 43 43.0 4 50.0 1 50.0 76 47.5 73
51.4




Frequency Percent Valid Percent Cumulative Percent
No Answer 98 32.5 32.5 32.5
Valid
Yes 33 10.9 10.9 43.4
No 171 56.6 56.6 100.0
Total 302 100.0 100.0
- -










nt nt nt nt nt nt nt






















% % % % % % %
" - -- -- -- - - --Question 7c: Healthy eatlnglvltamlns
Frequency Percent Valid Percent Cumulative Percent
No Answer 98 32.5 32.5 32.5
Valid
Yes 58 19.2 19.2 51.7
No 146 48.3 48.3 100.0
Total 302 100.0 100.0
.- - - - --~- - - - -










nt nt nt nt nt nt nt














% % % % %
No 74










Question 7d: Alternative therapies
Frequency Percent Valid Percent Cumulative Percent
No Answer 98 32.5 32.5 32.5
Valid
Yes 19 6.3 6.3 38.7
No 185 61.3 61.3 100.0
Total 302 100.0 100.0
- ._--_.__._--_._,._._.__.
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
23.1 36.1 44.0 50.0 50.0 32.5 32.4Answ 36
% 13 % 44 % 4 % 1 % 52 % 46 %er
Yes 13 8.3% 1 2.8% 2 2.0% 2 25.0 1 50.0 13 8.1% 6 4.2%% %
No 107 68.6 22 61.1 54 54.0 2 25.0 95 59.4 90 63.4% % % % % %
r--
Question 7e: Incorrect answer
Frequency Percent Valid Percent Cumulative Percent
No Answer 98 32.5 32.5 32.5
Valid
Yes 3 1.0 1.0 33.4
No 201 66.6 66.6 100.0
Total 302 100.0 100.0
----- -- -- .-
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
23.1 36.1 44.0 50.0 50.0 32.5 32.4Answ 36 13 44 4 1 52 46
er % % % % % % %
Yes 1 .6% 2 2.0% 2 1.3% 1 .7%





Frequency Percent Valid Percent Cumulative Percent
No Answer 98 32.5 32.5 32.5
Valid
Yes 45 14.9 14.9 47.4
No 159 52.6 52.6 100.0
Total 302 100.0 100.0
c











Cou % Cou %nt nt nt nt nt nt nt
No
23.1 36.1 44.0 50.0 50.0 32.5 32.4Answ 36 13 44 4 1 52 46












% % % % % %
No 94
60.3
19 52.8 43 43.0 2
25.0
1
50.0 81 50.6 78 54.9
% % % % % % %
Question 7g: None
Frequency Percent Valid Percent Cumulative Percent
No Answer 98 32.5 32.5 32.5
Valid
Yes 88 29.1 29.1 61.6
No 116 38.4 38.4 100.0
Total 302 100.0 100.0
c--- -- --










%nt nt nt nt nt nt nt
No











Yes 40 25.6 18 50.0 29 29.0 1
12.5 37 23.1 51 35.9
% % % % % %





50.0 71 44.4 45 31.7
% % % % % % %
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Attitudes towards ARV-related issues (Question 9-13)
-
Question 9: .,.he university should supply cheap antlretrovlrals..."
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Strongly Disagree 13 4.3 4.3 6.6
Disagree 14 4.6 4.6 11.3
Valid Neutral 47 15.6 15.6 26.8
Agree 82 27.2 27.2 54.0
Strongly Agree 139 46.0 46.0 100.0
Total 302 100.0 100.0
r-'- ~ - '---'---"'- - ------- --~-,_.-
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou 0,4 Cou %nt nt nt nt nt nt nt
No




9 5.8% 1 2.8% 3 3.0% 9 5.6% 4 2.8%Dlsagr
ee
Dlsagr
4 2.6% 3 8.3% 5 5.0% 2 25.0 5 3.1% 9 6.3%ee %
Neutral 18 11.5 6 16.7 23 23.0 26 16.3 21 14.8% % % % %
Agree 39 25.0 13 36.1 25 25.0 4 SO.O 1 50.0 37 23.1 45 31.7% % % % % % %
Strong
53.2 33.3 41.0 25.0 SO.O 48.8 43.0Iy 83
% 12 % 41 % 2 % 1 % 78 % 61 %Agree
Question 10: "Most people with HIVlAlDS have sinned..."
Frequency Percent Valid Percent Cumulative Percent
Valid No Answer 6 2.0 2.0 2.0
Strongly Disagree 234 77.5 77.5 79.5
Disagree 43 14.2 14.2 93.7
Neutral 13 4.3 4.3 98.0
Agree 2 .7 .7 98.7
159
DStronglYAgree I 45§].3 1.31 100.01Total 302 100.0 100.0___-L _
I











%nt nt nt nt nt nt nt
No

























ee % % % % %
Neutra
5 3.2% 2 5.6% 5 5.0% 1
12.5 7 4.4% 6 4.2%I %
Agree 1 .6% 1 2.8% 1 .6% 1 .7%
Strong
Iy 3 1.9% 1 2.8% 2 1.3% 2 1.4%
Agree
--- -- --- -_.-
Question 11: "If I had a friend... voluntary counselling and testing (VCT)."
Frequency Percent Valid Percent Cumulative Percent
No Answer 6 2.0 2.0 2.0
Strongly Disagree 4 1.3 1.3 3.3
Disagree 2 .7 .7 4.0
Valid Neutral 14 4.6 4.6 8.6
Agree 57 18.9 18.9 27.5
Strongly Agree 219 72.5 72.5 100.0
Total 302 100.0 100.0
1- - ---














nt nt nt nt nt nt nt
No





4 2.6% 4 2.5%Dlsagr
ee
Dlsagr
1 .6% 1 1.0% 2 1.3%ee
Neutral 12 7.7% 2 2.0% 10 6.3% 4 2.8%
Agree 29 18.6 9 25.0 15 15.0 3 37.5 1 SO.O 28 17.5 29 20.4% % % % % % %
Strong
68.6 72.2 80.0 62.5 50.0 69.4 76.1Iy 107
% 26 % 80 % 5 % 1 % 111 % 108 %Agree
I Question 12: ·If I knew someone•.. anllretrovlral treatment·.
Frequency Percent Valid Percent Cumulative Percent
No Answer 8 2.6 2.6 2.6
Strongly Disagree 4 1.3 1.3 4.0
Disagree 6 2.0 2.0 6.0
Valid Neutral 29 9.6 9.6 15.6
Agree 85 28.1 28.1 43.7
Strongly Agree 170 56.3 56.3 100.0
Total 302 100.0 100.0
---- -
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No




3 1.9% 1 1.0% 4 2.5%Dlsagr
ee
Dlsagr
5 3.2% 1 1.0% 5 3.1% 1 .7%ee
Neutral 17 10.9 3 8.3% 9 9.0% 17
10.6
12 8.5%% %
Agree 39 25.0 12 33.3 28 28.0 5
62.5
1 50.0 34 21.3 51 35.9% % % % % % %
Strong
88 56.4 20 55.6 58 58.0 3 37.5 1 50.0 94 58.8 76 53.5Iy % % % % % % %
161
~ 1IIIIII11I111
Question 13: ·If I knew somone... prepared to offer them support...• -
Frequency Percent Valid Percent Cumulative Percent
No Answer 6 2.0 2.0 2.0
Strongly Disagree 1 .3 .3 2.3
Disagree 4 1.3 1.3 3.6
Valid Neutral 15 5.0 5.0 8.6
Agree 89 29.5 29.5 38.1
Strongly Agree 187 61.9 61.9 100.0
Total 302 100.0 100.0
, ----_. -- _._-----_.-
I




% Cou % Cou % Cou 'I. Cou % Cou %
Cou
%
nt nt nt nt nt nt nt
No




1 .6% 1 .6%Dlsagr
ee
Dlsagr
3 1.9% 1 SO.O 2 1.3% 2 1.4%ee %
Neutral 7 4.5% 3 8.3% 5 5.0% 3 1.9% 12 8.5%
Agree 39 25.0 13 36.1 33 33.0 4 SO.O 42 26.3 47 33.1
% % % % % %
Strong












Sources of information on antiretrovirals (Question 2)
Question 2a: Television
Frequency Percent Valid Percent Cumulative Percent
Valid No Answer 7 2.3 2.3 2.3
Yes 274 90.7 90.7 93.0
No 21 7.0 7.0 100.0
162
[ ITotal I 3021 100.01 100.01 1
- - -
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
Answ 3 1.9% 1 2.8% 3 3.0% 6 3.8% 1 .7%
er
Yes 141 90.4 32 88.9 93 93.0 6 75.0 2 100.0 148 92.5 126 88.7% % % % % % %
No 12 7.7% 3 8.3% 4 4.0% 2
25.0
6 3.8% 15 10.6% %
Question 2b: Friends/Family
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Valid
Yes 175 57.9 57.9 60.3
No 120 39.7 39.7 100.0
Total 302 100.0 100.0
c -
Black White Indian Coloured Other Westvllle Howard
College
Cou
% Cou % Cou % Cou % Cou "1o Cou % Cou %nt nt nt nt nt nt nt
No
Answ 3 1.9% 1 2.8% 3 3.0% 6 3.8% 1 .7%
er
Yes 92 59.0 26 72.2 48 48.0 8 100.0 1 50.0 83 51.9 92 64.8% % % % % % %
No 61 39.1 9 25.0 49 49.0 1 50.0 71 44.4 49 34.5% % % % % %
- -
Question 2c: Radio
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Valid
Yes 242 80.1 80.1 82.5
No 53 17.5 17.5 100.0
Total 302 100.0 100.0
163
.-- -




% Cou % Cou % Cou %
Cou 0,4 Cou % Cou %nt nt nt nt nt nt nt
No
Answ 3 1.9% 1 2.8% 3 3.0% 6 3.8% 1 .7%
er
Yes 132 84.6 27 75.0 79 79.0 3 37.5 1
50.0 137 85.6 105 73.9
% % % % % % %
No 21 13.5 8 22.2 18 18.0 5
62.5 1 50.0 17
10.6 36 25.4
% % % % % % %
--'.----_._- ----_.. --.'-_.__.-
Question 2d: Billboards
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Valid
Yes 68 22.5 22.5 24.8
No 227 75.2 75.2 100.0
Total 302 100.0 100.0
r
--- --- -----
Black White Indian Coloured Other Westvllle
Howard
College
Cou % Cou % Cou 0,4 Cou % Cou % Cou %
Cou
%nt nt nt nt nt nt nt
No
Answ 3 1.9% 1 2.8% 3 3.0% 6 3.8% 1 .7%
er
Yes 31 19.9 6 16.7 30 30.0 1
12.5 39 24.4 29
20.4
% % % % % %
No 122 78.2 29 80.6 67 67.0 7 87.5 2
100.0 115 71.9 112
78.9
% % % % % % %
,
Question 2e: Politicians/Activists
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Valid
Yes 148 49.0 49.0 51.3
No 147 48.7 48.7 100.0
Total 302 100.0 100.0
164
Black White Indian Coloured Other Westvllle
Howard
College
Count % Count % Count % Count % Count % Count % Count '10
No
3 1.9% 1 2.8% 3 3.0% 6 3.8% 1 .7%Answer
Yes 86 55.1% 18 50.0% 39 39.0% 4 50.0% 1 50.0% 81 50.6% 67 47.2%
No 67 42.9% 17 47.2% 58 58.0% 4 50.0% 1 50.0% 73 45.6% 74 52.1%
-- -- .-
r Question 2f: Doctors/Nurses
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Valid
Yes 143 47.4 47.4 49.7
No 152 50.3 50.3 100.0
Total 302 100.0 100.0
Black White Indian Coloured Other Westvllle
Howard
College
Cou % Cou %
Cou '10 Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No











% % % % % % %
No 65 41.7 28 77.8 53 53.0 5 62.5 1 SO.O 61
38.1 91 64.1
% % % % % % %
- -- -- -- -- -
Question 2g: N_spapers
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Valid
Yes 245 81.1 81.1 83.4
No 50 16.6 16.6 100.0
Total 302 100.0 100.0
Black White Indian Coloured Other Westvllle
Howard
College
Cou I % Cou I % Cou I '10 Cou I % Cou I % Cou I % Cou I '10
nt nt nt nt nt nt nt







86.0 8 100.0 2 100.0 132
82.5 113 79.6







% % % % %
r -- -"Question 2h: Posters/Flyers on campus
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Valid
Yes 97 32.1 32.1 34.4
No 198 65.6 65.6 100.0
Total 302 100.0 100.0
- - -










nt nt nt nt nt nt nt
No


















% % % % % % %
..----- ------ ----- ---' --_.- .._--- -_._---
Question 21: Other
Frequency Percent Valid Percent Cumulative Percent
No Answer 7 2.3 2.3 2.3
Valid
Yes 21 7.0 7.0 9.3
No 274 90.7 90.7 100.0
Total 302 100.0 100.0
166
-






% Cou % Cou % Cou % Cou %nt nt nt nt nt nt nt
No
Answ 3 1.9% 1 2.8% 3 3.0% 6 3.8% 1 .7%
er











% % % % % % %
Perceived need for more information on rollout (Question 15)
- -- --- ---- ----- -
Question 15: More Information on provision of ARVs
Frequency Percent Valid Percent Cumulative Percent
No Answer 6 2.0 2.0 2.0
Valid
Yes 287 95.0 95.0 97.0
No 9 3.0 3.0 100.0
Total 302 100.0 100.0
-- --




% Cou % Cou % Cou % Cou %
Cou
%
Cou %nt nt nt nt nt nt nt
No
Answ 3 1.9% 1 2.8% 2 2.0% 5 3.1% 1 .7%
er
Yes 146 93.6 35
97.2
97 97.0 7 87.5 2
100.0 1SO 93.8 137 96.5
% % % % % % %




Appendix G: Significance tests
Awareness of antiretrovirals (Question 1)
a Not assuming the null hypothesis. --J





N IPercent N IPercent N IPercent
01AWARE' 016ACAMP 3021100.0% 01 .0% 3021100.0%






N IPercent NTPercent N IPercent
01 AWARE • 016DRACE 2921100.0% 01 .0% 2921100.0%





Count 153 35 98 286
I
Ves Expected Count 97.9 286.0152.8 35.3
I
01 AWARE
% within 016DRACE 98.1% 97.2% 98.0% 97.9%
Count 3 1 2 6
No Expected Count 3.2 .7 2.1 6.0
% within 016DRACE 1.9% 2.8% 2.0% 2.1%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0





Count 155 141 296
I
Ves Expected Count 156.8 139.2 296.0,
,OlAWARE
% within 016ACAMP 96.9% 99.3% 98.0%
Count 5 1 6,
No Expected Count 3.2 2.8 6.0
I
% within 016ACAMP .7% 2.0%3.1%
Count 160 142 302
ITotal Expected Count 160.0 142.0 302.0
I
% within 016ACAMP 100_0% 100.0% 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded)
Pearson Chi-Square .108(a) 2 .947
Likelihood Ratio .100 2 .951
N 01 Valid Cases 292




Nominal by Nominal Cramer's V .019 .947,
Contingency Coefficient .019 .947
N 01 Valid Cases 292
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (l-slded)
Pearson Chi-Square 2.264(b) 1 .132
Continuity Correctlon(a) 1.192 1 .275
Likelihood Ratio 2.500 1 .114
Fisher's Exact Test .219 .137
N 01 Valid Cases 302
a Computed only for a 2x2 table
b 2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.82.
Symmetric Measures
Value Approx. 51g.
Nominal by Nominal Phi -.087 .132
Cramer's V .087 .132
172 173
IContingency Coefficientr .0861 .132
N of Valid Cases I 3lJ2T
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.
ICramer's V .098 .253
IContingency Coefficient .098 .253
N of Valid Cases 285
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.
Awareness of university rollout (Question 14)





l N IPercent NI Percent N IPercent
IQ14ACCES • Q16DRACE 2851100.0% 01 .0% 2851100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 2.745(a) 2 .253
Likelihood Ratio 2.873 2 .238





N IPercent NI Percent N IPercent






Count 17 29 46
Yes Expected Count 24.0 22.0 46.0
;Q14ACCES
% within Q16ACAMP 11.0% 20.6% 15.6%
Count 137 112 249
I
No Expected Count 130.0 119.0 249.0
I % within Q16ACAMP 89.0% 79.4% 84.4%
Count 154 141 295
Total Expected Count 154.0 141.0 295.0
I % within Q16ACAMP 100.0% 100.0% too.O%
Chi-Square Tests
Value df Asymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (1-slded)
Pearson Chi-Square 5.077(b) 1 .024
Continuity Correctlon(a) 4.379 1 .036
Likelihood Ratio 5.108 1 .024
Fisher's Exact Test .026 .018
N of Valid Cases 295
a Computed only for a 2x2 table
b 0 cells (.0%) have expected count less than 5. The minimum expected count is 21.99.
--I Value rApprox. Slg.
Symmetric Measures
I





Count 29 6 11 46,
Yes Expected Count 24.5 5.6 15.8 46.0
,Q14ACCES
% within Q16DRACE 19.1% 17.1% 11.2% 16.1%
Count 123 29 87 239
No Expected Count 127.5 29.4 82.2 239.0
I % within Q16DRACE 80.9% 82.9% 88.8% 83.9%
Count 152 35 98 285
'Total Expected Count 152.0 35.0 98.0 285.0
I % within Q16DRACE 100.0% 100.0% 100.0% 100.0%





Nominal by Nominal Cramer's V .131 .024
Contingency Coefficient .130 .024
N of Valid Cases 295
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.




N Percent N Percent N Percent
Q3AAZT' Q16DRACE 292 100.0% 0 .0% 292 100.0%
Q3BNEVIR • Q16DRACE 292 100.0% 0 .0% 292 100.0%






Count 107 30 74 211
No Answer Expected Count 112.7 26.0 72.3 211.0
I % within Q16DRACE 68.6% 83.3% 74.0% 72.3%
Count 27 5 12 44
IQ3AAZT Ves Expected Count 23.5 5.4 15.1 44.0
% within Q16DRACE 17.3% 13.9% 12.0% 15.1%
I Count 22 1 14 37
No Expected Count 19.8 4.6 12.7 37.0
I % within Q16DRACE 14.1% 2.8% 14.0% 12.7%
Total Count 156 36 100 292




Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 5.293(a) 4 .259
Likelihood Ratio 6.587 4 .159
N of Valid Cases 292




Nominal by Nominal Cramer's V .095 .259,
Contingency Coefficient .133 .259
N of Valid Cases 292
a Not assuming the null hypothesis.





Count 107 30 74 211
No Answer Expected Count 112.7 26.0 72.3 211.0
% within Q16DRACE 68.6% 83.3% 74.0% 72.3%
,
Count 26 1 15 42
'Q3BNEVIR Ves Expected Count 22.4 5.2 14.4 42.0
,
% within Q16DRACE 16.7% 2.8% 15.0% 14.4%,
Count 23 5 11 39
No Expected Count 20.8 4.8 13.4 39.0,
% within Q16DRACE 14.7% 13.9% 11.0% 13.4%
Count 156 36 100 292,
Total Expected Count 156.0 36.0 100.0 292.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
177
Chi-Square Tests
Value <If Asymp. Slg. (2-slded)
Pearson Chi-Square 5.555(a) 4 .235
Likelihood Ratio 7.218 4 .125
N of Valid Cases 292




Nominal by Nominal Cramer's V .098 .235,
Contingency Coefficient .137 .235
N of Valid Cases 292
a Not assuming the null hypothesis.







Count 107 30 74 211
No Answer Expected Count 112.7 26.0 72.3 211.0
% within Q16DRACE 68.6% 83.3% 74.0% 72.3%
Count 6 0 1 7
Q3COTHER Yes Expected Count 3.7 .9 2.4 7.0
% within Q16DRACE 3.8% .0% 1.0% 2.4%
Count 43 6 25 74
No Expected Count 39.5 9.1 25.3 74.0
% within Q16DRACE 27.6% 16.7% 25.0% 25.3%
Count 156 36 100 292
ITotal Expected Count 156.0 36.0 100.0 292.0
I % within Q16DRACE 100.0% 100.0% 100.0% 100.0%
178
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 5.365(a) 4 .252
Likelihood Ratio 6.361 4 .174
N of Valid Cases 292




Nominal by Nominal Cramsr's V .096 .252,
Contingency Coefficient .134 .252
N of Valid Cases 292
a Not assuming the null hypothesis.




N Percent N Percent N Percent
Q3AAZT • Q16ACAMP 302 100.0% 0 .0% 302 100.0%
Q3BNEVIR • Q16ACAMP 302 loo.O"k 0 .0% 302 loo.O"k






Q3AAZT Count 102 116 218
No Answer Expected Count 115.5 102.5 218.0
% within Q16ACAMP 63.8% 81.7% 72.2%
Count 31 15 46
Yes Expected Count 24.4 21.6 46.0
% within Q16ACAMP 19.4% 10.6% 15.2%
179
,
I Count 27 11 38
I
No Expected Count 20.1 17.9 38.0
% within Q16ACAMP t6.9% 7.7% 12.6%
Count 160 142 302
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value dl Asymp. Slg. (2-slded)
Pearson Chi-Square 12.172(a) 2 .002
Likelihood Ratio 12.461 2 .002
N 01 Valid Cases 302




Nominal by Nominal Cramer'sV .201 .002
I
Conlingency Coefficient .197 .002
N 01 Valid Cases 302
a Not assuming the null hypothesis.







Q3BNEVIR Count 102 116 218
No Answer Expected Count 115.5 102.5 218.0
% within Q16ACAMP 63.8% 81.7% 72.2%,
Count 30 13 43
Yes Expected Count 22.8 20.2 43.0
% within Q16ACAMP 18.8% 9.2% 14.2%,




IExpected Count 21.7 19.3 41.0
1 % within Q16ACAMP 17.5% 9.2% 13.6%
Count 160 142 302,
Total Expected Count 160.0 142.0 302.0
1 % within Q16ACAMP 100.0% 100.0% 100.0%I
Chi-Square Tests
I Value dl Asymp. Slg. (2-slded)
Pearson Chi-Square 12.078(a) 2 .002
Likelihood Ratio 12.351 2 .002
N 01 Valid Cases 302




Nominal by Nominal Cramer's V .200 .002
Conlingency Coefficient .196 .002
N 01 Valid Cases 302
a Not assuming the null hypothesis.






Q3COTHER Count 102 116 218
I
No Answer Expected Count 115.5 102.5 218.0
I
% within Q16ACAMP 63.8% 81.7% 72.2%
I
Count 5 2 7,
Yes Expected Count 3.7 3.3 7.0,
% within Q16ACAMP 3.1% 1.4% 2.3%
No Count 53 24 77,
Expected Count 40.8 36.2 77.0
181
I I % within 016ACAMP 33.1% 16.9% 25.5%
ITotal
Count 160 142 302
Expected Count 160.0 142.0 302.0
% within 016ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value dl Asymp. Slg. (2-slded)
Pearson Chi-Square 12.077(a) 2 .002
Likelihood Rallo 12.351 2 .002
N 01 Valid Cases 302




Nominal by Nominal Cramer's V .200 .002,
Conllngency Coefficient .196 .002
N 01 Valid Cases 302
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.





N IPercent N IPercent N IPercent
I04ANSTIC ·016DRACE 2831100.0% 01 .0% 2831100.0%




04ANSnC Ves Count 39 19 42 100
Expected Count 53.4 12.4 34.3 100.0
182
% within 016DRACE 25.8% 54.3% 43.3% 35.3%,
Count 112 16 55 183
No Expected Count 97.6 22.6 62.7 183.0
% within 016DRACE 74.2% 45.7% 56.7% 64.7%
Count 151 35 97 283
'Total Expected Count 151.0 35.0 97.0 283.0
% within 016DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
I Value dl Asymp. Slg. (2-slded)
Pearson Chi-Square 14.167(a) 2 .001
I Likelihood Rallo 14.114 2 .001
IN 01 Valid Cases 283




,Nominal by Nominal Cramer's V .224 .001,
Conllngency Coefficient .218 .001
N 01 Valid Cases 283 ,
a Not assuming the null hypothesis.





I N IPercent N IPercent N 1Percent




04BRAPE Ves Counl 72 24 53 149
183
Expected Count 79.5 18.4 51.1 149.0
% within Q16DRACE 47.7% 68.6% 54.6% 52.7%
Count 79 11 44 134,
No Expected Count 71.5 16.6 45.9 134.0
I
% within Q16DRACE 52.3% 31.4% 45.4% 47.3%
Count 151 35 97 283
Total Expected Count 151.0 35.0 97.0 283.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 5.208(a) 2 .074
Likelihood Ratio 5.312 2 .070
N of Valid Cases 283




Nominal by Nominal Cramer's V .136 .074
Contingency Coefficient .134 .074
N of Valid Cases 283
a Not assuming the null hypothesis.





N IPercent N IPercent N IPercent
Q4CPMTCT' Q16DRACE 2831100.0% 01 .0% 2831100.0%
Count 126 30 1 75 231
I Yes Expected Count 123.3 28.6 79.2 231.0
IQ4CPMTCT
% within Q16DRACE 83.4% 85.7% 77.3% 81.6%
Count 25 5 22 52
I No Expected Count 27.7 6.4 17.8 52.0
I % within Q16DRACE 16.6% 14.3% 22.7% 18.4%
ITotal
Count 151 35 97 283
Expected Count 151.0 35.0 97.0 283.0
I % within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 1.922(a) 2 .382
Likelihood Ratio 1.892 2 .388
N of Valid Cases 283




Nominal by Nominal Cramer's V .082 .382
I
Contingency Coefficient .082 .382
N of Valid Cases 283 ,
a Not assuming the null hypothesis.






N IPercent N IPercent N IPercent











Count 99 29 71 199,
Yes Expected Count 106.2 24.6 68.2 199.0,
,04DTREAT % within 016DRACE 65.6% 82.9% 73.2% 70.3%
Count 52 6 26 84
No Expected Count 44.8 10.4 28.8 84.0,
% within 016DRACE 34.4% 17.1% 26.8% 29.7%
Count 151 35 97 283
'Total Expected Count 151.0 35.0 97.0 283.0
I
% within 016DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value elf Aaymp. Slg. (2-slded)
Pearson Chi-Square 4.657(a) 2 .097
Likelihood Ratio 4.913 2 .086
N 01 Valid Cases 283




Nominal by Nominal Cramer's V .128 .097
Contingency Coefficient .127 .097
N 01 Valid Cases 283
a Not assuming the null hypothesis.






N IPercent N IPercent N IPercent






Count 0 0 2 2
Yes Expected Count 1.1 .2 .7 2.0
I04EOTHER
% within 016DRACE .0% .0% 2.1% .7%
Count 151 35 95 281
I No Expected Count 149.9 34.8 96.3 281.0
% within 016DRACE 100.0% 100.0% 97.9% 99.3%
Count 151 35 97 283
Total Expected Count 151.0 35.0 97.0 283.0
% within 016DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
I Value elf Aaymp. Slg. (2-slded)
Pearson Chi-Square 3.862(a) 2 .145
Likelihood Ratio 4.310 2 .116
N 01 Valid Cases 283




,Nominal by Nominal Cramer's V .117 .145,
Contingency Coefficient .116 .145
N 01 Valid Cases 283
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.
Case Processing Summary
Cases,
I Missing IValid Total,
N IPercent IN IPercent I N IPercent
187
Q4ANSTIC • Q16ACAMP 293 100.0% 0 .0% 293 100.0%
Q4BRAPE • Q16ACAMP 293 100.0% 0 .0% 293 100.0%
Q4CPMTCT' Q16ACAMP 293 100.0% 0 .0% 293 100.0%
Q4DTREAT' Q16ACAMP 293 100.0"10 0 .0% 293 100.0%
Q4EOTHER' Q16ACAMP 293 100.0% 0 .0% 293 100.0%
Contingency Coefficient
N of Valid Cases
a Not assuming the null hypothesis.







Count 75 83 158,
158.01Yes Expected Count 82.5 75.5,
,Q4BRAPE
% within Q16ACAMP 49.0% 59.3% 53.9%
Count I 78 57 135
No Expected Count 70.5 64.5 135.0,
% within Q16ACAMP 51.0% 40.7% 46.1%
Count 153 140 293,
Total Expected Count 153.0 140.0 293.0,
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (l-slded)
Pearson Chi-Square 3.101(b) 1 .078
Continuity Correctlon(a) 2.702 1 .100
Likelihood Ratio 3.108 1 .078
Fisher's Exact Test .080 .050
N of Valid Cases 293
a Computed only for a 2x2 table





Count 40 64 104
Yes Expected Count 54.3 49.7 104.0
,Q4ANSnC
% within Q16ACAMP 26.1% 45.7% 35.5%
Count 113 76 189
No Expected Count 98.7 90.3 189.0
% within Q16ACAMP 73.9% 54.3% 64.5%
Count 153 140 293
Total Expected Count 153.0 140.0 293.0
% within Q16ACAMP 100.0% 100.0% 100.0%
b 0 cells (.0%) have expected count less lhan 5. The minimum expected count is 49.69.
Chi-Square Tests
Value df IAsymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (l-slded)
Pearson Chi-Square 12.229(b) 1 .000
Continuity Correctlon(a) 11.389 1 .001
Likelihood Ratio 12.302 1 .000
Fisher's Exact Test .001 .000
IN of Valid Cases 293
Ia Computed only for a 2x2 table II
Symmetric Measures I
I I~ Approx. Slg.
,Nominal by Nominal IPhi I -.2041 .000




,Nominal by Nomina" Cramer's V .103 .078,
Contingency Coefficient .102 .078
188 189
N of Valid Cases
a Not assuming the null hypothesis.
1 293 1 a Not assuming the null hypothesis.
,b Using the asymptotic standard error assuming the null hypothesis.







Count 128 112 240
I Yes Expected Count 125.3 114.7 240.0
Q4CPMTCT
% within Q16ACAMP 83.7% 80.0% 81.9%
Count 25 28 53
No Expected Count 27.7 25.3 53.0
% within Q16ACAMP 16.3% 20.0% 18.1%
Count 153 140 293
Total Expected Count 153.0 140.0 293.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value cif Asymp. Slg. (2-slded) Exact 51g. (2-slded) Exact Slg. (1-slded)
Pearson Chi-Square .661(b) 1 .416
ContinUity Correctlon{a) .437 1 .509
Likelihood Ratio .660 1 .416
Fisher's Exact Test I .450 .254
N of Valid Cases 293







Count 105 103 208
I
Yes Expected Count 108.6 99.4 208.0,
,Q4DTREAT
% within Q16ACAMP 68.6% 73.6% 71.0%
Count 48 37 85,
No Expected Count 44.4 40.6 85.0
I % within Q16ACAMP 31.4% 26.4% 29.0%
Count 153 140 293
'Total Expected Count 153.0 140.0 293.0
I % within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value cif Asymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (1-slded)
Pearson Chi-Square .868(b) 1 .352
Continuity Correctlon{a) .644 1 .422
Likelihood Ratio .870 1 .351
Fisher's Exact Test .370 .211
N of Valid Cases 293 ,
a Computed only for a 2x2 table
.b 0 cells (.0%) have expected count less than 5. The minimum expected count is 40.61.




Nominal by Nominal .352Cramer'sV .054
Contingency Coefficient .054 .352




,Nominal by Nominal eramer's V .047 .416
Contingency Coefficient .047 .416
N of Valid Cases 293
b 0 cells (.0%) have expected count less than 5. The minimum expected counl is 25.32. I
190 191






Count 0 2 2
Ves Expected Count 1.0 1.0 2.0
Q4EOTHER
% within Q16ACAMP .0% 1.4% .7%
Count 153 138 291
No Expected Count 152.0 139.0 291.0
I % within Q16ACAMP 100.0% 98.6% 99.3%
Count 153 140 293
Total Expected Count 153.0 140.0 293.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (l-8lded)
Pearson Chi-Square 2.201 (b) 1 .138
Continuity Correctlon(a) .598 1 .439
Likelihood Ratio 2.969 1 .085
Asher's Exact Test .227 .227
N of Valid Cases 293
a Computed only for a 2X2 table




Nominal by Nominal eramer's V .087 .138,
Contingency Coefficient .086 .138
N of Valid Cases 293
a Not assuming the null hypotheSis.
192
b Using the asymptotic standard error assuming the null hypothesis.




N Percent N Percent N Percent
QaACURE' Q16DRACE 292 100.0% 0 .0% 292 100.0%
QaBLIFE • Q16DRACE 292 100.0% 0 .0% 292 100.0%





Count 11 1 9 21,
No Answer Expected Count 11.2 2.6 7.2 21.0
% within Q16DRACE 7.1% 2.8% 9.0% 7.2%
Count 12 0 7 19
'QaACURE True Expected Count 10.2 2.3 6.5 19.0
% within Q16DRACE 7.7% .0% 7.0% 6.5%,
Count 133 35 84 252,
False Expected Count 134.6 31.1 86.3 252.0,
% within Q16DRACE 85.3% 97.2% 84.0% 86.3%
Count 156 36 100 292,
Total Expected Count 156.0 36.0 100.0 292.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 4.730(a) 4 .316
Likelihood Ratio 7.300 4 .121
193
N of Valid Cases N of Valid Cases




,Nominal by Nominal Cramer'sV .090 .316,
Contingency Coefficient .316.126
N of Valid Cases 292
a Not assuming the null hypothesis.






Count 14 1 10 25
No Answer Expected Count 13.4 3.1 8.6 25.0
I
% within Q16DRACE 9.0% 2.8% 10.0% 8.6%
Count 126 29 76 231
IQ8BUFE I True Expected Count 123.4 28.5 79.1 231.0
% within Q16DRACE 80.8% 80.6% 76.0% 79.1%
Count 16 6 14 36
False Expected Count 19.2 4.4 12.3 36.0
% within Q16DRACE 10.3% 16.7% 14.0% 12.3%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 3.185(a) 4 .527
Likelihood Ratio 3.648 4 .456 1
194




Nominal by Nominal Cramer's V .074 .527
I
Contingency Coefficient .104 .527
N of Valid Cases 292
a Not assuming the null hypothesis.






Count 18 2 14 34
No Answer Expected Count 18.2 4.2 11.6 34.0
% within Q16DRACE 11.5% 5.6% 14.0% 11.6%
Count 26 7 10 43
QaCANYBO True Expected Count 23.0 5.3 14.7 43.0
% within Q16DRACE 16.7% 19.4% 10.0% 14.7%
Count 112 27 76 215
False Expected Count 114.9 26.5 73.6 215.0
% within Q16DRACE 71.8% 75.0% 76.0% 73.6%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 4.241 (a) 4 .374
Likelihood Ratio 4.617 4 .329
195
IN of Valid Cases I 2921 I I
Ia 1 cells (11.1 %) have expected count less than 5. The minimum expected count is 4.19.1
---
Count 160 142 302
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.0% 100.0%
a 0 cells (.0%) have expected count less than 5. The minimum expec
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 5.198(a) 2 .074
Likelihood Ratio 5.478 2 .065





Nominal by Nominal Cremer's V .085 .374
I
Contingency Coefficient .374.120
N of Valid Cases 292
a Not assuming the null hypothesis.




Nominal by Nominal eramer's V .131 .074
I
Contingency Coefficient .130 .074
N of Valid Cases 302
a Not assuming the null hypothesis.






N PercentN Percent N Percent
iQaACURE • Q16ACAMP 302 100.0% 0 .0% 302 100.0%
Q8BLlFE • Q16ACAMP 302 loo.O",{, 0 .0% 302 100.0%







Count 15 10 25
I
No Answer Expected Count 11.8 25.013.2,
% within Q16ACAMP 9.4% 7.0% 8.3%
I
Count 127 113 240
iQ8BLIFE True Expected Count 127.2 112.8 240.0
I
% within Q16ACAMP 79.4% 79.6% 79.5%
I
Count 18 19 37
I
False Expected Count 19.6 17.4 37.0
I







Count 16 5 21,
No Answer Expected Count 11.1 9.9 21.0
I
% within Q16ACAMP 10.0% 3.5% 7.0%,
Count 12 9 21
'QaACURE True Expected Count 11.1 9.9 21.0,
% within Q16ACAMP 7.5% 6.3% 7.0%,
Count 132 128 260
I
False Expected Count t37.7 122.3 260.0,
% within Q16ACAMP 82.5% 90.1% 86.1%
196 197
Count 160 142 302
Total Expected Count 160.0 142.0 302.0
i % within Q16ACAMP 100.0% 100.0% 100.0%
I Count 160 142 302
Total Expected Count 160.0 142.0 302.0
I % within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square .638(a) 2 .727
Likelihood Ratio .641 2 .726
N of Valid Cases 302
Chi-Square Tests
Value dI Asymp. Slg. (2-slded)
Pearson Chi-Square .774(a) 2 .679
Likelihood Ratio .777 2 .678
N of Valid Cases 302
a 0 cells (.0%) have expected count less than 5. The minimum expected count is 11.75.




Nominal by Nominal Cramerls V .051 .679,
Contingency Coefficient .051 .679
N of Valid Cases 302
a Not assuming the null hypothesis.







Count 20 14 34
No Answer Expected Count 18.0 16.0 34.0
I % within Q16ACAMP 12.5% 9.9% 11.3%Count 24 20 44
!QaCANYBO True Expected Count 23.3 20.7 44.0
% within Q16ACAMP 15.0% 14.1% 14.6%
Count 116 108 224
I False Expected Count 118.7 105.3 224.0





Nominal by Nominal Cramer's V .046 .727
Contingency Coefficient .046 .727
N of Valid Cases 302
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.




I N Percent N Percent N Percent
Q5ABIOL • Q16DRACE 292 too.O% 0 .0% 292 100.0%
Q5BSOCIA • Q16DRACE 292 100.0% 0 .0% 292 100.0%
Q5CINCOR· Q16DRACE 292 100.0% 0 .0% 292 100.0%









Count 25 1 27 53
No Answer Expected Count 28.3 6.5 18.2 53.0
% within Q16DRACE 16.0"A. 2.8% 27.0% 18.2%
IQ5ABIOL
Count 100 25 60 185
Yes Expected Count 98.8 22.8 63.4 185.0
I % within Q16DRACE 64.1% 69.4% 60.0% 63.4%
I
Count 31 10 13 54
I No Expected Count 28.8 6.7 18.5 54.0
% within Q16DRACE 19.9% 27.8% 13.0% 18.5%
Count 156 36 100 292
Tolal Expected Count 156.0 36.0 100.0 292.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value dI Asymp. Slg. (2-alded)
Pearson Chl-Squsre 13.262(a) 4 .DIO
Likelihood Ratio 15.295 4 .004
N of Valid Cases 292




Nominal by Nominal eramer's V .151 .DIO,
Contingency Coefficient .208 .010
N 01 Valid Cases 292
a Not assuming the null hypothesis.




Count 25 1 27 53
No Answer Expected Count 28.3 6.5 18.2 53.0
% within Q16DRACE 16.0% 2.8% 27.0% 18.2%,
Count 7 2 6 15
Q5BSOCIA Yes Expected Count 8.0 1.8 5.1 15.0,
% within Q16DRACE 4.5% 5.6% 6.0% 5.1%,
Count 124 33 67 224,
No Expected Count 224.0119.7 27.6 76.7
I % within Q16DRACE 79.5% 91.7% 67.0% 76.7%
Count 156 36 100 292
'Tolal Expected Count 156.0 36.0 100.0 292.0,
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value dl Asymp. Slg. (2-slded)
Pearson Chi-Square 12.111(a) 4 .017
Ukellhood Ratio 14.175 4 .007
N 01 Valid Cases 292





Nominal by Nominal Cramer's V .144 .017
Contingency Coefficient .200 .017
N 01 Valid Cases 292
a Not assuming the null hypothesis.




I I I Q16DRACE I Tolal
200
I r- Crosstab r-------,
201
Count 25 1 27 53
I
No Answer Expected Count 18.2 53.028.3 6.5,
% within Q16DRACE 16.0% 2.8% 27.0% 18.2%
I
20 63Count 30 13
'Q5CINCOR Yes Expected Count 33.7 7.8 21.6 63.0
I
% within Q16DRACE 19.2% 36.1% 20.0% 21.6%,
Count 101 22 53 176
i
No Expected Count 94.0 21.7 60.3 176.0,
% within Q16DRACE 64.7% 61.1% 53.0% 60.3%
~
Count 156 36 100 292
'Total Expected Count 156.0 36.0 100.0 292.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value <If Asymp. Slg. (2-slded)
Pearson Chi-Square 14.827(a) 4 .005
Likelihood Ratio 16.345 4 .003
N of Valtd Cases 292




Nominal by Nominal Cramer's V .159 .005,
Contingency Coefficient .220 .005
N of Valid Cases 292
a Not assuming the null hypothesis.




I IIndian TotalBlack White
202
I Count 25 1 27 53No Answer Expected Count 28.3 6.5 18.2 53.0
IQ5DOTHER
% within Q16DRACE 16.0% 2.8% 27.0% 18.2%
Count 131 35 73 239
I
No Expected Count 127.7 29.5 81.8 239.0
% within Q16DRACE 84.0% 97.2% 73.0% 81.8%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value <If Asymp. Slg. (2-slded)
Pearson Chi-Square 11.472(a) 2 .003
Likelihood Ratio 13.523 2 .001
N of Valid Cases 292




Nominal by Nominal Cramer's V .198 .003,
Contingency Coefficient .194 .003
N of Valid Cases 292 ,
a Not assuming the null hypothesis.




N Percent N Percent N Percent
Q5ABIOL • Q16ACAMP 302 100.0% 0 .0% 302 100.0%
Q5BSOCIA • Q16ACAMP 302 100.0% 0 .0% 302 100.0%
Q5CINCOR • Q16ACAMP 302 100.0% 0 .0% 302 100.0%







Count 33 20 53
No Answer Expected Count 28.1 24.9 53.0
% within Q16ACAMP 20.6% 14.1% 17.5%
Count 94 100 194
Q5ABIOL Yes Expected Count 102.8 91.2 194.0
% within Q16ACAMP 58.8% 70.4% 64.2%
Count 33 22 55
No Expected Count 29.1 25.9 55.0
% within Q16ACAMP 20.6% 15.5% 18.2%
Count 160 142 302
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 4.517(a) 2 .104
Likelihood Rallo 4.548 2 .103
N of Valid Cases 302




Nominal by Nominal Cremer's V .122 .104
I
Contingency Coefficient .121 .104
N of Valid Cases 302
a Not assuming the null hypothesis.









Count 33 20 53
I
No Answer Expected Count 28.1 24.9 53.0,
% within Q16ACAMP 20.6% 14.1% 17.5%,
Count 13 3 16
'Q5BSOCIA Yes Expected Count 8.5 7.5 16.0,
% within Q16ACAMP 8.1% 2.1% 5.3%
I
Count 233114 119
No Expected Count 123.4 109.6 233.0
I % within Q16ACAMP 71.3% 83.8% 77.2%
Count 160 142 302,
Total Expected Count 160.0 142.0 302.0
I % within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 8.503(a) 2 .014
Likelihood Rallo 8.993 2 .011
N of Valid Cases 302




Nominal by Nominal Cramer's V .168 .014
Contingency Coefficient .165 .014
N of Valid Cases 302
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.
QSCINCOR • Q16ACAMP
Crosstab






Count 33 20 53,
No Answer Expected Count 28.1 24.9 53.0,
% within Q16ACAMP 20.6% 14.1% 17.5%,
Count 34 32 66
'Q5CINCOR Yes Expected Count 35.0 31.0 66.0
I
% within Q16ACAMP 22.5% 21.9%21.3%
I
Count 93 90 183,
No Expected Count 97.0 86.0 183.0
I
% within Q16ACAMP 58.1% 63.4% 60.6%
Count 160 142 302
'Total Expected Count 160.0 142.0 302.0
i
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value dI Asymp. Slg. (2-slded)
Pearson Chi-Square 2.234(a) 2 .327
Likelihood Ratio 2.258 2 .323
N of Valid Cases 302




Nominal by Nominal Cremer's V .086 .327
Conlingency Coefficient .086 .327
N of Valid Cases 302
a Not assuming the null hypothesis.




Count 33 20 53
No Answer Expected Count 28.1 24.9 53.0
,Q5DOTHER
% within Q16ACAMP 20.6% 14.1% 17.5%
Count 127 122 249,
No Expected Count 131.9 117.1 249.0
,
% within Q16ACAMP 79.4% 85.9% 82.5%
Count 160 142 302,
Tolal Expected Count 160.0 142.0 302.0
,
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (l-slded)
Pearson Chi-Square 2.224(b) 1 .136
Conlinulty Correctlon(a) 1.795 1 .180
Likelihood Ratio 2.248 1 .134
Fisher's Exact Test .172 .090
N of Valid Cases 302
a Computed only for a 2x2 table




Nominal by Nominal Cramer'sV .086 .136,
Conlingency Coefficient .136.086
N of Valid Cases 302
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.





a Not assuming the null hypothesis.
,b Using the asymptotic standard error assuming the null hypothesis.
~__I 8APprox.Slg.!
~ ~ ·~I
Nominal by Nominal [Cramer's V .214 .~, IContingency Coefficient .289 .~
N of Valid Cases 292 ,
Q6ASIDEF· Q16DRACE 292 100.0% 0 .0% 292 100.0%
Q6BUFE • Q16DRACE 292 100.0% 0 .0% 292 100.0%
Q6CSEX· Q16DRACE 292 100.0% 0 .0% 292 100.0%
Q6DADHER· Q16DRACE 292 100.0% 0 .0% 292 100.0%
Q6EACCES· Q16DRACE 292 100.0% 0 .O"k 292 100.0%
Q6FINCOR • Q16DRACE 292 100.0% 0 .0% 292 100.0%







Count 38 9 54 101
No Answer Expected Count 54.0 12.5 34.6 101.0
% within Q16DRACE 24.4% 25.0% 54.0% 34.6%,
Count 34 5 12 51
'Q6ASIDEF Yes Expected Count 27.2 6.3 17.5 51.0,
% within Q16DRACE 21.8% 13.9% 12.0% 17.5%
~
Count 84 22 34 140
Expected Count 74.8 17.3 47.9 140.0
% within Q16DRACE 53.8% 61.1% 34.0% 47.9%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0,





Count 38 9 54 101
No Answer Expected Count 54.0 12.5 34.6 101.0
% within Q16DRACE 24.4% 25.0% 54.0% 34.6%
Count 21 2 5 28
Q6BUFE Yes Expected Count 15.0 3.5 9.6 28.0
% within Q16DRACE 13.5% 5.6% 5.0% 9.6%
Count 97 25 41 163
No Expected Count 87.1 20.1 55.8 163.0
% within Q16DRACE 62.2% 69.4% 41.0% 55.8%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 26.709(a) 4 .~
Likelihood Ratio 26.178 4 .~
N of Valid Cases 292
a 0 cells (.0%) have expected count less than 5. The minimum expected count Is 6.29.1
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 28.079(a) 4 .~
Likelihood Ratio 27.706 4 .~
N of Valid Cases 292






Nominal by Nominal Cramer's V .219 .000
Contingency Coefficient .296 .000
N of Valid Cases 292
a Not assuming the null hypothesis.






Count 38 9 54 101,
No Answer Expected Count 54.0 12.5 34.6 101.0
I
% within 016DRACE 24.4% 25.0% 54.0% 34.6%
I
Count 9 3 1 13
I06CSEX Yes Expected Count 6.9 1.6 4.5 13.0
I
% within 016DRACE 5.8% 8.3% 1.0% 4.5%
I
Count 109 24 45 178,
No Expected Count 95.1 21.9 61.0 178.0
I
% within 016DRACE 69.9% 66.7% 45.0% 61.0%
Count 156 38 100 292
'Total Expected Count 156.0 36.0 100.0 292.0I
% within 016DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value dl Asymp. S19. (2-slded)
Peerson Chi-Square 27.476(a) 4 .000
Likelihood Ratio 27.782 4 .000
N of Valid Cases 292





Nominal by Nominal er.mer's V .217 .000
Contingency Coefficient .293 .000
N of Valid Cases 292
a Not assuming the null hypothesis.





Count 38 9 54 101
No Answer Expected Count 54.0 12.5 34.6 101.0
% within 016DRACE 24.4% 25.0% 54.0% 34.6%
Count 21 3 4 28
'06DADHER Yes Expected Count 15.0 3.5 9.6 28.0
% within 016DRACE 13.5% 8.3% 4.0% 9.6%
Count 97 24 42 163,
No Expected Count 87.1 20.1 55.8 163.0
0
% within 016DRACE 62.2% 66.7% 42.0% 55.8%
Count 156 38 100 292
'Total Expected Count 156.0 36.0 100.0 292.0
% within 016DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 27.637(a) 4 .000
Likelihood Ratio 27.575 4 .000
N of Valid Cases 292
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Nominal by Nominal Cramerls V .2t8 .000
Contingency Coefficient .294 .000
N 01 Valid Cases 292
a Not assuming the null hypothesis.







Count 38 9 54 101,
No Answer Expected Count 54.0 12.5 34.6 101.0,
% within Q16DRACE 24.4% 25.0% 54.0% 34.6%,
Count 21 15 16 52
'Q6EACCES Yes Expected Count 27.8 6.4 17.8 52.0
% within Q16DRACE 13.5% 41.7% 16.0% 17.8%
Count 97 12 30 139
I
No Expected Count 74.3 17.1 47.6 139.0,
% within Q16DRACE 62.2% 33.3% 30.0% 47.6%
Count 156 38 100 292
'Tolal Expected Count 156.0 36.0 100.0 292.0,
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value ell Aaymp. S19. (2-slded)
Pearson Chi-Square 44.928(a) 4 .000
Likelihood Ratio 41.509 4 .000
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:N 01 Valid Cases I 2921 I I




Nominal by Nominal Cramer's V .277 .000
Contingency Coefficient .365 .000
N 01 Valid Cases 292 I,
a Not assuming the null hypothesis.








Count 38 9 54 101
I
No Answer Expected Count 54.0 12.5 34.6 101.0
I
% within Q16DRACE 24.4% 25.0% 54.0% 34.6%,
Count 12 0 1 13
'Q6ANCOR Yes Expected Count 6.9 1.6 4.5 13.0
% within Q16DRACE 7.7% .0% 1.0% 4.5%,
Count 106 27 45 178
I
No Expected Count 95.1 21.9 61.0 178.0,
% within Q16DRACE 67.9% 75.0% 45.0% 61.0%
Count 156 38 100 292
'Tolal Expected Count 156.0 38.0 100.0 292.0
I
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value dl Aaymp. S19. (2-slded)
Pearson Chi-Square 31.121 (a) 4 .000
Likelihood Ratio 32.642 4 .000
213
N of Valid Cases I 292
a 2 cells (22.20k) have expected count less than 5. The minimum expected count is 1.60.
N of Valid Cases I 292 [ I 1




,Nominal by Nominal Cramer's V .231 .000
Contingency Coefficient .310 .000
N of Valid Cases 292
a Not assuming the null hypothesis.




Nominal by Nominal Cramer's V .218 .000,
Contingency Coefficient .294 .000
N of Valid Cases 292
a Not assuming the null hypothesis.








N Percent N Percent N Percent
06ASIDEF' 016ACAMP 302 100.0% 0 .0% 302 100.0%
Q6BUFE' 016ACAMP 302 100.0% 0 .0% 302 100.0%
Q6CSEX • 016ACAMP 302 100.0% 0 .0% 302 100.0%
Q6DADHER • 016ACAMP 302 100.0% 0 .0% 302 100.0%
Q6EACCES' 016ACAMP 302 100.0% 0 .0% 302 100.0%
Q6FINCOR • 016ACAMP 302 100.0% 0 .0% 302 100.0%






06ASIDEF Count 51 54 105,
No Answer Expected Count 55.6 49.4 105.0
I
% within 016ACAMP 31.9% 38.0% 34.8%





Count 38 9 54 101,
No Answer Expected Count 54.0 12.5 34.6 101.0,
% within 016DRACE 24.4% 25.0% 54.0% 34.6%,
Count 29 5 16 50
'06GOTHER Yes Expected Count 26.7 6.2 17.1 50.0
I
% within 016DRACE 18.6% 13.9% 16.0% 17.1%
I
Count 89 22 30 141
I
No Expected Count 75.3 17.4 48.3 141.0,
% within 016DRACE 57.1% 61.1% 30.0% 48.3%
Count 156 36 100 292
'Total Expected Count 156.0 36.0 100.0 292.0
I
% within 016DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 27.693(a) 4 .000
LIkelihood Ratio 27.607 4 .0001
214 215
Expected Count 28.6 25.4 54.0
% within Q16ACAMP 15.6% 20.4% 17.9%
Count 84 59 143,
No Expected Count 75.8 67.2 143.0
% within Q16ACAMP 52.5% 41.5% 47.4%
Count 160 142 302
Total Expected Count 160.0 142.0 302.0,
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value dl Asymp. Slg. (2-slded)
Pearson Chi-Square 3.693(a) 2 .158
Likelihood Ratio 3.702 2 .157
N 01 Valid Cases 302




Nominal by Nominal Cramer's V .111 .158
Contingency Coefficient .110 .158
N 01 Valid Cases 302
a Not assuming the null hypothesis.






Q6BLlFE Count 51 54 105
No Answer Expected Count 55.6 49.4 105.0
I
% within Q16ACAMP 31.9% 38.0% 34.8%
I
Yes Count 18 10 28
I Expected Count 14.8 13.2 28.0
216
,
I % within Q16ACAMP 11.3% 7.0% 9.3%
I
Count 91 78 169
I
No Expected Count 89.5 79.5 169.0,
% within Q16ACAMP 56.9% 54.9% 56.0%
Count 160 142 302
'Total Expected Count 160.0 142.0 302.0
I
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
I Value dI Asymp. Slg. (2-slded)
IPearson Chi-Square 2.307(a) 2 .316
I Likelihood Ratio 2.331 2 .312
IN 01 Valid Cases 302




I Nominal by Nominal er.mer'. V .087 .316,
Contingency Coefficient .316.087
N 01 Valid Cases 302
a Not assuming the null hypothesis.






Q6CSEX Count 51 54 105,
No Answer Expected Count 55.6 49.4 105.0
% within Q16ACAMP 31.9% 38.0% 34.8%
Yes Count 8 5 13,
Expected Count 6.9 6.1 13.0
217
% within Q16ACAMP 5.0% 3.5% 4.3%
Count 101 83 184
No Expected Count 97.5 86.5 184.0
% within Q16ACAMP 63.1% 58.5% 60.9%
Count 160 142 302
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.0% 100.0%1
I % within Q16ACAMP 13.1% 7.0% 10.3%
Count 88 78 166
No Expected Count 87.9 78.1 166.0
% within Q16ACAMP 55.0% 54.9% 55.0%
Count 160 142 302,
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.0% 100.0%I
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 3.531 (a) 2 .171
ILikelihood Ratio 3.605 2 .165
N of Valid Cases 302
a 0 cells (.0%) have expected count less than 5. The minimum expected count is 14.58.
Chi-Square Tests




Value Asymp. Slg. (2-slded)
I Pearson Chi-Square 1.471(a) 2 .479
Likelihood Ratio 1.475 2 .478





Nominal by Nominal Cramer's V .070 .479,
Contingency Coefficient .070 .479
N of Valid Cases 302
a Not assuming the null hypothesis.




Nominal by Nominal Cramer's V .108 .171
Contingency Coefficient .108 .171
N of Valid Cases 302
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.




Q6DADHER Count 51 54 105
No Answer Expected Count 55.6 49.4 105.0
% within Q16ACAMP 31.9% 38.0% 34.8%,
Yes Count 21 10 31






Q6EACCES Count 51 54 105
No Answer Expected Count 55.6 49.4 105.0
% within Q16ACAMP 31.9% 38.0% 34.8%
Yes Count 23 30 53 1, IExpected Count I 28.11 24.91 53.01
218 219
% within Q16ACAMP 14.4% 21.1% 17.5%
Count 86 58 144
No Expected Count 76.3 67.7 144.0,
% within Q16ACAMP 53.8% 40.8% 47.7%
Count 160 142 302
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded)
Pearson Chi-Square 5.401 (a) 2 .067
Likelihood Ratio 5.419 2 .067
N of Valid Cases 302




Nominal by Nominal eramer's V .134 .067
Contingency Coefficient .133 .067
N of Valid Cases 302
a Not assuming the null hypothesis.






Q6F1NCOR Count 51 54 105
I
No Answer Expected Count 55.6 49.4 105.0,
% within Q16ACAMP 31.9% 38.0% 34.8%
I
Yes Count 7 6 13,
Expected Count 13.06.9 6.1
220
,
'%;ithln Q16ACAMP 4.4%/, 4.2% 4.3%,
Count 102 82 184,
No Expected Count 97.5 86.5 184.0,
% within Q16ACAMP 63.8% 57.7% 60.9%
Count 160 142 302,
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.00/0 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded)
Pearson Chi-Square 1.268(a) 2 .530
Likelihood Ratio 1.267 2 .531
N of Valid Cases 302




,Nominal by Nominal Cremer's V .065 .530,
Contingency CoeNlclent .065 .530
N of Valid Cases 302
a Not assuming the null hypothesis.






Q6GOTHER Count 51 54 105,
No Answer Expected Count 55.6 49.4 105.0,
% within Q16ACAMP 31.9% 38.0% 34.8%,
Yes Count 33 19 52
I
Expected Count 27.5 24.5 52.0
221
% within Q16ACAMP 20.6% 13.4% 17.2%
Count 76 69 145
No Expected Count 76.8 68.2 145.0
% within Q16ACAMP 47.5% 48.6% 48.0%
Count 160 142 302
Total Expected Count 160.0 142.0 302.0,
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded)
Pearson Chi-Square 3.131(a) 2 .209
Likelihood Ratio 3.166 2 .205
N of Valid Cases 302




Nominal by Nominal Cramer's V .102 .209
Contingency Coefficient .101 .209
N of Valid Cases 302
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.




N Percent N Percent N Percent
Q7ASAFSE· Q16DRACE 292 100.0% 0 .0% 292 100.0%
Q7BEXERC·Q16DRACE 292 100.0% 0 .0% 292 100.0%
Q7CEAT· Q16DRACE 292 100.0% 0 .0% 292 100.0%
Q7DALT· Q16DRACE 292 100.0% 0 .0% 292 100.0%










Count 36 13 44 93
No Answer Expected Count 49.7 11.5 31.8 93.0
% within Q16DRACE 23.1% 36.1% 44.0% 31.8%
Count 3B 4 13 55
Q7ASAFSE Yes Expected Count 29.4 6.8 18.8 55.0
% within Q16DRACE 24.4% 11.1% 13.0% 18.8%
Count 82 19 43 144
No Expected Count 76.9 17.8 49.3 144.0,
% within Q16DRACE 52.6% 52.8% 43.0% 49.3%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0,
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded)
Pearson Chi-Square 15.315(a) 4 .004
Likelihood Ratio 15.446 4 .004
N of Valid Cases 292




Nominal by Nominal eramer's V .162 .004
Contingency Coefficient .223 .004
N of Valid Cases 292
a Not assuming lhe null hypothesis.
223






Count 36 13 44 93
No Answer Expected Count 49.7 11.5 31.8 93.0
% within Q16DRACE 23.1% 36.1% 44.0% 31.8%
Count 27 1 4 32
'Q7BEXERC Ves Expected Count 17.1 3.9 11.0 32.0
I
% within Q16DRACE 17.3% 2.8% 4.0% 11.0%,
Count 93 22 52 167
I
No Expected Count 89.2 20.6 57.2 167.0
I
% within Q16DRACE 59.6% 61.1% 52.0% 57.2"...
~
Count 156 36 100 292
'Total Expected Count 156.0 36.0 100.0 292.0
I
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Testa
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 21.694(a) 4 .000
Likelihood Ralio 23.116 4 .000
N of Valid Cases 292




,Nominal by Nominal Cramer's V .193 .000
Conlingency Coefficient .263 .000
N of Valid Cases 292
a Not assuming the null hypothesis.








Count 36 13 44 93
No Answer Expected Count 49.7 11.5 31.8 93.0
% within Q16DRACE 23.1% 36.1% 44.0% 31.8%
,
Count 46 4 6 56
Q7CEAT Ves Expected Count 29.9 6.9 19.2 56.0
% within Q16DRACE 29.5% 11.1% 6.0% 19.2%
Count 74 19 50 143,
No Expected Count 76.4 17.6 49.0 143.0,
% within Q16DRACE 47.4% 52.8% 50.0% 49.0%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Testa
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 27.735(a) 4 .000
Likelihood Ratio 29.975 4 .000
N of Valid Cases 292




Nominal by Nominal Cramer's V .218 .000,
Contingency Coefficient .295 .000
N of Valid Cases 292
a Not assuming the null hypothesis.








Count 36 13 44 93,
No Answer Expected Count 49.7 11.5 31.8 93.0,
% within Q16DRACE 23.1% 36.1% 44.0% 31.8%,
Count 13 1 2 16,
Q7DALT Yes Expected Count 8.5 2.0 5.5 16.0,
% within Q16DRACE 8.3% 2.8% 2.0% 5.5%
Count 107 22 54 183,
No Expected Count 97.8 22.6 62.7 183.0
I % within Q16DRACE 68.6% 61.1% 54.0% 62.7%
Count 156 36 100 292
'Total Expected Count 156.0 36.0 100.0 292.0
\
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value dl Asymp. Slg. (2-slded)
Pearson Chi-Square 15.704(a) 4 .003
Likelihood Ratio 16.137 4 .003
N 01 Valid Cases 292




,Nominal by Nominal Cramer's V .164 .003,
Contingency Coefficient .226 .003
N 01 Valid Cases 292
a Not assuming the null hypothesis.








Count 36 13 44 93,
No Answer Expected Count 49.7 11.5 31.8 93.0,
% within Q16DRACE 23.1% 36.1% 44.0% 31.8%,
Count 1 0 2 3
'Q7EINCOR Yes Expected Count 1.6 .4 1.0 3.0,
% within Q16DRACE .6% .0% 2.0% 1.0%,
Count 119 23 54 196
No Expected Count 104.7 24.2 67.1 196.0
I
% within Q16DRACE 83.9% 54.0% 67.1%76.3%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0,
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
I Value dl Asymp. Slg. (2-slded)
Pearson Chi-Square 14.699(a) 4 .005
Likelihood Ratio 14.903 4 .005
N 01 Valid Cases 292




Nominal by Nominal eramer's V .159 .005,
Contingency Coefficient .219 .005
N 01 Valid Cases 292
I
a Not assuming the null hypothesis.







Count 36 t3 44 93,
No Answer Expected Count 49.7 11.5 31.8 93.0,
% within Q16DRACE 23.1% 36.1% 44.0% 31.8%
Count 26 4 13 43,
Q7FOTHER Ves Expected Count 23.0 5.3 14.7 43.0
% within Q16DRACE t6.7% 11.1% 13.0% 14.7%
Count 94 19 43 156,
No Expected Count 83.3 19.2 53.4 156.0,
% within Q16DRACE 60.3% 52.8% 43.0% 53.4%
Count 156 36 100 292
Total Expected Count 156.0 36.0 100.0 292.0,






Count 36 13 44 93,
No Answer Expected Count 49.7 11.5 31.8 93.0,
% within Q16DRACE 23.1% 36.1% 44.0% 31.8%,
Count 40 18 29 87
'Q7GNONE Ves Expected Count 46.5 10.7 29.8 87.0,
% within Q16DRACE 25.6% 50.0% 29.0% 29.8%,
Count 80 5 27 112,
No Expected Count 59.8 13.8 38.4 112.0,
% within Q16DRACE 38.4%51.3% t3.9% 27.0%
Count 156 36 100 292,
Total Expected Count 156.0 36.0 100.0 292.0,
% within Q16DRACE 100.0%100.0% 100.0% 100.0%
Chi-Square Tests
Pearson Chi-Square 3O.244(a) I 4 .000
Likelihood Rallo 30.918T 4 .000
IN of Valid Cases 292T I
Ia 0 cells (.0%) have expected count less than 5. The minimum expected count is t 0.73·1
Value d1 Asymp. Slg. (2-slded)
Pearson Chi-Square 12.931 (a) 4 .012
Likelihood Rallo 12.942 4 .012
N of Valid Cases 292
a 0 cells (.0%) have expected count less than 5. The minimum expected count is 5.30.1




Nominal by Nominal Cramer's V .149 .012
I
Conllngency Coefficient .206 .012
N of Valid Cases 292
a Not assuming the null hypothesis.







Nominal by Nominal Cramer'sV .228 .000,
Contingency Coefficient .306 .000
N of Valid Cases 292
a Not assuming the null hypothesis. ,




a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.
Value Approx. Slg.
Phi .052 .660
, Nominal by Nominal Cramer's V .052 .660
I
Contingency Coefllclent .052 .660
N 01 Valid Cases 302
I
I Valid Missing Total
N Percent N Percent N Percent
Q7ASAFSE' Q16ACAMP 302 100.0% 0 .0% 302 100.0%
Q7BEXERC' Q16ACAMP 302 100.0% 0 .0% 302 100.0%
Q7CEAT' Q16ACAMP 302 100.0% 0 .0% 302 100.0%
Q7DALT' Q16ACAMP 302 100.0% 0 .0% 302 100.0%
Q7EINCOR' Q16ACAMP 302 100.0% 0 .0% 302 100.0%
Q7FOTHER • Q16ACAMP 302 100.0% 0 .0% 302 100.0%







Count 52 46 98
I
No Answer Expected Count 51.9 46.1 98.0,
% within Q16ACAMP 32.5% 32.4% 32.5%
I
Count 32 23 55
IQ7ASAFSE Yes Expected Count 29.1 25.9 55.0
I
% wllhln Q16ACAMP 20.0% 16.2"'{' 18.2%,
Count 76 73 149
I No Expected Count 78.9 70.1 149.0,
% within Q16ACAMP 47.5% 51.4% 49.3%
~ ---
Count 160 142 302
'Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded)
Pearson Chi-Square .831 (a) 2 .660
Likelihood Ratio .834 2 .659
N 01 Valid Cases 302






Count 52 46 98,
No Answer Expected Count 51.9 46.1 98.0,
% within Q16ACAMP 32.5% 32.4% 32.5%,
Count 20 13 33
'Q7BEXERC Yes Expected Count 17.5 15.5 33.0
,
% within Q16ACAMP 12.5% 9.2% 10.9%
I
Count 88 83 171
No Expected Count 90.6 80.4 171.0
% within Q16ACAMP 55.0% 58.5% 56.6%,.
Count 160 142 302,
Total Expected Count 160.0 142.0 302.0,
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded)
Pearson Chi-Square .929(a) 2 .628
Likelihood Ratio .937 2 .626
N 01 Valid Cases 302




Nominal by Nominal Cramer'a V .055 .628
Contingency Coefficient .055 .628
N of Valid Cases 302
a Not assuming the null hypothesis.






Count 52 46 98,
No Answer Expected Count 51.9 46.1 98.0
% within Q16ACAMP 32.5% 32.4% 32.5%
Count 30 28 58 1
'Q7CEAT Ves IExpected Count I 30.71 27.31 58.0,
% within Q16ACAMP 18.8% 19.7% 19.2%
Count 78 68 146,
No Expected Count n.4 68.6 146.0,
% within Q16ACAMP 48.8% 47.9% 48.3%
Count 160 142 302
,
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 1oo.O"k 100.0%
Icramer's V .013 .976,
IContingency Coefficient .013 .976
N of Valid Cases 302
a Not assuming the null hypothesis.






Count 52 46 98
No Answer Expected Count 51.9 46.1 98.0
% within Q16ACAMP 32.5% 32.4% 32.5%
Count 13 6 19
Q7DALT Ves Expected Count 10.1 8.9 19.0
% within Q16ACAMP 8.1% 4.2% 6.3%
Count 95 90 185
No Expected Count 98.0 87.0 185.0
% within Q16ACAMP 59.4% 63.4% 61.3%
Count 160 142 302
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square .049(a) 2 .976
Likelihood Ratio .049 2 .976
N of Valid Cases 302
a 0 cells (.0%) have expected count less than 5. The minimum expected count is 27.27.
Symmetric Measures
I





Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 2.016(a) 2 .365
Likelihood Ratio 2.070 2 .355
N of Valid Cases 302
a 0 cells (.0%) have expected count less than 5. The minimum expected count is 8.93·1
Symmetric Measures
Value Approx. S19.
Nominal by Nominal Phi .082 .365,
Cramer's V .082 .365
233
IContingency Coefficient I .081 I .365
N of Valid Cases 1 3021
a Not assuming the null hypothesis.






Count 52 46 98
No Answer Expected Count 51.9 46.1 98.0
% within 016ACAMP 32.5% 32.4% 32.5%
Count 2 1 3
07EINCOR Ves Expected Count 1.6 1.4 3.0
% within 016ACAMP 1.3% .7% 1.0%, f--.
Count 106 95 201
No Expected Count 106.5 94.5 201.0,
% within 016ACAMP 66.3% 66.9% 66.6%
Count 160 142 302
Total Expected Count 160.0 142.0 302.0
% within 016ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. 519. (2-slded)
Pearson Chi-Square .231 (a) 2 .891
Likelihood Ratio .236 2 .889
N of Valid Cases 302




Nominal by Nominal Cremer's V .028 .89t,
Contingency Coefficient .891.028
234
N of Valid Cases . nUl' 3021 I
a Not assuming the null hypothesis. I






Count 52 46 98
No Answer Expected Count 51.9 46.1 98.0,
% within 016ACAMP 32.5% 32.4% 32.5%
Count 27 18 45
'07FOTHER Ves Expected Count 23.8 21.2 45.0,
% within 016ACAMP 16.9% t2.7% t4.9%,
Count 81 78 159,
No Expected Count 84.2 74.8 159.0,
% within 016ACAMP 50.6% 54.9% 52.6%
Count 160 142 302
'Total Expected Count 160.0 142.0 302.0,
100.0%1% within 016ACAMP 100.0% 100.0%
Chi-Square Tests
Value df Asymp. 519. (2-slded)
Pearson Chi-Square 1.155(a) 2 .561
Likelihood Ratio 1.163 2 .559
N of Valid Cases 302
a 0 cells (.0%) have expected count less than 5. The m,nimum expected count is 21. t 6.
Symmetric Measures
Phi .062 .561
, Nominal by Nominal Cramer's V .062 .561
1
Contingency Coefficient .561.062
N of Valid Cases 302
a Not assuming the null hypothesis.
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Count 52 46 98
No Answer Expected Count 51.9 46.1 98.0
% within Q16ACAMP 32.5% 32.4% 32.5%
Count 37 51 88
'Q7GNONE Yes Expected Count 46.6 41.4 88.0
% within Q16ACAMP 23.1% 35.9% 29.1%
Count 71 45 116
No Expected Count 61.5 54.5 116.0
% within Q16ACAMP 44.4% 31.7% 38.4%
Count 160 142 302
Total Expected Count 160.0 142.0 302.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value <If Asymp. Slg. (2-slded)
Pearson Chi-Square 7.376(a) 2 .025
Likelihood Ratio 7.408 2 .025
N of Valid Cases 302




,Nominal by Nominal Cramer's V .156 .025
Contingency Coefficient .154 .025
N of Valid Cases 302
236
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis
Attitude-related questions (Ouestions 9-13)
Kruskal-Wallis Test
Ranks



























Q9SUPPLV Q10SIN Q11VCT Q12ADVIS Q13SUPPO
Chi-Square 6.074 5.868 4.603 .280 2.083
<If 2 2 2 2 2
Asymp. Slg. .048 .053 .100 .869 .353
a Kruskal Wallis Test
b Grouping Variable: Q16DRACE
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Mann-Whitney Tests (Question 9)
Mann-Whilney Tests






Asymp. Slg. (2-taIlOO) .698
Ranks
Q16DRACE N Mean Rank Sum of Ranks
White 36 66.42 2391.00







'Asymp. Slg. (2-taIlOO)I .0531
,a Grouping Variable: 016DRACE
Ranks
I Q16DRACE N Mean Rank Sum of Ranks
I Black 156 99.95 15591.50
IQ9SUPPLY While 36 81.57 2936.50
Total 192
Ranks
Q16DRACE N Mean Rank Sum of Ranks
Black 156 135.53 21142.00





Wllcoxon W I 11754.000I
Z I -2.037
: Asymp. Slg. (2-taIlOO) I .042
a Grouping Variable: 016DRACE
Ranks
Q16ACAMP N Mean Rank Sum of Ranks
Westvllle 160 153.11 24498.00
Q9SUPPLY Howard College 142 149.68 21255.00
Total 302
Westvllle 160 146.78 23485.00
Ql0SIN Howard College 142 156.82 22268.00
Total 302
IQllVCT
Westvllle 160 145.20 23232.50
Howard College 142 158.60 22520.50
Total 302
Westvllle 160 151.33 24212.50
Q12ADVIS Howard College 142 151.69 21540.50
Total 302
Westvllle 160 159.03 25445.50
Q13SUPPO Howard College 142 143.01 20307.50
Total 302
238 239
Mann-Whllney U 11102.000 10605.000 10352.500 11332.500 10154.500
WllcoxonW 21255.000 23485.000 23232.500 24212.500 20307.500
Z -.363 -1.367 -1.701 -.041 -1.854
Asymp. Slg. (2-lalled) .716 .172 .089 .968 .064
a Grouping Variable: Q16ACAMP
Chi-Square Tests
I Value cif Asymp. Slg. (2-slded)
Pearson Chi-Square 1.553(a) 2 .460
Likelihood Ralio 1.668 2 .434
N of Valid Cases 285
a 1 cells (16.7%) have expected count less than 5. The minimum expected count is 2.33.




N Percent N Percent N Percent
Q2ATV' Q16DRACE 285 100.0% 0 .0% 285 100.0%
Q2BFRIEN • Q16DRACE 285 100.0% 0 .0% 285 100.0%
Q2CRADIO • Q16DRACE 285 100.0% 0 .0% 285 100.0%
Q2DBILLB • Q16DRACE 285 100.0% 0 .0% 285 100.0%
Q2EPOUT' Q16DRACE 285 100.0% 0 .0% 285 100.0%
Q2FDOC • Q16DRACE 285 100.0% 0 .0% 285 100.0%
Q2GNEWS • Q16DRACE 285 100.0% 0 .0% 285 100.0%
Q2HPOSTE • Q16DRACE 285 100.0% 0 .0% 285 100.0%







Count 141 32 93 266
I
Yes Expected Count 142.8 32.7 90.5 266.0,
% within Q16DRACE 92.2% 91.4% 95.9% 93.3%
,Q2ATV
Count 12 3 4 19,
No Expected Count 10.2 2.3 6.5 19.0
I % within Q16DRACE 7.8% 8.6% 4.1% 6.7%
Count 153 35 97 285,
Total Expected Count 153.0 35.0 97.0 285.0




Nominal by Nominal Cramer's V .074 .460
Contingency Coefficient .074 .460
N of Valid Cases 285
a Not assuming the null hypothesis.






Count 92 26 48 166
Yes Expected Count 89.1 20.4 56.5 166.0
,Q2BFRIEN
% within Q16DRACE 60.1% 74.3% 49.5% 58.2%
Count 61 9 49 119,
No Expected Count 63.9 14.6 40.5 119.0
,
% within Q16DRACE 39.9% 25.7% 50.5% 41.8%
Count 153 35 97 285
'Total Expected Count 153.0 35.0 97.0 285.0









, Nominal by Nominal Cramer's V .128 .098
Contingency Coefficient .127 .098
Value Approx. Slg.
Phi .087 .336
Nominal by Nominal Cramer's V .087 .336
Contingency Coefficient .087 .336
N of Valid Cases 285
a Not assuming the null hypothesis.






Count 31 6 30 67
Yes Expected Count 36.0 8.2 22.8 67.0
Q2DBILLB
% within Q16DRACE 20.3% 17.1% 30.9% 23.5%
Count 122 29 67 218
No Expected Count 117.0 26.8 74.2 218.0
% within Q16DRACE 79.7% 82.9% 69.1% 76.5%
Count 153 35 97 285
Total Expected Count 153.0 35.0 97.0 285.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-sided)
Pearson Chi-Square 4.655(a) 2 .098
Likelihood Ratio 4.561 2 .102
N of Valid Cases 285













,Nominal by Nominal Cramer'sV .157 .030
Contingency Coefficient .155 .030
N of Valid Cases 285






Count 132 27 79 238
Yes Expected Count 127.8 29.2 81.0 238.0
,Q2CRADIO
% within Q16DRACE 86.3% 77.1% 81.4% 83.5%
Count 2t 8 18 47,
No Expected Count 25.2 5.8 16.0 47.0
I % within Q16DRACE 13.7"10 22.9% 18.6% 16.5%
Count 153 35 97 285
Total Expected Count 153.0 35.0 97.0 285.0
I % within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Likelihood Ratio
N of Valid Cases
a 0 cells (.0%) have expected count less than 5. The minimum expected count is 5.77.1
Value elf Asymp. Slg. (2-slded)
Pearson Chi-Square 2.180(a) 2 .336
Likelihood Ratio 2.124 2 .346
N of Valid Cases 285 1,
242 243
N of Valid Cases 1 2851 Q2FDOC * Ql6DRACE
a Not assuming the null hypothesis.





Count 86 18 39 143
I
Ves Expected Count 76.8 17.6 48.7 143.0,
,Q2EPOLlT
% within Q16DRACE 56.2% 51.4% 40.2% 50.2%
Count 67 17 58 142
No Expected Count 76.2 17.4 48.3 142.0
I
% within Q16DRACE 43.8% 48.6% 59.8% 49.8%
Count 153 35 97 285
I
Total Expected Count 153.0 35.0 97.0 285.0
I
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 6. 106(a) 2 .047
Likelihood Ratio 6.136 2 .047
N of Valid Cases 285




Nominal by Nomlnll eramer's V .146 .047,
Contingency Coefficient .047.145
N of Valid Casei 285
a Not assuming the null hypothesis.







Count 88 7 44 139
Ves Expected Count 74.6 17.1 47.3 139.0
% within Q16DRACE 57.5% 20.0% 45.4% 48.8%
Q2FDOC
Count 65 28 53 146
No Expected Count 78.4 17.9 49.7 146.0
I % within Q16DRACE 42.5% 80.0% 54.6% 51.2%
Count 153 35 97 285
ITolel Expected Count 153.0 35.0 97.0 285.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
I
Value df Asymp. Slg. (2-slded)
Pearson Chi-Square 16.731 (a) 2 .000
Likelihood Ratio 17.627 2 .000
N of Valid Cases 285




Nominal by Nominal Cramer's V .242 .000
I
Contingency Coefficient .235 .000
N of Valid Cases 285
a Not assuming the null hypothesis.




lIT Q16DRACE IIndian TotalBlack White
Count 121 28 86 235
Ves Expected Count 126.2 28.9 80.0 235.0
Q2GNEWS
% within Q16DRACE 79.1% 80.0% 88.7"10 82.5%
Count 32 7 11 50
No Expected Count 26.8 6.1 17.0 50.0
% within Q16DRACE 20.9% 20.0% 11.3% 17.5%
Count 153 35 97 285
Total Expected Count 153.0 35.0 97.0 285.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value dl Asymp. Slg. (2-slded)
Pearson Chi-Square 3.929{a) 2 .140
Likelihood Ratio 4.165 2 .125
IN 01 Valid Cases 285




Nominal by Nominal Cramer's V .117 .140
Contingency Coefficient .117 .140
N 01 Valid Cases 285
a Not assuming the null hypotheSis.





Q2HPOSTE Ves Count 54 8 33 95
246
I
Expected Count 51.0 11.7 32.3 95.0
,
% within Q16DRACE 35.3% 22.9% 34.0% 33.3%,
Count 99 27 64 190,
No Expected Count 102.0 23.3 64.7 190.0,
% within Q16DRACE 64.7% 77.1% 66.0% 66.7%
Count 153 35 97 285
Total Expected Count 153.0 35.0 97.0 285.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value dl Asymp. Slg. (2-slded)
IPearson Chl-Squere 2.014{a) 2 .365
Likelihood Ratio 2.128 2 .345
'N 01 Valid Cases 285




Nominal by Nominal Cramer's V .084 .365,
Contingency Coefficient .084 .365
N 01 Valid Cases 285 ,
a Not assuming the null hypothesis.






Q210THER Count 12 3 4 19
Ves Expected Count 10.2 2.3 6.5 19.0
% within Q16DRACE 7.8% 8.6"10 4.1% 6.7"10
No Count 141 32 93 266
Expected Count 142.8 32.7 90.5 266.0
247




,Nominal by Nominal Cramer's V .131 .024,
Contingency Coefficient .130 .024





Count t48 126 274
Yes Expected Count 143.0 131.0 274.0
Q2ATV
% within Q16ACAMP 96.1% 89.4% 92.9%
Count 6 15 21
No Expected Count 11.0 10.0 21.0
% within Q16ACAMP 3.9% 10.6% 7.1%
Count 154 141 295
Total Expected Count 154.0 141.0 295.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (l-slded)
Pearson Chi-Square 5.061 (b) 1 .024
Continuity Correctlon(a) 4.092 1 .043
Likelihood Ratio 5.180 1 .023
Fisher's Exact Test .039 .021
N of Valid Cases 295
a Computed only for a 212 table




N Percent N Percent N Percent
Q2ATV • Q16ACAMP 295 100.0% 0 .0% 295 100.0%
Q2BFRIEN • Q16ACAMP 295 100.0% 0 .0% 295 100.0%
Q2CRADIO' Q16ACAMP 295 100.0% 0 .0% 295 100.0%
Q2DBILLB • Q16ACAMP 295 100.0% 0 .0% 295 100.0%
Q2EPOUT • Q16ACAMP 295 100.0% 0 .0% 295 100.0%
Q2FDOC' Q16ACAMP 295 100.0% 0 .0% 295 100.0%
Q2GNEWS • Q16ACAMP 295 100.0% 0 .0% 295 100.0%
Q2HPOSTE • Q16ACAMP 295 100.0% 0 .0% 295 100.0%




Nominal by Nominal Cramer'sV .074 .460
Contingency Coefficient .074 .460
N of Valid Cases 285
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.
I I % within Q16DRACE 92.2% 91.4% 95.9% 93.3%
Count 153 35 97 265
Total Expected Count 153.0 35.0 97.0 265.0
I % within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Slg. (2-slded)
Pearson Ch'-Square 1.553(a) 2 .460
Likelihood Ratio 1.668 2 .434
N of Valid Cases 285
a 1 cells (16.7%) have expected count less than 5. The minimum expected count is 2.33.








Count 83 92 175
Ves Expected Count 91.4 83.6 175.0
,Q2BFRIEN
% within Q16ACAMP 53.9% 65.2% 59.3%
Count 71 49 120
No Expected Count 62.6 57.4 120.0,
% within Q16ACAMP 46.1% 34.8% 40.7%
Count 154 141 295,
Totel Expected Count 154.0 141.0 295.0,
% within Q16ACAMP 100.0% 100.0% 100.0%
Chl-Squsre Tests
I Velue df Asymp. Slg. (2-slded) Exect Slg. (2-slded) Exect Slg. (1-slded)
Peerson Chl-Squere 3.931 (b) 1 .047
Continuity Correctlon(e) 3.475 1 .062
Likelihood Retlo 3.946 1 .047
Asher's exect Test .058 .031
N of Velld Ceses 295
a Computed only for a 2x2 table




Nomlnel by Nomlnel Cremer's V .115 .047
I
Contingency Coefficient .115 .047
N of Velld Ceses 295
a Not assuming the null hypothesis.








Count 137 105 242
I
Ves Expected Count 126.3 115.7 242.0
!Q2CRADIO
% within Q16ACAMP 89.0% 74.5% 82.0%
Count 17 36 53
I
No Expected Count 27.7 25.3 53.0
% within Q16ACAMP 11.0% 25.5% 18.0%
Count 154 141 295
Totel Expected Count 154.0 141.0 295.0
I % within Q16ACAMP 100.0% 100.0% 100.0%
Chl-Squere Tests
Velue df Asymp. Slg. (2-slded) Exect Slg. (2-slded) Exact Slg. (1-slded)
Peerson Chl-Squere 10.490(b) 1 .001
Continuity Correctlon(e) 9.530 1 .002
Likelihood Retlo 10.636 1 .001
Asher's Exect Test .001 --~
:N of Velld Ceses I 2951 I I J I
a Compuled only for a 2x2 table I




I Nomlnel by Nomlnel Cremer's V .189 .001
I
Contingency Coefficient .185 .001
N of Velld Ceses 295
a Not assuming the null hypothesis.






Count 39 29 68
Ves Expected Count 35.5 32.5 68.0
Q2DBILLB
% within Q16ACAMP 25.3% 20.6% 23.1%
Count 115 112 227
No Expected Count 116.5 106.5 227.0
I % within Q16ACAMP 74.7% 79.4% 76.9%
ITotal
Count 154 141 295
Expected Count 154.0 141.0 295.0
% within Q16ACAMP 100.0% 100.0"10 100.0%
Chi-Square Tests
Value df Asymp. S19. (2-slded) Exacl S19. (2-slded) Exact S19. (l-slded)
Pearson Chi-Square .939(b) 1 .332
Continuity Correctlon(a) .690 1 .406
Likelihood Ratio .943 1 .332
Fisher's Exacl Test .407 .203
N of Valid Cases 295
a Computed only for a 2x2 table I




Nominal by Nominal Cramer's V .056 .332,
Contingency Coefficient .056 .332
N of Valid Cases 295
a Not assuming the null hypothesis.






Counl 61 67 146
Ves Expected Count 77.3 70.7 146.0
,Q2EPOLIT
% wllhln Q16ACAMP 52.6% 47.5% 50.2%
Counl 73 74 147,
No Expected Count 76.7 70.3 147.0,
% within Q16ACAMP 47.4% 52.5% 49.6%
Count 154 141 295,
Total Expected Count 154.0 141.0 295.0
% wllhln Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. S19. (2-slded) Exact S19. (2-slded) Exact S19. (l-slded)
Pearson Chi-Square .760(b) 1 .363
Continuity Correctlon(a) .570 1 .450
Likelihood Ratio .760 1 .363
Fisher's Exact Tesl .415 .225
N of Valid Cases 295
a Computed only for a 2x2 table





, Nominal by Nominal Cramer'sV .051 .363,
Contingency Coenlclent .363.051
N of Valid Cases 295 ,
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.
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I Count 93 50 143
Ves Expected Count 74.7 68.3 143.0
IQ2FDOC
% within Q16ACAMP 60.4% 35.5% 48.5%
Count 61 91 152
No Expected Count 79.3 72.7 152.0
I % within Q16ACAMP 39.6% 64.5% 51.5%
Count 154 141 295
1Total Expected Count 154.0 141.0 295.0






Count 132 113 245,
Ves Expected Count 127.9 117.1 245.0
i
% within Q16ACAMP 85.7% 80.1% 83.1%
!Q2GNEWS
Count 22 28 50,
No Expected Count 26.1 23.9 SO.O,
% within Q16ACAMP 16.9%14.3% 19.9%
Count 154 141 295
'Total Expected Count t54.0 141.0 295.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (l-slded)
Pearson Chi-Square 1.624(b) 1 .203
Continuity Correctlon(a) 1.252 1 .263
likelihood Ratio 1.624 1 .203
Fisher's Exact Test .217 .132
N of Valid Cases 295
a Computed only for a 2x2 table
b 0 cells (.0%) have expected countless than 5. The minimum expected count is 23.90.
N of Valid Cases I 2951 I I I I
a Computed only for a 2>2 table I
b 0 cells (.0%) have expected countless than 5. The minimum expected count is 68.35. I
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded) Exact Slg. (2-elded) Exact Slg. (l-slded)
Pea.son Chi-Square 18.314(b) 1 .000
Continuity Correctlon(a) 17.329 1 .000
likelihood Ratio 18.519 1 .000




Nominal by Nominal Cramer's V .249 .000
Contingency Coefficient .242 .000
N of Valid cases 295
a Not assuming the null hypothesis.




, Nominal by Nominal eramer's V .074 .203,
Contingency Coefficient .074 .203
N of Valid Cases 295
a Not assuming the null hypothesis.






Count 56 41 97
I
Ves Expected Count 50.6 46.4 97.0,
,Q2HP05TE
% within Q16ACAMP 36.4% 29.1% 32.9%
Count 98 100 198,
No Expected Count 103.4 94.6 198.0
i
% within Q16ACAMP 63.6% 70.9% 67.1%
Count 154 141 295
'Total Expected Count 154.0 141.0 295.0,
100.0%1% within Q16ACAMP 100.0% 100.0%
Chl-Squans Tests
I Value d1 Asymp. 51g. (2-slded) Exact 51g. (2-slded) Exact 51g. (l-slded)
IPearson Chl-Squans 1.770(b) 1 .183
IContinuity Correctlon(a) 1.456 1 .228
ILikelihood Ratio 1.776 1 .183
IFisher's Exact Test .215 .114
IN of Valid Cases 295
a Computed only for a 2x2 table




Nominal by Nominal Cramer's V .077 .183
Contingency Coefficient .077 .183
N of Valid Cases 295
a Not assuming the null hypothesis.







Count 10 11 21,
Ves Expected Count 11.0 10.0 21.0,
IQ210THER
% within Q16ACAMP 6.5% 7.8% 7.1%
Count 144 130 274
I
No Expected Count 143.0 131.0 274.0
1
% within Q16ACAMP 93.5% 92.2% 92.9%
Count 154 141 295,
Total Expected Count 154.0 141.0 295.0,
100.0% 100.00101% within Q16ACAMP 100.0010
Chi-Square Tests
Value d1 Asymp. 51g. (2-slded) Exact 51g. (2-slded) Exact 51g. (l-slded)
Pearson Chl-Squans .190(b) 1 .663
Continuity Correctlon(a) .044 1 .834
Likelihood Ratio .190 1 .663
Asher's Exact Test .821 .416
N of Valid Cases 295
a Computed only for a 2x2 table




,Nominal by Nominal Cramer'a V .025 .663
I
Contingency Coefficient .025 .663
N of Valid Cases 295
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.
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N IPercent N IPercent N IPercent





Count 146 35 97 278
Yes Expected Count 148.7 34.0 95.3 278.0
Q151NFO
% within Q16DRACE 95.4% 100.0% 99.0% 97.2%
Count 7 0 1 8
No Expected Count 4.3 1.0 2.7 8.0
I % within Q16DRACE 4.6% .0% 1.0% 2.8%
iTotal
Count 153 35 98 286
Expected Count 153.0 35.0 98.0 286.0
% within Q16DRACE 100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
I Value d1 Asymp. Slg. (2-slded)
Pearson Chi-Square 3.924(a) 2 .141
Likelihood Ratio 4.981 2 .083
N of Valid Cases 286




I Nominal by Nominal Cramer's V .117 .141
Contingency Coefficient .116 .141
N of Valid Cases 286
a Not assuming the null hypothesis.
b Using the asymptotic standard error assuming the null hypothesis.
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QI5INFO· Q16ACAMP






Count 150 137 287
Yes Expected Count 150.3 136.7 287.0,
,Q151NFO
% within Q16ACAMP 96.8% 97.2% 97.0%
Count 5 4 9
I
No Expected Count 4.7 4.3 9.0
I
I % within Q16ACAMP 3.2% 2.8% 3.0%
Count 155 141 296
ITolal Expected Count 155.0 141.0 296.0
% within Q16ACAMP 100.0% 100.0% 100.0%
Chi-Square Tests
Value d1 Asymp. Slg. (2-slded) Exact Slg. (2-slded) Exact Slg. (I-sided)
Pearson Chi-Square .038(b) 1 .846
Continuity Correctlon(a) .000 1 1.000
Likelihood Ratio .038 1 .845
FIsher's Exact Test 1.000 .559
N of Valid Cases 296
a Computed only for a 2x2 table




,Nominal by Nominal Cramer's V .011 .846,
Contingency Coefficient .011 .846
N of Valid Cases 296
a Not assuming the null hypothesis.
259
b Using the asymptotic standard error assuming the null hypothesis.
Significance Tests: notes
I) For the chi-square test, it is assumed that expected frequencies for each category should be at
least I. Also, no more than 20% of categories should have expected frequencies less than 5. In
order to fulfil these conditions, for some variables it has been necessary to filter out the category
"no answer" (using the "select cases" option). For other variables, the expected counts in some
cells are simply too few to fulfil these conditions. In these cases the chi-square tests have still
been used and reported in an attempt to reveal broad trends, but it should be noted that bigger
samples would be necessary for more valid results. Footnotes generated by SPSS indicate which
variables have more than 20% of categories with expected categories less than 5.
2) When significance tests have been used to search for statistically significant relationships
between dependant variables and race, only the Black, White and Indian race-groups have been
tested. This is due to the very small numbers of Coloured and Other students who participated in
the study. In the case of chi-square tests, these latter two race groups have been fJ..ltered out.
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